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Abstract 
A lessor understood co-chaperone, the Hsp70/Hsp90 organising protein (Hop), has been 
found to play an important role in modulating the activity and co-interaction of two 
essential chaperones; Hsp90 and Hsp70. The best understood aspects of Hop so far 
indicate that residues in the concave surfaces of the three tetratricopeptide repeat (TPR) 
domains in the protein bind selectively to the C-terminal motifs of Hsp70 and Hsp90. 
Recent research suggests that P. falciparum Hop (PfHop), PfHsp90 and PfHsp70 do 
interact and form complex in the P. falciparum trophozooite and are overexpressed in this 
infective stage. However, there has been almost no computational research on malarial 
Hop protein in complex with other malarial Hsps.The current work has focussed on several 
aspects of the in-silico characterisation of PfHop, including an in-depth multiple sequence 
alignment and phylogenetic analysis of the protein; which showed that Hop is very well 
conserved across a wide range of available phyla (four Kingdoms, 60 species). Homology 
modelling was employed to predict several protein structures for these interactions in P. 
falciparum, as well as predict structures of the relevant TPR domains of Human Hop 
(HsHop) in complex with its own Hsp90 and Hsp70 C-terminal peptide partners for 
comparison. Protein complex interaction analyses indicate that concave TPR sites bound to 
the C-terminal motifs of partner proteins are very similar in both species, due to the 
excellent conservation of the TPR domain’s “double carboxylate binding clamp”. Motif 
analysis was combined with phylogenetic trees and structure mapping in novel ways to 
attain more information on the evolutionary conservation of important structural and 
functional sites on Hop. Alternative sites of interaction between Hop TPR2 and Hsp90’s M 
and C domains are distinctly less well conserved between the two species, but still 
important to complex formation, making this a likely interaction site for selective drug 
targeting. Binding and interaction energies for all modelled complexes have been 
calculated; indicating that all HsHop TPR domains have higher affinities for their 
respective C-terminal partners than do their P. falciparum counterparts. An alternate motif 
corresponding to the C-terminal motif of PfHsp70-x (exported to the infected erythrocyte 
cytosol) in complex with both human and malarial TPR1 and TPR2B domains was 
analysed, and these studies suggest that the human TPR domains have a higher affinity for 
this motif than do the respective PfHop TPR domains. This may indicate potential for a 
cross species protein interaction to take place, as PfHop is not transported to the human 
erythrocyte cytosol.  
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Chapter 1: Introduction and Literature Review 
1.1 Malaria 
Malaria is a febrile illness caused by parasites of the apicomplexa phylum (Alberts et al., 
2002), primarily by five species of parasites of the genus Plasmodium that affect humans 
(P. falciparum, P. vivax, P. chabaudi, P. yoeleii (Alberts et al., 2002) and the more 
recently discovered P. knowlesi (WHO: Global Malaria Programme, 2011). Malaria 
contracted from P. falciparum is the most deadly (cerebral infection), and it predominates 
in Africa. P. vivax is less dangerous but more widespread and the other three species are 
found much less frequently (Alberts et al., 2002). The malaria-causing protist is 
transmitted to humans (primary host) exclusively through the bite of malaria-infected, 
pregnant female mosquitoes (vector hosts) of any of 60 Anopheles species (Alberts et al., 
2002). 
In 2010, there were approximately 216 million reported cases of malaria and an estimated 
655 000 deaths (WHO: Global Malaria Programme, 2011). The worldwide death rates due 
malaria have been reported to have decreased by approximately 25% since 2000, and by 
33% in the WHO African Region, however it was estimated that 3.3 billion people were at 
risk of contracting malaria at any one time in 2010. In that year, with an estimated 81% of 
cases and 91% of all malaria related deaths in all geographic regions, the WHO African 
Region populations were at the highest risk of acquiring malaria. Pregnant women and 
children younger than five years have been the most severely affected; the disease is 
responsible for approximately 22% of all childhood deaths (WHO: Global Malaria 
Programme, 2011). 
1.2 Parasite Life Cycle 
The malaria-causing protist is transmitted to humans (primary host) exclusively through 
the bite of malaria-infected, pregnant female mosquitoes (vector hosts) of any of 60 
anopheles species (Alberts et al., 2002). P. falciparum exists in at least 8 distinct forms, 
requiring both the human and mosquito hosts to complete its sexual cycle (Alberts et al., 
2002). Gametes are formed in the blood stream of the human host but can only fuse to 
form a zygote in the gut of the anopheles mosquito. The greatest challenges facing the 
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parasite during human infection are overcoming change in temperature and pH from 
mosquito midgut to the human bloodstream (Alberts et al., 2002).  
The mosquito midgut environment, which is approximately ambient and pH 8.5-9.5 
respectively, is so basic due to the increase in pH observed during digestion of a blood 
meal, resulting in conversion of carbon dioxide to bicarbonate via carbonic anhydrase 
activity (Corena et al., 2005). This activity is essential to parasite development as it helps 
to induce gametogenesis of Plasmodium parasites (del Pilar Corena et al., 2005).On the 
other hand, the mature red blood cell is a characteristically nutrient poor environment, but 
the modification of the parasite-infected cell allows the red-blood cells to become 
permeable to influx of small molecules (via diffusion), making this environment consistent 
with the surrounding blood plasma, (37°C and pH 7.34). 
In the human body, the malaria parasite migrates to the liver to invade hepatocytes, where 
it develops through the ‘ring’ and trophozoite stages, then divides to form an average of 20 
daughter cells in the schizont stage, which in turn go on to infect red blood cells (Tilley, 
Dixon, & Kirk, 2011).This makes it unique in contrast to a number of other intracellular 
parasites which invade the nucleated, metabolically active cells that allow easy access to 
cellular ingredients provided by the host cell (Charpian et al., 2008). 
Thus the parasite, trapped within the red blood cell must find its own way to access 
nutrients from the extracellular environment (i.e. the blood plasma). To deal with these 
constraints, the parasite has developed cryptic methods of transporting a number of select 
proteins (critical for mediating functions such as nutrient acquisition, cytoadherance and 
evasion of the human immune system) to the host erythrocyte cytoplasm and 
plasmalemma. It does this, for reasons that are still not completely understood, by inducing 
the formation of a parasitophorous vacuole (see Figure 1.1), creating a compartment within 
the red blood cell, enclosed by the parasitophorous vacuole membrane (PVM) (Charpian et 
al., 2008). 
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Figure 1.1: The parasitic vacuole system of malaria in a red blood cell. PPM and PVM 
are the parasite plasma membrane and parasitophorous vacuole membrane, respectively. 
In order to acquire nutrients for parasitic growth, proteins must cross both the parasite 
plasma membrane (PPM) and the PVM. It has been indicated that transported parasite 
proteins contain short peptide sequences, such as the PEXEL (Plasmodium export 
element) motif, that seems to direct traffic of many soluble and membrane proteins to the 
infected erythrocyte by means as yet to be elucidated (Charpian et al., 2008). However, 
there are other proteins that do not possess these PEXEL (or similar) motifs that have been 
found to be transported to the host cytosol. An example of this is a P. falciparum heat-
shock protein 70 variant (PfHsp70-x), which was characterised in-silico, found not to 
possess this PEXEL motif (Hatherley, 2012) and its transport to the host cytosol was 
recently determined experimentally (Kulzer et al, 2012).  
1.3 Malaria Treatment and Drug Resistance 
The biggest problem for traditional treatment of malaria with chloroquine and other more 
recently used drug combinations is the development of drug resistance in the parasite. 
Resistant P. falciparum strains have been found to overexpress an ABC transporter 
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membrane protein in the presence of chloroqine, which actively pumps the drug out of the 
parasite cell (Alberts et al., 2002). As such, the search for new drug targets is ongoing. 
Heat shock proteins (Hsps) seem to be a good choice, as they assist the parasite in coping 
during the transferral from mosquito midgut environment to the human bloodstream and 
may even play a role in helping the parasite to develop resistance (Gitau et al, 2012).  Most 
Hsps are well conserved across taxa, so human and P. falciparum proteins are very similar. 
This may cause problems for selective drug targeting but also safeguards against 
developing resistance, as the genes expressing Hsps are less likely to mutate. 
1.4 Heat Shock Proteins 
The malaria parasites’ Hsps are responsible for several of its key biological mechanisms. 
Most important is the thermo-protective, primary chaperone function, assisting the parasite 
to survive the transition from mosquito midgut to the human bloodstream, and then 
adaptation to two different cellular environments; mature erythrocytes and hepatocytes 
(Shonhai, 2010). Correct transmembrane export unfolding and refolding (Charpian et al., 
2008) is critical to the parasites pathogenicity and allows it to survive the relatively 
nutrient and protein poor environment of the red blood cell (Charpian et al., 2008; 
Shonhai, 2010). This allows facilitating parasite interorganelle protein trafficking and 
regulation of parasite growth, infectivity and pathogenicity (Shonhai, 2010). 
1.5 Hsp70/Hsp90 Organising Protein (Hop) 
Through several years of research and analyses inyeast, the Hsp90 complex, including 
Sti1/Hop,is classified as a stress-inducible chaperone complex (Albanèse et al., 2006). Hop 
was first mentioned in 1986 and 1989 (Giordano et al., 1989) where a 62kD protein was 
immunoprecipitated with E1A protein and other heat shock proteins in adenovirus infected 
cells. It was isolated and characterised in yeast as Sti1 – Stress Inducible protein 1 (Nicolet 
& Craig, 1989). It was first identified in human as IEF SSP 3521, as it was over expressed 
after simian 40 virus transformation (Honore et al., 1992). It has also been described as 
p60 in aves (Smith et al., 1993). It has since been predicted from several species’ genomes 
(Odunuga, Longshaw, & Blatch, 2004) and was  recently characterised in P. Falciparum 
(Gitau et al., 2012). 
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1.5.1 Intracellular Localization of Hop 
 
The distribution of Hop in the cell, as well as in the body seems to be extremely 
widespread. It has been found to have a primarily cytoplasmic distribution in mouse cells 
(Lässle et al., 1997). However, approximately 6% of the cellular fraction is thought to be 
associated with the Golgi apparatus and vesicles (Honore et al., 1992), cell surface 
(Martins et al., 1997; Zanata et al., 2002) and within the membrane fraction (Mehrpour et 
al.,2010; Sakadu et al., 2005). Certain conditions including G1/S arrest et al., 2004) and 
heat-shock or treatment with leptomycin B promote nuclear localization in mouse, and two 
nuclear localisation signals have been identified in the HsHop protein sequence (Daniel et 
al., 2008). Both mouse Hop and HsHop have also been reported to be recruited to stress 
granules along with several other cochaperones (Lapointe, Lasko, & Hobman, 2009). 
1.5.2 Extracellular Localization of Hop 
There is a large amount of evidence to suggest that Hop is externally localised, primarily 
in the mammalian brain tissue. However, there is also some research being done on Hop 
secretion by other tissue culture cells in mice (Eustace & Jay, 2004; Lima et al., 2007) and 
ovarian cancer cells in humans (Wang et al., 2010). Hsp90 complex secreted with co-
chaperones p23, Hop, Hsp70 and Hsp40 increases the ATP-independent activation of 
matrix metalloproteinase 2 (MMP-2) in a breast cancer cell-line (Sims, McCready, & Jay, 
2011). Proteins of the MMP family are involved in the breakdown of extracellular matrix 
important for normal physiological processes, such as embryonic development, 
reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and 
metastasis (Devarajan et al., 1992). 
Extracellular Hop may be able to differentiate between normal glial cells and glioma (brain 
or spinal tumour cells), as it stimulates the proliferation of only glioma through activation 
of the MAPK (Americo et al., 2007) and PI3K pathways in mice and rats (Erlich et al., 
2007). Intra-hippocampal infusion of antibodies to Hop have been found to impair memory 
in rats, hence the interest in this protein for Alzheimers research (Coitinho et al., 2007). In 
mice, it has been found that there is a prion protein (PrPc) interacting peptide of Hop 
secreted by astrocytes (Lima et al., 2007) that confers neuroprotection (Romano et al., 
2007; Zanata et al., 2002), dependent on interaction with and activation of certain kinases 
(Lopes et al., 2005). PrPc-dependent stimulation of translation by Hop has been found to 
be mediated by mTOR signalling, which is in turn activated by several cell processes of 
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interest to disease related research; tumor formation and angiogenesis, insulin resistance, 
adipogenesis and T-lymphocyte activation (Roffé et al., 2010). Hop also modulates 
activity of α7 nicotinic acetylcholine receptor for which PrPc may act as receptor or co-
receptor in mice (Roffé et al., 2010). Additionally, Hop:PrPccomplex formation may play a 
role in neurosphere formation in mice, and thus promote neural stemness (Weiss & Dos 
Santos, 2009).  
 
1.5.3 Hsp90 Chaperone Suite and the Role of Hop 
In an overview of two models for Hsp chaperone complex functioning recently put 
forward by Southworth and Agard (2011) and Schmid et al. (2012), yeast Hop (ScHop) 
first binds to an Hsp90 dimer, stabilizing the Hsp90 client-loading conformation by 
inhibiting ATP binding. Hop consists of a TPR1, DP1, TPR2A, TPR2B and DP2 region 
(see Figure 1.2). The TPR1–DP1 fragment is connected by a long flexible linker region to 
the rigid TPR2A–TPR2B block (Schmid et al., 2012). The DP2 domain is linked to 
TPR2B by another short linker region.  
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Figure 1.2: Simplistic overview of the Hsp90:Hop:Hsp70:client chaperone suite 
formation, adapted from Southworth & Agard (2012).A) Hsp90 homodimer in relaxed, 
open conformation. B) One of the Hsp90 C-terminal EEVD peptides in the Hsp90 
homodimer bind TPR2A while the Hsp90-M domain interacts with TPR2B, inhibiting 
Hsp90 ATPase activity. C) Hsp70:client complex then binds to TPR1, via the C-terminal 
EEVD motif on Hsp70. D) Hsp70 and client are transferred to TPR2B. E) Client is 
transferred to the Hsp90’s hydrophobic, homodimer cleft and Hsp70 releases. F) Hop 
releases, allowing ATP to bind and processing of the client protein by Hsp90. The cycle is 
completed after ATP hydrolysis and release of ADP and the activated client occurs, and 
Hsp90 returns to the relaxed open state in A. 
In the Hsp90:Hop complex, one of the Hsp90 C-terminals in the Hsp90 homodimer binds 
the concave surface of TPR2A while the Hsp90-M domain interacts with the covex surface 
of TPR2B (see Figure 1.2 A and B), leading to the inhibition of the Hsp90 ATPase 
(Southworth & Agard, 2011a). The Hsp70:client complex then binds, owing to higher 
affinity, Hsp70 C-terminal is initially bound to TPR1 and it is thought that DP1 may 
stabilize the bound client (Schmid et al., 2012), interacting with Hop and Hsp90 (see 
Figure 1.2 C). Subsequently, Hsp70 and client are transferred to TPR2B–DP2 (Figure 1.2 
D) which facilitates the release of the client protein to hydrophobic residues in the Hsp90 
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interdimer cleft (Southworth and Agard, 2011). From this position, the client is then 
transferred to Hsp90. Once Hop and Hsp70 are released, and ATP can bind Hsp90, the 
Hsp90 N-Terminal domains dimerize, forming the closed state represented in Figure 1.2 F.  
Previous studies on this mechanism of the ATPase inhibition suggest that the closed Hsp90 
does not entirely enclose its client proteins but provides a bipartite binding surface whose 
formation and inhibition are coupled to the chaperone ATPase cycle (Ali et al., 2006).The 
cycle is completed after ATP hydrolysis and release of ADP and the activated client, and 
Hsp90 returns to a relaxed open state in Figure 1.2 A (Southworth &Agard, 2011). 
1.5.4 In-depth Review of the Structure of Hop 
A peer-reviewed overall structure for Hop has not been published to the Protein Data Bank 
(PDB) for any species as yet, however there have been multiple studies done to discern 
Hsp70:Hop and Hsp90:Hop complex structure (Lee, Graf, Mayer, Richter, & Mayer, 
2012a; Romano et al., 2009; Schmid et al., 2012; Southworth & Agard, 2011a). These 
studies have isolated and determined several domains, whose individual structures have 
been solved via X-ray crystallography,nuclear magnetic resonance (NMR) and cryogenic 
electron microscopy (Cryo-EM) experiments. 
1.5.5 Three TPR Domains 
There are three, well-conserved and very similar functional Tetricopeptide Repeat (TPR) 
domains (Lee et al., 2012); TPR1 and the tightly linked TPR2A and TPR2B in both yeast 
and human Hop (see Table 1.2). The N-terminal TPR region (TPR1) bindsthe EEVD C-
terminal Hsp70 peptide motif (Chen et al., 1996; Lässle et al.,1997; Chen and Smith, 1998; 
van Der Spuy et al., 2000) and Hsp104 (Abbas-Terki et al., 2001);  the TPR2B domain 
also binds the EEVD C-terminal residues of Hsp70, as well as the Hsp90 M domain 
(Scheufler et al., 2000; Southworth & Agard, 2011a) and the TPR2A domain binds the 
MEEVD C-terminal residues of Hsp90 (see Figures1.2 and 1.3). 
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Table 1.1: TPR regions involved in the functioning of Hop. 
Complex 
and 
Organism 
Image Contact Residues PDB ID and 
Reference 
Hsp90 
Mdomain and 
TPR2A&B 
Yeast 
 In the complex, TPR2A 
is oriented towards the 
C-terminal part of 
Hsp90-M directly 
contacting the outside 
of Hsp90-M only with 
residues of helix 7 
(residues 368–374).  
 Unpublished  
structure  
produced by 
homology 
modelling 
(Schmid et al., 
2012) 
Hsc70 c-
terminal and 
TPR2A 
Yeast 
 Lys- 301 and Asn-298 
Lys-229, Asn-233, and 
Asn-264, Arg-305 
 
3ESK (Kajander 
et al., 2009) 
Hsp90 c-
terminal and 
TPR2A 
Human 
 Lys 229, Asn 233, Asn 
264, Lys 301, and Arg 
305 
1ELR (Scheufler 
et al., 2000) 
Hsc70 c-
terminal and 
TPR1 
Human 
 Lys 8, Asn 12, Asn 43, 
Lys 73, and Arg 77 
 
1ELW (Scheufler 
et al., 2000) 
Hsp70 c-
terminal and 
TPR2B 
Yeast 
 Lys 229, Asn 233, Asn 
264, Lys 301, Arg 305,  
3UPV (Schmid et 
al., 2012) 
Hsp90 C-
terminal and 
Hsp70 C-
terminal and 
TPR2A&B 
Yeast 
 See Figure 1.3. 3UQ3 (Schmid et 
al., 2012) 
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Figure 1.3: Concave surface interaction in ScHopTPR2 A) TPR2A, showing active 
residues forming the binding site with C-terminal MEEVD motif in Hsp90. B) TPR2B, 
showing active residues forming the binding site with C-terminal EVD motif in Hsp90 
(images produced in Discovery Studio Visualizer–Accelrys Inc., 2009). 
This EEVD motif has a general pI of 3.4247. However there is an isoform of PfHsp70 
(PfHsp70-x (Hatherley, 2012)) that significantly differs itself from human, yeast and three 
other PfHsp70 isoforms by instead possessing, among other anomalous features, a C-
terminal EEVN Motif, which possesses a general pI of 3.6136 (calculated in MATLAB, 
using the bioinformatics toolkit). This may indicate a functionally significant difference 
between HsHsp70:HsHop binding and PfHsp70-x:PfHop binding. 
1.5.6 Two DP Domains 
The Hop protein possesses two structurally similar domains; DP1, which lies between 
TPR1 and TPR2A; and DP2, positioned between TPR2B and the C-terminal end of Hop 
(Schmid et al., 2012). The alignment for these domains in yeast is displayed in Figure 1.4. 
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Figure 1.4: Global alignment of the sequence data for PDB entries 2llw and 2llv. 
The DP regions are so-called owingto the well conserved DP (Aspartic acid and Proline) 
repeats within these structures (Odunuga et al., 2004; Schmid et al., 2012). Recent 
structural studies in yeast show that DP domains and especially the DP2 domains are 
important for Hsp90 client processing in yeast (Schmid et al., 2012).  The NMR crystal 
structures associated with this study are shown below (viewed in PyMOL, Figure 1.5): 
 
Figure 1.5: The superposed, 21 NMR solution models for ScHopDP domains. A) DP1 
(PDB entry: 2LLV) and B) DP2 (PDB entry: 2LLW). The models appear to be in good 
agreement for DP1. DP2 models were also in good agreement, but more flexible. 
From Figure 1.5, it is not plain to see, but DP2 is comprised of five helices, forming an 
elongated v-shape. DP1 is comprised of roughly the same five helices, but with a short 
additional helix near the n-terminal, and is more globular than DP2. This difference has 
been noted in the literature, and DP1 is reported as being ‘denser’ than DP2 (Schmid et al., 
2012). 
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Figure 1.6: DP1 (red rockets) and DP2 (grey ribbons) superposed. A) The four C-
terminal helices (foreground) coincide relatively closely for the two structures. B) A 180° 
rotation about the horizontal axis in A. This view shows where the alignment of the two 
DP regions ends; the N-terminal segments seem to diverge from the fifth helix, which 
stretches away from the main body of the domain in DP2, but for DP1, folds in on itself, 
almost burying the additional sixth helix inside the protein. 
To examine the differences in structure both structures were aligned, superimposed and 
visualised in molviewer (The MathWorks Inc., 2009), see Figure 1.6. As can be seen from 
both Figure 1.4 and 1.6, the four C-terminal helices align better and relatively closer for 
the two structures than do the N-terminal segments, which diverge from the fifth helix 
onward. These stretch away from the main body of the domain in DP2, but for DP1, folds 
in on itself. 
 
Figure 1.7: Three DP2 Alanine substitution mutant types studied by Chen and Smith 
(2008). 
 
The exact functionality of the DP regions is not yet entirely clear, and there are conflicting 
results with respect to the effects of mutations in DP2. Chen and Smith (2008) found that 
Alanine substitution in the relatively well conserved DPEV motif (Odunuga et al., 2003) 
region of DP2 (see Figure 1.7) disrupts interaction with Hsp70 possibly by perturbing 
some inter-domain interaction or structural integrity in certain strains of yeast. However, 
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Flom et al (2007) found that complete deletion of DP2 (let alone point mutation within 
DP2) did not inhibit the Hsp70 interaction in other strains. It is probable that these 
conflicting results reflect yeast strain-specific differences.  
 
 
Figure 1.8: The amino acid property views for DP2 (bottom, PDB entry: 2llw) and 
DP1 (top, PDB entry: 2llv). A&B) Amino Acid Charge, Positive = red, Negative = blue. 
C&D) Hydrophobic Amino Acids = green. E&F) Aspartic Acid and Proline alpha carbons 
labelled and highlighted. 
Other properties of these two proteins were compared in molviewer (see Figure 1.8). In 
general both possess an equal distribution of both negatively and positively charged amino 
acids, and hydrophobic residues are positioned internally. Both possess DP-repeats 
between the helix regions.  
1.5.7 Nuclear Localisation Signal (NLS) Regions 
A short bipartite Nuclear Localisation Signal (NLS) exists, overlapping the C-terminal 
edge of TPR2A (Daniel et al., 2008; Longshaw et al., 2004). A second, putative NLS may 
exist in the DP2 domain, although its functionality has yet to be shown (Odunuga et al., 
2004). 
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1.6 Current Antimalarial Hsp Drugs 
Hsps are currently being studied as potential drug targets for a range of diseases such as 
cancer (Odunuga et al, 2004) and neurodegenerative diseases (Romano et al., 2009). Table 
1.1 highlights a list of Hop and Hsp90 inhibitors. 
Table 1.2: A selection of currently researched potential inhibitors of Hsps interacting 
with Hop 
Inhibitor Structure/complex Binding/inhibition site Reference 
Celastrol Cdc37:Hsp90 Hsp90 C-terminal (Zhang et al., 2009) 
Cytotoxic 
sugars 
Hsp90 Hsp90 C-terminal (Donnelly et al., 2010) 
Biotin-related Hsp90:HopTPR2a Hsp90 C-terminal (Yi et al., 2009) 
“AntP-TPR” 
peptide 
Hsp90:HopTPR2a Competes with Hop for 
Hsp90 C-terminal 
(Horibe et al., 2011) 
Novobiocin and 
Couermycin 
Hsp90 Hsp90 C-terminal (Matts et al., 2011) 
Gealdinimycin 
and 17AAG 
Hsp90 Hsp 90 ATP Binding 
Pocket 
(Kumar, Musiyenko, & 
Barik, 2003) 
Sansalvamide A 
and 
analogs 
Hsp90 N-terminal and Middle 
Domain 
(Kunicki et al., 2011) 
Prion Protein 
Fragments 
Hop:prion Hop TPR2a (Romano et al., 2009) 
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1.7 Possibility for Human and Malarial Hsp Interaction 
While the mature erythrocyte does not possess a nucleus or mitochondria, and therefore 
does not synthesise new proteins, analysis of the red blood cell proteome does however 
show that the mammalian (at least, in mice and human) red blood cell maintains 
approximately 700 proteins throughout its 120 day lifetime (Pasini et al., 2008) including 
two cytosolic Hsp70s and a cytosolic Hsp90 (Gromov & Celis, 1991). While there is no 
direct experimental evidence for the presence of Hop in the mature red blood cell (and this 
is probably because no one has gone looking for it), the presence of Hsp70 and Hsp90 
(especially considering the role Hop plays coordinating these Hsps) and other Hsps (Pasini 
et al., 2008), suggest that human Hop could be present in the red blood cell. 
If the above conclusion is correct, and in light of a recent finding which show that a 
PfHsp70 variant (PfHsp70-x) is transported to the host erythrocyte (Kulzer et al, 2012); it 
is possible that cross-species interaction between PfHsp70-x (and possibly even PfHsp90) 
and HsHop could occur. As yet, this possibility has not been investigated experimentally 
or in silico. 
1.8 Overall Research Rationale for the Project 
The results of the Human Genome Project (and other genome projects since, e.g. Brayton 
et al. (2007) and Cornillot et al. (2012)) have provided many potential drug targets that 
were once hard to come by, and the pharmacological industry is now left with the 
challenge of mining genomic data in search of the proteins that will be most effective in 
fighting human disease (Smith, 2003). Although new data is being published every day, 
relatively few of the known 35,000 genes in the human genome have described functions 
(Overington et al., 2006).  The constant rate at which drugs against new proteins are 
launched starkly contrasts the significantly lower rate of developing drugs against new 
protein families (Overington, Al-Lazikani, & Hopkins, 2006).  
Two Hsps, Hsp90 and Hsp70, are currently the subjects of intense research to find new 
drugs and their corresponding drug-targets in the fight against increasingly drug resistant 
P. falciparum. Unfortunately, Hsps are well conserved in most species, thus human and P. 
falciparum proteins are very similar. Careful computational analysis of the proteins will 
save time when it comes to determining the feasibility of testing new drugs and their 
protein targets in the wet lab. A lessor understood co-chaperone, the Hsp70/Hsp90 
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organising protein, has been found to play an essential role in modulating the activity and 
co-interaction of these two essential chaperones. The best understood aspects of Hop so far 
indicate that three Tetratricopeptide repeat (TPR) domains in the protein bind to specific 
C-terminal motifs in Hsp70 and Hsp90.  
Developing a drug against a particular target is an expensive and high-risk investment 
(close to a billion US dollars). Once a drug target enters a pharmaceutical company’s 
research and development phase, it may take up to 12 years to develop the final marketable 
product, assuming it makes it to that point (Smith, 2003). Clinical trials disappoint for two 
basic reasons: drugs don’t work or they turn out to be unsafe. This is primarily as a result 
of errors in the validation process (Smith, 2003). Most drugs are inhibitors that block the 
action of a particular target protein, and may cause disruption in the human cell if they 
inhibit other non-target proteins essential to cell functioning (Ma & Nussinov, 2007). The 
only way to be completely certain that a protein is instrumental in a given disease is to test 
the inhibition of that protein in humans, however, its role in disease must be clearly 
understood before it is used to screen for drug susceptibility, let alone before human trials 
(Overington et al., 2006). 
So far, protein structures for both the Hop TPR domains and the respective C-terminal 
motifs for Hsp70 and Hsp90 in complex have been published for two species (Homo 
sapiens and Saccharomyces cerevisiae). Recent research suggests that Hop, Hsp90 and 
Hsp70 do in fact interact and form complex in the P. falciparum trophozoite (within the 
infected host erythrocyte) and is overexpressed in this infective stage. While it has been 
found that P. falciparum transports parasite proteins to the host erythorocyte cell, it has 
only been suggested that it may be doing the same for its Hsp's. However, recent data 
show that a PfHsp70 variant (PfHsp70-x) is transported to the host eythrocyte. It has been 
suggested that PfHsp's may interact with human Hsps, effectively annexing the host cell 
proteins for parasite protein refolding. In this case, there is potential for complex to form 
between PfHsp70-x and human Hop. However, there has been almost no computational 
research on malarial Hop protein in complex with other malarial Hsps, let alone human 
Hop with malarial Hsps. 
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1.9 Aims  
The current work was undertaken to focus on several aspects of the in-silico 
characterisation of PfHop. The aims of this work were to yield a valuable starting point to 
understand the scope of both the variability and conservation of several domains, motifs 
and residues on which functional interaction studies have been centred in PfHop and 
HsHop, in order to identify regions of the protein that could potentially function as drug 
target sites. In order to do this, the primary objectives of the work were to build 
comparable homology models of Hop in complex with several of its protein/peptide 
partners in both human and P. falciparum and compare the interactions involved in 
complex formation.   
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Chapter 2: Multiple Sequence Alignment and Phylogenetic 
Analyses 
2.1 Introduction 
Earlier this year, P. falciparum Hop was localised and isolated from the trophozooite 
(infective) stage of the parasite (Gitau et al., 2012). This analysis included a very basic 
multiple sequence alignment of the protein (which included an error in sequence and taxon 
identity), leaving much to be determined with regards to understanding this protein’s 
phylogeny. An earlier review by Odunuga et al (2008) included a multiple sequence 
alignment that was very thorough and from a wider range of taxa. However, considering 
recent advances in determining the structure of Hop, a new in-depth multiple sequence 
alignment of Hop protein with representatives from four Kingdoms (Animalia, Fungae, 
Plantae and Protozoa), fifteen major taxonomic groups and 60 species was undertaken as 
part of the current work.  
 
2.2 Multiple Sequence Alignment 
The aims of this project were to compare two species’ Hop proteins and determine how 
different they are from each other, in order to determine the feasibility of targeting this 
protein for drug research. However, it is only possible to completely gauge how different 
two sequences are within the context of a scale of variability (Pei et al., 2008). This is the 
premise for multiple sequence alignment (MSA).  
In most cases, alignments should be done at the protein level. One exception is when there 
has been a frame shift mutation in one of the sequences such that the amino acid sequences 
differ significantly but the DNA sequences coding for those proteins can still be aligned. 
The optimal choice also depends on the level of evolutionary relationship being 
investigated, as well as the purpose of the research. If closely related species/strains are 
being analysed, then DNA analysis will be more informative as it allows detection of 
synonymous changes (Harrison & Langdale, 2006). If more distant evolutionary 
relationships are being studied, then analysis of protein sequences is more appropriate 
because the protein sequences change more slowly.  
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2.2.1 BLAST 
The Basic Local Alignment Search Tool (BLAST) was originally designed to detect 
homologous nucleotide sequences of a query sequence by directly approximating 
alignments that optimize a measure of local similarity; the Maximal Segment Pair (MSP) 
score (Altschul et al., 1990). It has since been implemented and optimised within an online 
public interface (Johnson et al., 2008) to run on large-scale globally accessible protein and 
nucleotide sequence databases such as NCBI and GENBANK and their respective curated 
versions (Pruitt & Maglott, 2001). Several algorithms have been further developed for 
homolog-searches using different types of sequences with greater efficiency (Altschul et 
al., 1997; Price, Dehal, & Arkin, 2008). It is currently one of the most widely used tools 
for conducting bioinformatics research and is an excellent resource for teaching some of 
the foundational principles of bioinformatics (Kerfeld & Scott, 2011). 
Protein BLAST requires the submission of a query sequence to use for searching selected 
databases. Once matches have been found they are aligned and scored according to the 
Expect value (E), which is a value that estimates how often one will find false matches by 
chance when searching a database of a particular size. The closer the E-value is to zero, the 
more significant the match is and it decreases exponentially as the MSP of the match 
increases. The E value takes account for the length of the query sequence, because shorter 
sequences have a higher probability of occurring in the database by chance.  
A good place to start when looking for conserved domains is the NCBI domain recognition 
tool when performing a pBLAST against the query of interest. When P. falciparum was 
pBLAST against the non-redundant RefSeq database several domains were recognised 
(Figure 2.1). 
 
Figure 2.1: Domains in the Hop protein sequence recognised by NCBI pBLAST tool. 
The three TPR repeat motif domains are recognised as they are a common feature in 
several proteins and have been extremely well characterised by the scientific community. 
The two DP domains were not recognised most likely because their structures were only 
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elucidated in 2012 and a lot of work remains to be done with regards to the 
characterisation of these domains. Interestingly, an XPC (xeroderma pigmentosum group 
C protein) binding domain was recognised in the region that was expected to contain the 
DP2 domain. This domain is part of a protein called hHR23, belongs to a protein 
superfamily designated cl15287. Members of this family adopt a structure that is very 
similar to that describing DP2 (see Figure 2.2), consisting of four alpha helices, arranged 
in an array. They bind specifically and directly to XPC to initiate nucleotide excision 
repair (NER) (Kamionka & Feigon, 2004). The protein is of interest owing to its role in a 
very rare autosomal recessive genetic disorder known as xeroderma pigmentosum (XP), 
whereby afflicted individuals are NER deficient. These individuals often die very young 
owing to cancers developed through disruption of the oncogenes (that are not repaired) 
during exposure to UV light (Kamionka & Feigon, 2004). 
 
Figure 2.2: BLAST identified DP domain structures. A) ScHop DP2 (PDB ID: 2LLW). 
B) Human hHR23 XPC binding domain (PDB ID: 1OQY). 
The XPC binding domain (Figure 2.2B) bears some structural similarity to the DP2 
domain but appears more globular, like ScHop DP1. Hydrophobic interactions between the 
C-terminal helix and the rest of the protein are most likely the reason for this globular 
structure, while hydrophilic patches on the outer surface of the protein are reportedly 
responsible for domain functioning (Kamionka & Feigon, 2004). This is very similar to 
both ScHop DP domains, where hydrophobic residues are interior to the protein (see 
Figure 1.8D and B).  
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2.2.2 COBALT 
COBALT performs local alignment in a constraint-based way by looking for conserved 
domains and forming pairwise alignments around these regions and then constraining the 
rest of the multiple sequence alignments in a progressive sequencing manner. It works 
slowly, but the algorithm appears to function more accurately if there are conserved 
regions in the sequences being aligned (Papadopoulis and Agarwala, 2007). 
2.2.3 MAFFT 
MAFFT is a MSA program that uses fast Fourier transforms (FFT) to convert the amino acid 
sequence in question to a sequence of vectors, representing the volume and polarity of each 
residue. This is because evolution favours amino acid substitutions which retain similar 
physico-chemical properties (Jones, Taylor, & Thornton, 1992) and the MAFFT program is 
then capable of scoring residue pairs according to their vectors. Homologous regions between 
two proteins in an alignment are identified based on these values. MAFFT uses an improved, 
simplified scoring system that enables an alignment to be performed with greater efficiency 
than other widely used MSA programs. Owing to its wide use and popularity, MAFFT has 
been developed to utilise several different alignment strategies optimised to specific types of 
data (Katoh & Toh, 2008). MAFFT’s E-INSi protocol has been developed to tackle proteins 
such as RNA polymerase, which has several conserved motifs embedded in long, 
unaligned regions. This is a useful feature that allows distantly related proteins with one or 
more long, non-conserved regions to be aligned. This algorithm must be used with caution 
as it assumes that the arrangement of the conserved domains is shared by all sequences 
(Katoh et al., 2005). For proteins with global homology, the G-INSi protocol uses iterative 
refinement to improve the accuracy of the alignment. This is done using the WSA scoring 
method, based on a matrix created by analysing only the well conserved segments of 
sequences (Katoh et al., 2005). 
2.3 Motif Analysis 
Multiple Expectation Maximisation for Motif Elicitation (MEME) is a tool for identifying 
biologically functional motifs in a group of related DNA or amino acid sequences (Bailey 
and Charles, 1994). It does this by discovering motifs in a collection of sequences through 
using expectation maximisation (which enables parameter estimation in probabilistic 
models with incomplete data (Do & Batzoglou, 2008)) to fit a two-component finite 
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mixture model  (Figueireido, 2002) to the sequence set. The tool can estimate how many 
times each motif (even with differing numbers of occurrence per sequence) occurs on each 
sequence in an unaligned dataset. It returns this motif as a sequence logo with several 
scores (Bailey and Charles, 1994; see also Appendix 5). The E value for each motif is an 
estimate of the expected number of motifs with the log likelihood ratio of the returned 
motif (with the same width and site count) that one would find in a set of random 
sequences of the same number as the input set (Bailey and Charles, 1994).  
 
2.3.1 MEME Block Diagrams: 
Each sequence is displayed as a line overlain with block diagrams in colours that represent 
specific found motif numbers, and scored according to the positional p-value (Bailey and 
Gribskov, 1998). The p-value of a sequence is computed from the score generated by 
matching the motif site/s on any given sequence with the position specific scoring matrix 
for the motif. The p-value returns the probability of a random sequence having an 
equivalent match score or higher (Bailey et al., 2009). The height of the block representing 
a motif site gives an indication of the significance of the match; the height is proportional 
to the negative logarithm of the sequence’s p-value, cut off at the height for a p-value of 
1e-10. As such, taller blocks represent motifs that are more significant (Bailey et al., 2009).  
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2.3.2 MEME Sequence Logos 
MEME motifs are represented by position-specific probability matrices that dictate the 
probability of each possible letter appearing at a specific position in all occurrences of the 
motif (Bailey and Charles, 1994). This logo contains a stack of letters at every position in 
the motif. The height of the individual letters in a stack is the probability (in bits) of the 
letter at that position multiplied by the “total information content” (the number of times 
that residue occurs within that residue site in each motif site in the dataset) of the stack 
(Bailey et al., 2009). Thus the total height of the stack is reduced if the residue site is not 
well conserved at that position in the motif.  
Table 2.1: Amino acid colour codes for sequence logos in MEME. 
 
For proteins, the colours of the individual letters in the motif are based on the biochemical 
properties of the various amino acids according to the convention in Table 2.1 (from Kyte 
and Doolittle, 1982). 
  
Amino acids Colour Properties 
A C F I L V W M Blue Hydrophobic 
N Q S T Green Polar, non-charged, non-aliphatic  
D E Magenta Acidic 
K R Red Positively charged 
H Pink Positively charged, cyclic 
sidechain  
G Orange Simple, non-polar 
P Yellow Cyclised 
Y Turquoise Non-polar, aromatic 
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2.3.3 MAST 
MAST jobs can be completed in parallel to MEME jobs within the MEME Suite 
Webserver  (Bailey et al., 2009). MAST determines the probability that two motifs are 
significantly different by calculating the pairwise correlations between each pair of motifs. 
The maximum, found by trying all alignments of the two motifs, is the sum of Pearson's 
correlation coefficients for aligned columns divided by the width of the shortest motif in 
the pair (Bailey and Gribskov, 1998). Pairs of motifs with higher correlations are too 
similar and should not be considered as separate motifs. The server returns a pairwise 
“similarity” table where correlations above the similarity threshold (i.e. with lower 
significant difference) are shown in red text. Additionally, the server returns a top scores 
table, where each of the sequences in the original dataset are displayed as lines, overlain 
with the original block representation of motifs (as for MEME block diagrams) and ranked 
according to the lowest MAST E-value. The MAST E-value is equal to the combined 
position p-value of the sequence times the number of sequences in the database (Bailey 
and Gribskov, 1998). More simply, it is the expected number of sequences in a random 
database of the same size that would match the all motifs on the sequence in question as 
well as the sequence itself does.  
2.4 Phylogenetic Analysis  
MSA is also an incredibly important step in protein structure analysis; it allows the 
researcher to identify well conserved domains (and thus most likely functional) and 
important residues (such as those involved in binding ligands or other proteins). It has 
become well established practise to use MSA and phylogenetic analyses to help predict the 
structure of unknown proteins, as conserved functional domains tend to have conserved 
folds, particularly within those domains (Benner, 2001). Phylogenetic analyses have been 
found to effectively assist in predicting unknown gene function, which is the backbone of 
current drug discovery, by tracing genes of known function and comparing how they are 
related to unknown genes (Searls, 2003).  
2.4.1 Species Trees versus Protein Trees 
Species trees (Phylogenetic trees) form a pattern of branching of species lineages via the 
process of predicted or inferred speciation. Gene/protein Trees are formed through the 
inferred mutation and recombination events and seem to be broken into several pieces 
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owing to recombination within populations. Protein trees are usually contained within the 
branches of species phylogeny. If in agreement, protein sequences should show the same 
branching topology as a species tree, but may have more terminals when analogous and 
orthologous genes encoded for the proteins are considered (Harrison & Langdale, 2006). 
This is because genes can undergo recombination, insertion, deletion within species and do 
this several times. Genes can also break the confines of species lineages in other ways. A 
good outgroup may allow the tree to indicate true evolutionary direction. 
In the absence of a suitable outgroup, the root may be positioned by assuming 
approximately equal evolutionary rates over all the branches. In this way the root is put at 
the midpoint of the longest pathway between two operational taxonomic units (Harrison & 
Langdale, 2006). This is the molecular clock method, which has other problems associated 
with it (as it is based on the assumption that all sequences have equal evolutionary rates). 
2.4.2 MEGA 
MEGA is a software package that equips biologists with all major phylogenetic analysis 
tools (Kumar, Tamura, & Nei, 1994). With the latest release, the collection of analysis 
tools in MEGA now includes the maximum likelihood (ML) methods for molecular 
evolutionary analysis (Tamura et al., 2011). Phylogenetic inference from amino acid 
sequence data uses mainly empirical models of amino acid replacement and has therefore 
been dependent on the Dayhoff and JTT amino acid substitution models (Jones et al., 
1992), and other more recent models (Whelan and Goldman, 2001). Maximum likelihood 
analyses calculate the probability that a data set fits a tree derived from that data set, given 
a specified model of sequence evolution (analogous to models of amino acid substitution 
used to find homologous sequences). To select a model of sequence evolution, the data 
must be roughly compared against a set of models of sequence evolution, then the model 
that best describes the observed pattern of sequence variation (has a higher optimality 
criterion) is selected  for further analyses (Harrison & Langdale, 2006).  
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2.4.3 Evolutionary Model Selection 
Model selection is well established for making inferences from observational data, 
especially when data are collected from complex systems (Harrison & Langdale, 2006). 
This is critically important when addressing evolutionary research questions where 
experimental manipulation is not possible. In general, the researcher selects a model by 
scoring the model to the data with some form of optimality criterion. The optimality 
criterion for the correct model describing the structure of a phylogenetic tree is a score 
calculation based on the substitution of characters (such as nucleotides or amino acids) to 
explain the observed sequences at the terminal branches of a tree (Harrison & Langdale, 
2006). To calculate such a score, one needs some measurement of change. Observed 
difference is often used but may underestimate the degree of actual change. For example, 
if there are three increments of change, one character may have changed once and then 
back to its original state again (back mutation). In this case, there will be no observable 
difference, but there have been two changes and such back mutations need to 
estimated.This is usually done with a network such as a hidden Markov model. The 
optimal model will depend on the kind of data that is being used to construct a tree, i.e. 
what the characters and character states are. If one uses protein sequences, the characters 
may be sites and the states the different amino acids.  
Model selection programs in phylogenetic application packages are commonly used to 
select appropriate models based on aligned sequence data. MEGA5 provides the goodness-
of-fit test of the substitution models with and without assuming the existence of 
evolutionary rate variation among sites. The goodness-of-fit of each model to the data is 
measured by the Bayesian information criterion (BIC, Beaumont & Rannala, 2004) and a 
corrected revision of the Akaike information criterion score (AICc).  
Both of these criterion indicators persistently select substitution models that are more 
complex than the true model. However, the true model usually appears among the top 3 
when BIC was used and among the top 5 when AICc was used (Tamura et al., 2011). As 
such, several maximum likelihood trees should be built with a variety of models, and all 
resulting trees compared to their bootstrapped trees as well as to each other, in order to 
find the most correct tree.  
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2.4.4 EnsEMBL Compara-Gene Trees 
EnsEMBL (Kersey et al., 2010) trees for a specific gene of interest are based on maximum 
likelihood phylogenetic trees built by TreeBest (Li, 2006) utilising the TreeFam Database. 
TreeFam (Li, 2006; Li et al., 2006) was developed to provide curated phylogenetic trees 
for all animal gene families, as well as automatically predict orthologs and paralogs.  
These trees, representing the evolutionary history between the genes, are then compared to 
their species trees in order to differentiate between duplication and speciation events (Li & 
Durbin, 2007).  The latest release of TreeFam contains curated trees for 1314 families and 
automatically generated trees for another 14351 families from 25 fully sequenced animal 
genomes, as well as four genomes from plant and fungal outgroup species. EnsEMBL 
utilises TreeFam and TreeBest to automatically group genes into families and for building 
phylogenetic trees (Kersey et al., 2010) and thus these trees are not without error and must 
be used with caution. The gene tree for a particular gene is accessible via the left-hand 
navigation menu of the gene’s page on EnsEMBL, along with ortholog and paralog data 
which are available for querying via the BioMart interface and/or a Perl API (Kersey et al., 
2010; Ruan et al., 2008). 
 
2.5 Methods and Software 
2.5.1 Sequence Retrieval 
Sequences for approximately 70 organisms from a wide range of taxa were acquired from 
the NCBI (Tatusova et al., 2012) and PlasmoDB.org Databases. P. falciparum Hop protein 
was downloaded from PlasmoDB and then used for protein BLAST against every 
eukaryote genome available in the NCBI BLAST’s Genome Map viewer. All sequences 
with an E value > e-50 were downloaded and saved to .fasta format files. A summary of all 
sequences originally attained is presented in Appendix 1. The high E value was selected to 
filter out non Hop-homologs with the TPR regions, as this motif is a common (and highly 
conserved in structure and binding site composition) motif in other proteins  such as 
FKBP51 and FKBP52 (Cheung-Flynn et al., 2003). Sequence representatives were found 
from four Kingdoms and several Phyla. No prokaryote sequences were analysed as the 
primary focus of this study was eukaryote organisms (i.e. H. sapiens and P. falciparum). 
Interestingly, there were no suitable homologs of Hop in the three avian species searched 
(Turkey, Chicken and Zebra Finch) as well as the single Marsupial (Monodelphis 
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domestica) species searched. To account for the possibility that protozoan and avian Hop 
proteins are too diverse, another vertebrate species’ Hop sequence (H. sapiens) was used to 
BLAST the genomes of the three avian species, still returning no Hop homologues with an 
Evalue > e-50. An NCBI search for “Hop/Sti1” protein for “Avian/Aves/Gallus gallus” 
returned a poor homologue under the title of “hsc70-interacting protein St13”. To check for 
the likelihood that all sequences shared homology to all other sequences, a short script (see 
Appendix 2, Section A) was written to filter through a .fasta file of pairwise of alignments 
of all sequences (produced in Jalview) for a minimum sequence identity of 30% (Rost, 
1999). This resulted in selection of the final 60 sequences to be used for MSA. 
2.5.2 Multiple Sequence Alignment 
All 60 sequences were initially aligned in COBALT, a relatively new sequence alignment 
algorithm that has recently been promoted on the BLAST webpage. A second alignment 
was produced using MAFFT’s E-INSi’s protocol. Hop possesses two problematic regions 
making the selection of this protocol optimal: the linker region between DP1 and TPR2A 
and that between TPR2B and DP2. From looking at all MSA results, it is possible to see 
that these regions possess the most gaps and unaligned regions. A second MAFFT 
protocol, the L-INSi method produced slightly less comparable results. These results were 
compared with a further alignment program DIALIGN-TX (Subramanian, Kaufmann, & 
Morgenstern, 2008), using two different parameter sets: default and increased width of low 
conserved regions expected to be found. A final MSA method for the whole protein was 
settled on (utilising the E-INSi protocol) and this was then used for phylogenetic analysis. 
2.5.3 Meme Whole Protein Analysis 
Sequences were sent to the MEME webserver (Bailey et al., 2009) to search for conserved 
motifs/domains in sequences. The unaligned sequences were submitted to the MEME 
server, with the following parameters: motif width to be searched for was between 2-150 
residues; motif can occur any number of times in a sequence (this is owing to previous 
research finding TPR1 and TPR2B to be very similar in structure) and site limitations were 
left empty (this is the default, i.e. no sequences are excluded from the analysis).  This 
approach was used each time in subsequent MEME analysis. These parameters were kept 
constant when searching for 5, 10, 15 and 20 motif sets in all 60 sequences.  
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2.5.4 Domain Analysis  
Once a final MSA method for the whole protein was settled on (MAFFT E-INSi protocol), 
whole Hop was realigned (MAFFT E-INSi) with fragments of Hop protein relating to 
well-studied structural domains in human and yeast, namely the TPR1, DP1, TPR2A&B 
and DP2 domains. These fragments were obtained by retrieving the protein sequences 
from several published structures of these domains on the PDB; namely 1ELW (TPR1), 
2LLV (DP1) 3UQV (TPR2A&B) and 2LLW (DP2). This strategy highlighted regions of 
good alignment for most domains (except DP1). Once realigned, the fragments were 
removed and the four regions roughly corresponding to each domain were cut out of the 
alignment in Jalview (Waterhouse et al., 2009) and saved separately. The three TPR motif 
and DP2 motif regions were resent to MAFFT for global realignment using the G-INSi 
protocol. DP1 was realigned using the L-INSi protocol and E-INSi protocols. The final 
aligned domains were also used for phylogenetic analysis.  
2.5.5 MEME Domain Analysis 
These domain datasets were then also submitted to MEME using the parameter set listed 
above, however, making the max sequence length for that dataset the max length of the 
motifs to be searched for. Only 15 motifs were sought per domain.  
 
2.5.6 Phylogenetic Analysis 
The protein phylogenies were created in MEGA.  AICc and BIC scores were used to 
determine the correct evolutionary models to use for maximum likelihood analysis. The 
overall phylogeny was selected from the top three models selected from lowest BIC 
scores. Both slow, Maximum Likelihood (ML) and fast, Neighbour-Joining (NJ) tree-
building algorithms were used for the full-length Hop Protein analysis. Three different 
evolutionary models were tested in the construction the full-length Hop ML protein tree, 
rtREV, JTT and WAG, however owing to the excessively long run time to build ML trees 
using the WAG and JTT models, these methods were only used for comparison of the full-
length protein. 
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2.6 Results 
2.6.1 Sequence Selection 
See Appendix 1 for all pBLAST results.  Exactly 60 out of approximately 70 sequences 
were selected for final MSA analysis. These included representatives from the vertebrates, 
apart from the aforementioned avian and marsupial species. Additionally the A. gambiae 
species sequence was not utilised do to a lack of information in the database as to the 
origins of the sequence. Using the script in Appendix 2, Section A it was determined that 
these final 60 sequences all shared 30% sequence identity with every other sequence. 
2.6.2 Multiple Sequence Alignment 
The full-length protein MAFFT E-INSi alignment was viewed with Jalview. Several 
coloration options were used to get an overview on certain properties of the protein that are 
of significance to the current work. In Figure 2.3, it is easily seen from the first three 
panels that the regions relating to DP1 and the linker regions possess the least 
conservation. These regions are also the least well aligned regions, and the sites of most 
insertions and deletions. The exact residues relating to these regions will be analysed in 
depth in Section 2.6.4. 
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Figure 2.3: General features of Hop Protein for all sequences analysed. The residues 
in the first three panels are coloured by Blosum62 scoring if they are above the respective 
identity threshold. Blosum62: Gaps are coloured white. If a residue matches the consensus 
sequence residue at that position it is coloured dark blue. If it does not match the consensus 
residue but the two residues have a positive Blosum62 score, it is coloured light blue. 
Hydrophobicity: Amino acids are coloured according to the hydrophobicity table of Kyte 
and Doolittle (1982). The most hydrophobic residues according to this table are on the red 
end of the spectrum and the most hydrophilic ones are on the blue end. Buried index: 
according to Jalview, residues in the dark-blue end of the spectrum are most likely to be 
buried while those in the lime end are not. Helix Propensity: according to Jalview, residues 
in the purple end of the spectrum are most likely to occur in helices while those in the lime 
end are not. 
Overall analysis of hydrophobicity throughout the protein suggests that as a whole the 
protein is mainly composed of hydrophilic residues sporadically interspersed with 
hydrophobic residues, with the exception being a short stretch of residues near the C-
terminal regions of both DP motifs. Similar analysis of buried residues indicated that 
extremely few residues with a high propensity for remaining buried within the protein 
were found in the TPR Regions of the protein, while two short stretches of residues with a 
moderate buried index seemed to correspond to the same regions in the DP motifs 
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possessing a high hydrophobicity. Considering the structure of Hop as it is currently 
understood, and the fact that it is primarily cytosolic (Lassle, Blatch, Kundra, Takatori, & 
Zetter, 1997), it is no surprise that the most of the residues are low buried index residues 
with high helix propensity (Figure 2.3). 
2.6.3 Phylogenetic Analysis 
Several trees were constructed using several different tree-building methods and 
evolutionary models (see Appendix 3, Section A). The method that produced the most 
reliable tree, in terms of BIC scores (see Appendix 3, Section A, Table A3.1), bootstrap 
consensus (see Appendix 3, Section A, Figure A3.1), as well as consensus with other 
models, was the Maximum Likelihood method, using the rtREV evolutionary model.  This 
protein tree was then compared to the Compara-Gene tree for PfHop on EnsEMBL. 
 
Figure 2.4: Major taxonomic groups in the rtREV Hop Protein Tree. (Graphic 
produced with MEGA’s tree-viewer tool). 
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From Figure 2.4, it is plain to see that the statistical support values for the branching 
resolution of most the major groups are good (only five of fifteen major branches below 
75, mostly within the plants and invertebrates). The branching resolution between the 
insect and nematode phyla has the lowest statistical support, with a bootstrap value of 24. 
This is the only region of disagreement between this tree and its bootstrapped support tree 
(see Figure A3.1, Appendix 3, Section A). 
Comparison of Gene and Protein Trees  
Analysis of the EnSEMBL Compara-Gene tree (see Appendix 4) for Hop indicates that the 
protein tree has some consensus (in terms of branching) with the gene tree. Both trees 
show that O. anatinus (Monotremata) is the first outgroup to the mammals. The gene tree 
indicates that the next outgroup is Reptilia (A. carolensis), followed by the Amphibia (X. 
tropicalis), whereas the protein tree indicates that the opposite is true. There is however 
poor statistical support for the branch that splits the amphibian from the mammals and 
monotreme (bootstrap value of 55) in the protein tree, which may help account for the 
disparity between the two trees. The two trees agree that the next outgroup is Osteichthyes 
(i.e. D. rerio and other ray-finned fish).  
There is again disagreement as to the next outgroups to the vertebrates (i.e. the invertebrate 
animals); in the protein tree, the first outgroup is the Hemichordata (S. kowalevskii), 
followed by the Urochordata (C. intestinalis), then the grouped Insecta and Nematoda, 
followed by the Porifera (A. queenslandica) and finally, the Cnideria. In the gene tree there 
are no representatives for the Hemichordata and Cnideria, however, the poriferan is the 
first outgroup to the vertebrates, followed by a urochordate and finally the grouped 
nematodes and insects. Notably, there are four poorly supported areas of branching 
between the plants and invertebrates, making this area of the protein tree the least well 
resolved. 
The gene tree indicates that the fungi are the first outgroup to the mammals, followed by 
the protozoans. Finally, Viridiplantae (Plantae) is outgrouped to all others. In the protein 
tree however, the plants are the next outgroup to the animals, followed by the fungi and 
finally the protozoa. This may be explained by poor resolution in branching between the 
plants and animals on the protein tree, or perhaps owing to a larger number of plant species 
used by the gene tree, thereby getting a more accurate estimation of variation within the 
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plants and thus allowing them to be more easily distinguished from the other groups. 
Owing to the discrepancy in methods and species used to build both trees, more in-depth 
analysis of branching is not really possible. Ideally, a gene tree should have been built 
using the genes for all 60 protein sequences for a more reliable comparison, but owing to 
time constraints this was not feasible. 
As explained in the introduction, EnsEMBL Compara-Gene Trees are built with automated 
methods, and there are still many more automated trees on TreeFam than curated trees, and 
the gene tree for Hop should be treated with caution and used as a guideline for Hop 
phylogeny. The full protein tree for all Hop sequences used, indicating the various levels 
of taxonomic resolution used to assess the protein for later analysis, is displayed in high 
resolution on the next page for reference (Figure 2.5). 
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Figure 2.5: All taxonomic units in the rtREV Hop Protein Tree. 
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2.6.4 Domain Analysis 
A maximum of 11 motifs (the longest being 113 residues), were found for all sequences of 
Hop, full-length protein (see Appendix 5, Section 3). The Mast output for all sequences 
(see Appendix 5, Section 3, Figure A5.3C) was reordered to reflect the top to bottom 
groupings of each species’ Hop sequence in the protein tree for Hop (Figure 2.6).To the 
author’s knowledge, this method of comparing MEME/MAST results according to the 
phylogeny of the sequences used is a novel approach. It yielded a satisfying view of 
domain sttructuring and conservation within selected taxonomic groups. 
 
Figure 2.6: The Hop Protein (rtREV model) tree alongside Mast (Meme) results for 
each organism. See Appendix 5, Section 3, Figure A5.3.1-A5.3.11, for motif sequence 
logos). The three arrows are highlighting the (top to bottom) positions of HsHop, ScHop 
and PfHop, which correlate to Figures 2.14-2.16, respectively. 
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From Figure 2.6, one can see that there are various well-conserved domains that are 
reflected by motif representations. These motifs were aligned to condensed alignments of 
the various regions in Hop in Figures 2.7-2.12 and their significance is discussed on the 
following pages. 
2.6.5 TPR1 
For most of the species within the fungi and protozoan kingdoms, TPR1 is represented by 
Motifs 8 (dark grey) or 10 (light grey) at the N-terminal, 2 (dark blue) centrally and 9 
(dark green) at the C-terminal, in that order. The exceptions are two Apicomplexan species 
N. caninum and T. gondii, and these species possess the same motif (motif 5, yellow) for 
TPR1 that the animal and plant Kingdoms share (Figure 2.6). Conversely there are several 
exceptions within the animal kingdom that share the same motifs for TPR1 with the fungi 
and protozoan kingdoms. One of these is a vertebrate, O. anatinus (commonly referred to 
as ‘duck-billed platypus’). Considering how well Hop is conserved across the mammalian 
phylum and the fact that phylum Monotremata is the next outgroup to the mammals, the 
most likely reason the sequence for TPR1 is not represented by motif 5 is because the 
sequence is truncated at the N-terminal region (partial sequence, see Appendix 1, also see 
Figure 2.6), and it is this N-terminal region that allows motif 5 to be recognised. The other 
two animals are N. vitripennis (jewel wasp) and H. magnipapillata (cnidarian). 
  
  
 
 
Figure 2.7: Condensed alignment representing the Hop TPR1 region for the major taxonomic groups (Figure 2.4) and species of interest, aligned with 
the relevant motifs numbered and coloured according to Figure 2.6. Several features are highlighted in the alignment (coloured regions) and the 
“carboxylate binding clamp” residues positions are bordered in black and coloured cyan. ‘~’ indicates lack of consensus. 
 
MotifS 0 
Mostly vertebrate and 
plant sp, ~ 
E = 2.3e -1l76 
MammaL Consensusl1·125 
Mooo/remel1-97 
Repli1el1.122 
Amphibiarl1.122 
Fistt1-122 
Urochorda/eJ1-120 
Insec1l1-122 
Poriter3'1-123 
Cnidaria'1-119 
MonocOV1·120 
EudiCOV1·120 
FungL COnsensuSl1·129 
PrOiozoa _ COnsensuSl1·125 
ApiComplexa _ COnsensuSl1·125 
Plasroodium _ COnsensuSl1·125 
Plasroodium _ ralCiparum'1·125 
HorocuapienSl1·122 
YOR027W11·124 
Motif 10 o Mostly fungi and 
protozoan: E = 1.3e-486 
Motif8 • Other fungi and 
protozoan: E = 6.1 e-5711 
20 30 40 
, , , 
l EK ofjl<A LSAC" .... I DDA LQCYSEA I KLDPQ-
················FySEA I KLDP K-
... ~E!iK~~viiN: ~E~ ijl~!i~~jm:~· ... T AEA I KHYSEA I KLD SA· •••• LDEAVKCY TEA I KLDP K· 
--- ME ---- VDEA IRCYTEALSVDPS· 
----- MADE ---- YKEA IGHYTE A 
--- MDKV-- ALAEGK ---- YDEA I- HYTEA 
-- MST ---- TD VA I ELYTEA 
------ ANE ---- LEDA IAFYSKA 
····YEEAARHFTDA 
----YATA ITHFT EA 
--YE TA IEKF TQA ELDP 
'-'1 'IL Gf1KAFO,\GK- - - -YEEAVEYFSKA 
1EL GfjI<AFO""- - - - FEDAVKFFTDA 
1EL GfjI<C FQEGK- - - - FEDSVKYFSDA 
~!~~~:~:~;F'O;:E:~G::K- - - -YEEAVKYFSDA - - - - I DDALQCYSEA ----yDKA IELFTKA EVSE 
':~~c~~t.t~~ll>:~~~A~~~~M 
-:b~~.. ~~~~Ilf~~~~fi.J~~ 
60 70 
, , 
~::~;:::~::~~::~~!::~~K TVD KTVD ED ACK T I E 
TKA LEDGGK TVE 
KV I E I 
EDAEKTVS 
LKKYDEA LADAM KTVE 
KTVE 
LHR YEEA LSDAKK TIE 
LKDYQKA LEDA NKC TEI 
LGRYYEA LEDA NKC ISI 
lllElGA'YASLGRFYEALEDANKC I S 
lbllloA'YSS LGRFYEA LE SA NKC I S I 
LGRFYEA LE SA NKC ISI 
AA YAK,COD 'YOKA YE.DGC KTVD 
LKK FSDA LNDANE CVK I 
90 100 11 0 120 
, , , , 
EF LNRFEE AKR TYEE GLKHE ANNP QLKEG LQNMEAR LAER 
EF LNRFEE AKR TYEE GLKHEA NNPQL KEG LQNME AR LTER 
EF LNRF EEAKK TYAEG LKHEPGNAQL KEG LQNM ESR LAER 
EF LNRF EE AKK TYEEG LRH EPAN AQ LKEG LQNM EAR LAER 
EFLGRLEDARVTYQEGLRQEPSNQQLKDGLQN IEAKLAEK 
KG"A LAFL KfIYEEA I<MI,YEEGLKYDSQNEQLKKGVEQCEKELTGP 
KG"A LAYLGfl-DDA IEAY--GLK-DPTNAQLLSGL-EVKAQ-LSF 
TYLEKYSEAEEMYYKG LEQE PNNDQL KKG LQ ECQDKKKSE 
LGI\AYSY LGC,DMEA'YEI,YEKG LKYEPD NAQL KTAMQ ELDN KMSRQ 
LGLGDAASAVAAYEKG LALDPTN EG LKAG LADA KKAAAAP 
IGLSKFDEAVDSYKKG LEIDPSNEMLKSGLADASRSRVSS 
HGLGD LLAAHDAYEEA LKLDP SNAQAKEG LNAVKRA IDAE 
~i~~~~1 HGLRR YD EAEA TYL KG L KVD P NN E S L KDG L E KVE KD KAAE HGLRQLDNAE KTYLE GLKIDPNNESLKDGLEKVRKDKDME HGLR QLDN SEK TYLEG LKLDPNN KS LKDG LE KVRKEKE ME HGLR QLSNAE KTYLEG LKIDPNNKSLQDALSKVRNENMLE EF LNRF EEAKR TYEEG LKHEA NNP QLKEG LQNM EAR LA ER 
IJ:jLGA,\H LGLGD LD EAE S NY KKA L E LDA S N KAAKEG LD QV HR TQQAR 
Motif2. Mostly fungi and protozoa 
E = 6.5e .16~ P 
Motif 9(3 Mostly fungi and protozoa 
E = 1.1e -491 
 
 52 
MAST analysis for TPR1 (see Appendix 5 Figure A5.3B) indicates that motif 5 shares high 
similarity to motif 2 (0.76) and motif 10 (0.63) which means that these two motifs may not be 
significantly different to the overlapping residue sites in motif 5. Motif 8 and 10 share the 
highest similarity (0.78), and are very likely not significantly different. 
From Figure 2.7, one can see that the mammalian/vertebrate motif 5 (above the alignment) is 
very well conserved; almost all residues have a bit score greater than 3, while the fungal and 
protozoan motifs (displayed below the alignment) are more variable. Two interesting features 
of TPR1 that motif analysis did not detect are the start motifs; M[IV]NKEEAQL, well 
conserved for apicomplexans (pink box, Figure 2.7) and MEQVNEL which is well conserved 
for mammals (green box). Two other short motifs appear to be highly conserved across all 
species; NHVLYSNRS around position 50 and KPDWXKGYXR around position 80, and 
their conservation is reflected in motif 2. 
2.6.6 DP1 and the Long Linker  
As discussed in section 2.2.1, the DP1 and linker region is the least well aligned (see Figure 
2.8). Interestingly, there are only two motifs that are specific to the DP1 region, and these are 
present only in certain invertebrates, plants, all fungi and the euglenazoans. These are motif 7 
(teal) and 11 (mauve). The vertebrates and the urochordate possess motif 6 (lime green, 
Figure 2.6), which groups the hydrophobic region of DP1 and the long linker (Figure 2.8) as 
well as TPR2A (Figure 2.9). This could indicate that this whole region is a functional group in 
the vertebrates. MAST analysis indicates that Motif 11 has a high similarity score (0.65) to 
the overlapping residues on motif 6. This may indicate that the C-terminal region of DP1 is 
not significantly different in all species except the apicomplexans. The apicomplexa are 
definitely the exception to the rule for this region of the protein. They do not possess the 
DP/NP repeats that define the region (coloured by helix propensity, Figure 2.8), although they 
have chemically comparable substitutions in some of these DP positions (NP/NS).  
Additionally, the apicomplexan long linker region is a glutamic acid-rich region, whereas  for 
all other species this region is glutamic acid-rich, but interspersed with proline. In fact, in the 
vertebrates there is a short proline (x7) repeat (bordered in black, coloured in lime, Figure 
2.11). This difference in the linker region may indicate a large structural difference for HsHop 
and PfHop, as the P. falciparum region most likely has alpha-helical secondary structure. 
Intriguingly, it may also provide clues for the alternate functioning of mammalian Hop in 
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neural cells. Several neurodegenerative disorders result from the cytotoxicity conferred by 
misfolded proteins. The cytotoxicity and aggregation property of a few mutant proteins are 
known to be modulated by the flanking sequences, such as a proline repeat tract (Siwach et 
al., 2011). The mammalian proline repeat tract has been shown to amend the cytotoxicity of a 
wide range of misfolded proteins coded by genetically engineered mutants. Additionally, the 
proline repeat tract may confer protection against the cytotoxicity of misfolded proteins by 
interfering with their conformation during translation and folding (Siwach et al., 2011). Hop’s 
interaction with the Hsp90 chaperone suite places it in an ideal position to perform a similar 
function. 
Proline is an exceptionally unusual amino acid in that it is cyclized, and is extremely 
restricted to certain phi and psi backbone conformations, thus a multi-proline peptide is even 
more limited. There is a repository of research reviewed by Williamson (1994) suggesting 
that a sequence of four or more proline residues in a row adopts a single preferred 
conformation in solution, known as the poly-proline II helix. This is an extended structure 
with three residues per turn. It is found primarily in some pancreatic polypeptide hormones 
and neuropeptides which mediate multi-protein complexes (Williamson, 1994).  
 
  
 
 
Figure 2.8: Condensed alignment representing the Hop DP1 region and long linker (position 86 – 148, coloured by helix propensity) for the major 
taxonomic groups (Figure 2.4) and species of interest, aligned with the relevant motifs numbered and coloured according to Figure 2.6. Several features 
are highlighted in the alignment; the DP repeats (coloured by helix propensity) and the C-terminal region of DP1 (position 72 – 84, coloured by 
hydrophobicity) residues positions are bordered in black. ‘~’ indicates lack of consensus. 
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2.6.7 TPR2A 
For almost the entire invertebrate, plant, fungi and protozoan species, TPR2A is represented 
by motifs 8 (dark grey) or 10 (light grey) at the N-terminal and motif 4 (bright pink) at the C-
terminal (see Figure 2.4). The exception is the urochordate, Ciona intestinalis (marine 
seasquirt), and this species possesses the same motif (motif 6, green) for the C-terminal end of 
DP1, long linker and TPR2A that the vertebrate species share (Figure 2.6). MAST analysis  
(see Appendix 5 Figure A5.3B), indicates that motif 6 shares high similarity to motif 4 (0.66) 
and motif 8 (0.62) which means that these two motifs are not significantly different to the 
overlapping residue sites in motif 6, an overall indication that TPR2A may not be 
significantly different in all species analysed. 
From Figure 2.10, one can see that the C-terminal portion of motif 6 (above the alignment) is 
very well conserved; almost all residues have a bit score greater than 3, while the fungal and 
protozoan motifs (displayed below the alignment) are more variable. Two interesting features 
of TPR2A that motif analysis did not detect in non-mammals are the first NLS, identified to 
be functional in mammals (Daniel et al., 2008; Odunuga et al., 2004).It also failed to 
distinguish a short, manually identified motif that appears to be highly conserved across most 
species; NXKAAVY (around position 51),its conservation is somewhat reflected in motif 4. 
Apart from the lysine at position 88, which displays arginine variability in the plants, all the 
“carboxylate binding-clamp” residues are highly (90-100%) conserved. 
2.6.8 Linker Helix and TPR2B  
For almost the entire vertebrate group, TPR2B is represented by the same motif that describes 
TPR1 in the vertebrates, invertebrates and plants, the N-terminal residues of motif 5 (yellow). 
The exceptions are the amphibian, Xenopus tropicalis, and the two ray-finned fishes, 
Oreochromis niloticus and Danio rerio (see Figure 2.6). These species are represented by the 
same motifs as those representing the invertebrate, plant, fungal and protozoan species (motif 
1 in cyan at the N-terminal). All of these species that are non-fungal are further represented by 
the N-terminal residues of motif 9 (the same as that at the C-terminal of fungal and protozoan 
TPR1) at the C-terminal (see Figure 2.6). MAST analysis (see Appendix 5 Figure A5.3B) 
shows that none of these motifs have very high similarity to each other; an overall indication 
that TPR2B may be significantly different for groups possessing different motifs in this 
region. 
  
 
Figure 2.9: Condensed alignment representing the Hop TPR2A region for the major taxonomic groups (Figure 2.4) and species of interest, aligned 
with the relevant motifs numbered and coloured according to Figure 2.6. Several features are highlighted in the alignment; the first NLS (bordered in red) 
and the “carboxylate binding clamp” residues positions are bordered in black and coloured cyan. A short motif is highlighted from position 51 – 56. ‘~’ 
indicates lack of consensus. 
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From Figure 2.10, one can see that the N-terminal portion of motif 5 (above the alignment) is 
very well conserved; almost all residues have a bit score greater than 3, while the invertebrate, 
fungal and protozoan motifs (displayed below the alignment) are more variable. Two 
interesting features of TPR2A that motif analysis did not distinguish are the second putative 
NLS (bordered in red), yet to be shown to be functional (Odunuga et al., 2004) and a short 
motif around position 190 that appears to be highly conserved across most species; 
LYSNRAA (bordered in black). Apart from the lysines at positions 154 and 220, which 
display arginine variability in the fungi, all the “carboxylate binding-clamp” residues 
(coloured in cyan and bordered in black) are highly (90-100%) conserved. The REY clamp 
residues (coloured in lime and bordered in black) are 100% conserved in all species. 
In addition to the afore mention conserved regions, TPR2B has been reported to possesses the 
charged-Y motif; an 11-amino acid motif that was originally described for the non-concave 
Hsp90 interactions on the primary TPR motifs in FKB31 and FKB32 (Cheung-Flynn et al., 
2003) and later identified as a feature of Hop (Odunuga et al., 2004). This motif has the 
consensus organization -+-+XϕYXXMFXXXX-, where - represents glutamic or aspartic acid, 
+ represents lysine or arginine, ϕ represents a hydrophobic amino acid, and X represents any 
amino acid. It is interesting to note that the identifying tyrosine in this motif is the tyrosine 
found in the REY clamp. There is also a negatively charged amino acid five positions further 
downstream which may also be related to the functioning of this motif (Cheung-Flynn et al., 
2003). The only motif describing this area bears some resemblance to this charged-Y motif; 
the overall analysis of the regex for this region in motif 1 is [+-][ϕ-]-+XϕYXXPEXXXX[ϕ-
X]. This is not a distinct match so consensus sequences for the mammal and Plasmodium 
sequences were analysed separately in Figure 2.11. 
 
  
  
 
 
Figure 2.10: Condensed alignment representing the Hop TPR2B region for the major taxonomic groups (Figure 2.4) and species of interest, aligned 
with the relevant motifs numbered and coloured according to Figure 2.6. Several features are highlighted in the alignment; the second NLS (bordered in 
red), the charged-Y motif (shaded in yellow), the “carboxylate binding clamp” residues (bordered in black and coloured cyan) and the REY clamp residues 
(bordered in black and coloured lime). A short motif is highlighted from position 186 – 192. ‘~’ indicates lack of consensus. 
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Figure 2.11: Comparison of the mammalian and Plasmodium consensus sequences with 
the charged-Y motif consensus. Matches are in capitals, mismatches in small letters. 
The mammalian consensus sequence for the charged-Y motif in Hop has six out of nine 
functional matches to the general consensus organisation for the charged-Y motif, while the 
Plasmodium consensus has only four out of nine matches. If this motif is truly a functional 
feature of Hop, it is a good starting point for assessing the alternate sites of Hop interaction 
with Hsp90, as this charged motif represents an Hsp90 interaction site on other proteins with 
TPR motifs.  
2.6.9 Short Linker and DP2 
The linker joining TPR2B and DP2 is relatively better aligned and more conserved than the 
long linker joining DP1 and TPR2A (bordered in black and coloured by helix propensity in 
Figure 2.12). It should be noted that a portion of this linker is represented by several of the C-
terminal residues in motifs 5 and 9.  As can be seen from the MEME results, DP2 is the only 
region in Hop that is represented by a single motif in all species; motif 3 (red) in Figure 2.6.   
This motif covers most of the C-terminal portion of DP2. Mast analysis (see Appendix 5 
Figure A5.3B) shows that motif 3 has low similarity to all other motifs found, even those 
describing DP1: motif 7 (similarity = 0.49) and 11 (similarity = 0.51). This indicates that DP2 
is distinct from DP1, in spite of the periodic DP repeats (coloured by helix propensity in 
Figure 2.12) and the hydrophobic stretch of C-terminal residues (coloured by hydrophobicity 
in Figure 2.12). 
 
 
  
  
 
 
 
Figure 2.12: Condensed alignment representing the Hop DP2 region and short linker (position 1 – 24, coloured by helix propensity) for the major 
taxonomic groups (Figure 2.4) and species of interest, aligned with the relevant motifs numbered and coloured according to Figure 2.6. Several features 
are highlighted in the alignment; the DP repeats (coloured by helix propensity) and the C-terminal region of DP2 (position 89 – 96, coloured by hydrophobicity, 
bordered in black). Two short, manually identified motifs are highlighted from positions 44 – 50 and 86 – 89.  
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2.7 Conclusions  
In an overview of Chapter two, one can conclude three main points that will assist with 
homology modelling and comparison of PfHop and HsHop. Firstly, Hop is very well 
conserved among all eukaryotes, particularly with regard to the “carboxylate binding-clamp” 
residues within the concave surfaces of the three TPR motifs, and in Hs- and PfHop these 
residues are identical for all three TPR motifs. Secondly, while Hop is very well conserved 
with regards to the TPR active site residues, domain organisation and other structurally 
important features such as the REY clamp, there are regions that are significantly different 
between human and P. falciparum and may be indicated by structural and functional 
disparities between the two proteins. These include what appears to be the significantly 
different (or possibly a complete absence of the) DP1 region in the Apicomplexa, the proline-
rich stretch in the long linker region of the mammals and the difference in the overall 
structure of the “charged-Y” motif within TPR2B. These are the regions that are carefully 
analysed for structural and interaction studies and may provide sites that will one day prove to 
be exploitable for selective drug targeting. 
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Chapter 3: Homology Modelling 
3.1 Introduction 
 
Homology (or comparative) modelling is a strategy by which bioinformaticists try to bridge 
what is called the “sequence structure gap” (Eswar et al., 2008; Tastan Bishop et al., 2008). 
This gap is the result of an explosion of techniques that allows us to elicit gene and protein 
sequence information at ever-decreasing cost but with a corresponding lack of cheap and fast 
methods to determine three dimensional (3D) protein structures (Berman et al., 2003).  
Protein structure determination relies mainly on the time-consuming and expensive 
techniques such Nuclear Magnetic Resonance (NMR) spectroscopy, X-Ray Crystallography  
and High Resolution Electron Microscopy. There are also the theoretical methods of 
predicting the tertiary structure of a protein referred to as ab initio prediction or threading 
(Wu & Zhang, 2007).  
 
The ability to accurately predict the tertiary structure of a protein, using nothing but the amino 
acid sequence with significant success has only ever been achieved with relatively small 
peptides. The computational requirements for modelling, taking into consideration all the 
physical and chemical attributes for all amino acid combinations, increases exponentially as 
sequence length increase. A relatively small protein would take several months to create a 
single correct model predicting its structure (Wu & Zhang, 2007). However, owing to the 
functional conservation of structure guided by natural selection and consistency of protein 
chemistry and folding governed by energy minima, it is feasible to model protein structures 
on closely related (homologous) template proteins via computational methods  (Eswar et al., 
2008; Tastan Bishop et al., 2008; Tastan Bishop & Kroon, 2011). This task relies heavily on 
complicated mathematical algorithms, requiring its automation. However, with machine 
governed automation there is always room for error; while computers are excellent at 
performing mathematical operations quickly, they cannot match human brains when it comes 
to discerning a functional pattern (such as protein fold) from massive amounts of data (Eiben 
et al., 2012; Khatib et al., 2011).  
 
This means that model prediction is in fact a strategic process comprised of several steps. This 
includes identifying features of the target sequence that may assist with determining its 
functional structure. This can be done by identifying known functional domains through a 
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homolog search with BLAST, or using a secondary structure prediction program like JPRED. 
The next step is to find accurate template models based on crystal structure data. These 
templates should at the very least have 30% identity with the target (Vyas et al., 2012; Pei, 
2008). However, in combination with MSA and structural alignment it is possible to build 
very accurate models even with sequence identities of less than 20% (Tastan Bishop & Kroon, 
2011) One then uses a variety of programs to align the target sequence to the template and 
calculate a new model, which must be checked for aberrant loop regions that don’t align and 
alternate rotamer conformations of side chains. If necessary, this model should then be refined 
or optimised (which is a simulation that allows atom positions in a model to vibrate into the 
lowest possible energy positions (Tastan Bishop & Kroon, 2011)). After refinement, several 
types of score can be used to test the accuracy of the model (Pawlowski, Gajda, Matlak, & 
Bujnicki, 2008). A human user has to guide the model prediction process by understanding 
both the concepts behind the software used and working around the limitations, double 
checking and back-tracking if necessary as a model is built (Tastan Bishop et al., 2008). 
 
3.1.1 Modeller 
Modeller is a program that comparatively predicts the tertiary structure of proteins (Sali & 
Blundell, 1993) utilising information on the intraprotein interactions within existing natively 
folded protein structures in the Protein Databank (PDB) (Berman et al., 2003; Berman et al., 
2000). It is implemented exclusively within the Python programming environment. The PDB 
is a repository for 86 487 protein structures determined by methods such as NMR and X-ray 
crystallography. A subset of these structures was used to create a set of restraints that describe 
the range of spatial conformations a residue may occupy within a specific environment (i.e., 
solvent accessibility, contact, distance, torsional angle) (Sali & Blundell, 1993). These spatial 
restraints are expressed as a probability density function (pdf) for a specific structure or 
feature. Models are constructed to satisfy the spatial restraints for each fold or interaction 
feature based on alignment between the sequences of the template and the target (Eswar et al., 
2008).  
 
The 3D models are then optimised such that their overall pdf’s violate the input (template) 
restraints as little as possible. Optimisation is an iterative process that involves alternating 
refinement steps; prediction of the rotamer orientations, recalculating the resulting shifts in 
the backbone atoms (for local energy minimization), then readjustment of the rotamers to the 
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new backbone, etc (Sali & Blundell, 1993). This will continue until the method converges at 
the global energy minima for the model. Slower refinement will theoretically result in more 
extensive sampling of the energy space for the model, and thus more likely result in lower 
energy (more native-like) models (Misura & Baker, 2005).  
 
Usually, only a single, good quality template (>30% sequence similarity, greater target 
coverage, etc.) is required for model building. However, several templates may need to be 
used to account for large gapped regions, or low sequence similarity. If the target-template 
alignment contains several different templates with many insertions and/or deletions, it is 
necessary to calculate multiple models for the same alignment (Eramian et al., 2008; Eswar et 
al., 2008; Tastan Bishop et al., 2008). This allows for better sampling of the different template 
segments and the conformations of the unaligned regions, and will usually result in a more 
accurate model, through selection of the best model (usually that with the lowest energy) 
based on a comparative score, such as the DOPE score (Shen & Sali, 2006). The most 
accurate models usually have Cα RMSD values within 0.5Å of the true native structure 
(Eswar et al., 2008). However, for targets aligned to template/s with high sequence and 
structural similarity and few, small, gapped regions (less than five residues), building multiple 
models will not necessarily result in better accuracy of the best model produced.  
 
3.1.2 PyRosetta 
PyRosetta is a stand-alone implementation of the Rosetta molecular modelling package 
(Leaver-Fay et al., 2011) that can be installed locally and run within a simple programming 
environment (Chaudhury, Lyskov, & Gray, 2010). Having similar computational performance 
to Rosetta, it can be employed for functions such as protein docking, protein folding, loop 
modelling and design using the major Rosetta sampling and scoring functions (Lyskov & 
Gray, 2008; Misura & Baker, 2005; Tyka et al., 2011). This is possible because it possesses 
Python bindings to libraries and databases that constitute Rosetta functions. The program may 
be used in two ways; script-based and interactively, using a customised Python shell called 
iPython. The interactive shell contains a number of help features; autocomplete commands for 
familiarising one’s self with the software and the ability to link the command shell to PyMOL 
for real-time visualisation of molecular changes during building, docking, refinement and 
scoring (Baugh, Lyskov, Weitzner, & Gray, 2011). Customized scripting is best suited to 
developing reusable packages and tools for research (Chaudhury et al., 2010). See, for 
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example, the “Tkinter Minimisation Toolkit” produced by Jared Adolf-Bryfogle and accessed 
at http://www.rosettacommons.org/node/2344 (Fox Chase Cancer Center, Drexel College of 
Medicine).  
 
3.1.3 Refinement in Rosetta 
The ClassicRelax mode in Rosetta carries out the task of structural refinement (Tyka et al., 
2011). After creating a crude model generated by ab-initio structure prediction or a low 
quality model created with homology modelling, one utilises the Rosetta energy function to 
refine the structure while searching through conformational space. This is a movement of the 
protein backbone and side-chain torsion angles by relatively small amounts from the starting 
structure. It has been shown to dramatically lower the full-atom energy of a model as it uses 
the Rosetta energy function, which is highly sensitive to steric clashes, to improve side-chain 
interactions significantly (Khatib et al., 2011; Misura & Baker, 2005; Tyka et al., 2011). A 
more flexible, modern version of the initial relax algorithm is FastRelax; it functions by 
running many alternating side chain repacking and minimisation cycles of non-deterministic 
Monte Carlo simulated annealing, which randomly searches combinations of side-chain 
conformations chosen from a library of possible rotamers. The structure’s RMSD can oscillate 
up to 2-3Ǻ from the starting conformation during these minimisation cycles (Leaver-Fay et 
al., 2011; Tyka et al., 2011). 
 
Relax does not perform extensive refinement and only searches the immediate local 
conformational space (Tyka et al., 2011). Researchers can create and customize their own 
minimisation protocols with this capability through the creation of “mover” methods and 
“packer” tasks in Rosetta. These tasks and methods can be restricted to certain aspects of the 
model in question, such as repacking of side chains only, or minimisations of loop regions 
only (Chaudhury et al., 2010; Leaver-Fay et al., 2011; Tyka et al., 2011). 
 
The ClassicRelax protocol in Rosetta has been validated through an application to the 
refinement of several de novo structures (Misura & Baker, 2005). Analysis showed that there 
were important structural differences between the refined models and the refined idealized 
native structures owing to errors in local backbone and side-chain conformation, as well as 
strand alignment (Misura & Baker, 2005). This study suggested that problems with backbone 
and side chain conformation are common when the true structure contains an energetically 
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unusual feature, such as an energetically unfavourable side chain rotamer or local backbone 
conformation that results in steric clashes. Additionally, low energy models with an excess of 
helical secondary structure relative to the true native structures are biased for by the Rosetta 
energy score (Lazaridis & Karplus, 1998). This is because the rotamer conformation space for 
well-formed helices is condensed and more thoroughly sampled. Additionally, helices 
contribute more favourable attractive energies and have stable hydrogen bonding networks, 
contributing favourably to the overall hydrogen bond energy. A much larger rotamer 
conformation space must be sampled to align and pair neighbouring beta strands and result in 
comparable energetically favourable structures and overall Rosetta energies (Misura & Baker, 
2005). This phenomenon may favour the minimisation of Hop homology models as it is 
comprised entirely of helices and loop orlinker secondary structures. Conversely, should the 
native structure for PfHop differ from homologs used as templates by containing beta strands 
or sheets, this step may introduce errors. 
 
3.1.4 Structure Quality Validation 
Crystal structure quality is primarily assessed through resolution, R-value and R-free scores. 
Resolution is usually recognised as a measure of the level of detail present in the diffraction 
pattern in an X-ray crystallography experiment and the resulting electron density map. The 
resolution of a model can be anything from 1-2 Å, which is highly ordered, making it  easy to 
accurately predict the position of every atom in the electron density map, and 3 Å or higher, 
which is disordered; showing only the basic surface of the protein chain. There are other 
methods, where understanding of the atomic position is not as important as getting an 
overview of tertiary and quaternary structure.  High-resolution TEM techniques, such as cryo-
EM, would result in low resolution images which may be used to create refined models with 
resolution as low as 15 Å using computational techniques (Southworth & Agard, 2011).  
Electron cryo-microscopy, a recently developed TEM technique, has been utilised to create 
images of virus particles at a resolution of 3 – 4 Å, almost atomic resolution (Grigorieff & 
Harrison 2011). 
 
The atomic model built during the process of determination through X-ray crystallography is 
used to calculate a simulated diffraction pattern based on that model. The R-value indicates 
the closeness of the match between the simulated diffraction pattern and the experimentally-
observed diffraction pattern. An R-value of 0 indicates a perfect match, while 0.63 is the score 
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one would expect from a random selection of atoms. The values for most structures in the 
PDB are around 0.20. The problem with relying solely on R-values is that subsequent 
refinement is often used to improve the atomic model and make it better fit the experimental 
data (improve the R-value), which introduces bias. To assess the extent of this bias, a second 
indicator is calculated; the R-free value. Before refinement begins, approximately 10% of the 
observed data are removed from the data set, leaving only 90% of the data free for use during 
refinement. The R-free value is then calculated by seeing how well the refined model predicts 
the 10% control data. Ideally the R-free will be similar to the R-value, in practice however, it 
is slightly higher; with a value of about 0.26.   
 
Traditionally, most model quality assessment programs focus on the evaluation of the entire 
protein structure using some form of qualitative or relative scoring function (Chaudhury et al., 
2010; Shen & Sali, 2006; Zemla et al., 2002) rather than detection of correct and incorrect 
regions. The most accurate models generally have the lowest free energy of all empirically 
predicted models under physiological conditions (Sali & Blundell, 1993; Shen & Sali, 2006). 
Free energy functions enable the prediction and assessment of the best models from a subset, 
where the free energy surface of a protein can be derived by thoroughly sampling the potential 
energy surface defined by a molecular mechanics force field, such as those utilised by 
CHARMM (Eramian et al., 2008). Owing to inherent errors in potential energy functions and 
long computational run time, an alternative to calculating the free energy surface of a protein 
is to use a scoring function whose global minimum corresponds to the true structure from a 
sample of random structures of different sequences deposited in the Protein Data Bank  
(Eramian et al., 2008; Shen & Sali, 2006).  
 
Such a scoring term is referred to as a “knowledge-based” or “statistical” potential and is not 
an explicit physical energy term, but one that may be used qualitatively. Statistical potentials 
are grouped by several characteristics: protein aspect representation (e.g., residue centroids, 
Cα-atoms and all-atoms), the restrained spatial features, and the reference state (Lazaridis & 
Karplus, 1998, 1999). Scores utilising all-atom representation, such as the DOPE and Rosetta 
energy scores, are generally more accurate than those for an amino acid residue 
representation. This usually results in increased accuracy for best model selection.  
 
Programs that are capable of evaluating specific regions or residues of the model in question 
often recommend evaluating a score that is averaged over a long stretch of residues. Two such 
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programs are ANOLEA and VERIFY3D.  ANOLEA uses a highly sensitive atomic mean 
force potential (AMFP) to calculate the non-local energy profile of a structure (in graphical 
output). Very high scores represent areas in the model where stereo-chemistry is not feasible 
and misalignments have occurred. These regions almost invariably point to loops or areas 
where alternate rotamer conformations are possible (Melo & Feytmans, 1998). VERIFY3D 
was developed to produce a 3D profile of the atomic coordinates of a structure which, when 
the model is accurate, matches that of its own sequence resulting in high scores (Luthy, Bowie 
& Eisenberg, 1992).  
 
3.1.5 Normalised DOPE Score 
The Discrete Optimised Protein Energy (DOPE) score is an atomic distance-dependent 
statistical potential used to evaluate structures. It is based on a physical reference state that 
corresponds to non-interacting atoms within a uniform sphere, with the finite size and 
spherical shape of proteins dependent on a sample native structure (Shen & Sali, 2006). The 
normalized version of the DOPE score (N-DOPE, Eramian et al., 2008) is commonly used; it 
is a standard Z-score derived from basic statistics of raw DOPE scores (mean and standard 
deviation); where positive scores are likely to be poor models, while scores lower than -1 are 
likely to be closest to the native structure (Eswar et al., 2008). The performance of normalised 
DOPE score was superior compared to thirteen other commonly used statistical potentials, 
however, it increased when the overall accuracy of the subset of models being assessed was 
increased (Eramian et al., 2008). This is a commonly observed trend for other scoring 
functions, if to a lesser extent. Additionally, the average correlation of normalised DOPE to 
Rosetta and RMSD scores exhibits slight improvement when limited to high-accuracy targets 
(Tastan Bishop & Kroon, 2011).  
 
3.1.6 Rosetta Energy Score 
The Rosetta energy score was initially developed to distinguish misfolded models from native 
structures (Lazaridis & Karplus, 1998). A revised function for proteins in solution utilizes an 
improved CHARMM19 polar hydrogen potential energy function complemented by a simple 
Gaussian model for the solvation free energy and described in detail by Lazaridis and Karplus 
(1999). Although many aspects of this scoring function are heuristic, it differs significantly 
from ‘‘knowledge-based’’ potentials and can be used for molecular dynamics simulations as 
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well as for comparing a high-accuracy subset of structures (Lazaridis & Karplus, 1999). The 
Rosetta energy function involves significant approximations, such as modelling solvent 
implicitly rather than explicitly and neglecting long-range electrostatics which results in 
assignment of higher energies to the more accurate models than to the incorrect models. These 
cases appear to be primarily for native structures that are not globular (Lazaridis & Karplus, 
1998), like Hop, or that have differences in helix and sheet content between the native 
structure and the unrefined models for reasons explained previously. However, the Rosetta 
energy performs relatively well regardless (Eramian et al., 2008) and when considered 
alongside the normalised DOPE, has a good correlation to the DOPE score for high-accuracy 
models (Tastan Bishop & Kroon, 2011). 
 
3.1.7 MetaMQAPII 
MetaMQAPII is a program designed to accurately assess the local structural quality of a 
model as well as overall tertiary accuracy (Pawlowski et al., 2008). This program is a meta-
server that incorporates results from eight other model quality assessment servers; 
VERIFY3D, ProSA (Wiederstein & Sippl, 2007), ANOLEA, BALA-SNAPP 
(Krishnamoorthy & Tropsha, 2003), TUNE (Lin, May & Taylor, 2002), REFINER (Boniecki 
et al., 2003) and PROQRES (Wallner & Elofsson, 2006). MetaMQAPII assesses each residue 
in a structure by first placing it into one of 315 electrostatic environment groups. For each of 
these groups, a unique linear regression model has been developed to determine the RMSD of 
a residue within that group from its location in the native structure, depending on how well it 
was scored by the combination of eight different quality assessment servers (Pawlowski et al., 
2008). The meta-server then outputs a PDB coordinate file of the model, where the B-factors 
for each residue have been replaced with the ranking score from the overall assessment. These 
scores can then be visualised in most molecular visualisation software and are represented on 
a colour spectrum from blue (correct, low RMSD from native)  to red (incorrect, high RMSD 
from native) to quickly identify problematic regions (Pawlowski et al., 2008). Along with this 
coordinate file, MetaMQAPII also returns a log file containing the predicted GDT_TS score 
(Zemla et al., 2002), an overall RMSD value describing the predicted deviation in angstroms 
from the true protein structure, and a table containing all residue scores returned from each of 
the eight model quality assessment programs used by the meta-server.  
 
 
 
 70 
 
3.2 Methods and Software 
3.2.1 Structure Retrieval 
All structures used for homology modelling were retrieved from the PDB Repository. Except 
for 4GCO, all structures were referenced structures associated with peer-reviewed literature. 
The structure 4GCO from C. elegans is not associated with a publication; more information 
can be found from: http://kiemlicz.med.virginia.edu/mcsg/deposits/index. The structures were 
viewed with visualization programs such as PyMOL (DeLano, 2002), Discovery Studio 
Visualizer (Accelrys Software Inc., 2007) and MATLAB’s MolViewer (The MathWorks Inc., 
2009). 
 
3.2.2 Homology Modelling 
Non-protein atoms (water and ions) were removed from coordinate files by selecting and 
saving only the peptide chains, in PyMOL. Homology models were generated using Modeller 
(Eswar et al., 2008; Shen & Sali, 2006) in high throughput fashion to predict PfHopTPR2A-
PfHsp90 (C-terminal motif) and PfHopTPR2B (and TPR1)-PfHsp70 (C-terminal motif) 
complexes using published templates as well as HsHop (relevant TPR regions) in complex 
with the PfHsp90 and PfHsp70-x C-terminal motifs. For every template-target combination, 
100 models were built using the standard ”automodel” routine of the program with a very 
slow refinement option. See Appendix 2, Section B, for examples of modelling scripts used.  
 
3.2.3 Model Validation 
The quality of the homology models was evaluated by calculating several parameters. While 
the primary indicator used to select for top models was the N-DOPE Z score, two other 
energy scores; the Cα-RMSD (from template) and Rosetta Energy scores were calculated for 
all models. See Appendix 6, Section C, for examples of the scripts used to calculate and 
compare these various scores. Ramachandran plots produced in Rampage (Lovell et al., 
2003), as well as visualisation of MetaMQAPIIscores obtained for each monomer from the 
MetaMQAPII web server (Pawlowski et al., 2008) were used to assess model quality at the 
level of individual residues. 
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3.2.4 Post-modelling Optimisation and Modification  
Models were further refined using the Tkinter Minimisation Toolkit (produced by Jared 
Adolf-Bryfogle, Lab of Dr. Roland Dunbrack, Fox Chase Cancer Center, Drexel College of 
Medicine) which utilises the Classic- and FastRelax protocols in PyRosetta.  
3.3 Results and Discussion 
3.3.1 Template Analysis Summary 
This section contains a final summary of all templates used to create working human and P. 
falciparum homology models. The data pertaining to the templates summarised in Tables 3.1 
and 3.2 will be discussed in depth in sections in Section 3.3.2. 
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Table 3.1: Complex structure template summary. 
Template 1ELW 3UQ3 3UPV SchmidCYS 
Organism H. sapiens S.cerevisiae S. cerevisiae S. cerevisiae 
Hop Domain Chain A: HsTPR1 
 
Chain A: 
ScTPR2A&B 
Chain A: ScTPR2B Chain B: 
ScTPR2A&B (chain 
B is 3UQ3) 
Hop Partner/s Chain C: HsHsp70-
GPTIEEVD  
C-terminal motif 
Chain B: 
ScHsp90-
MEEVD  
C-terminal motif 
 
Chain C: 
ScHsp70-EVD  
C-terminal motif 
 Chain B: 
 ScHsp70-PTVEEVD     
 C-terminal motif 
 Chain A: ScHsp90   
M and C Domains 
Structure 
Determination 
XRD XRD XRD Combination of 
Spin-labelling and 
Docking 
Techniques 
Resolution 1.60 Å 2.60 Å 1.60 Å N/A 
R-Value 0.180 0.222 0.186 N/A 
R-Free 0.215 0.279 0.254 N/A 
N-DOPE Z -2.569 -1.562 -2.352 -1.069 
Rosetta Energy -257.680 -229.453 -161.600 199.047 
Minimised N-
DOPE Z 
-2.536 -1.666 -2.378 -1.166 
Minimised 
Rosetta Energy 
-368.205 -811.139 -400.139 -1680.626 
Interaction 
Energy* 
-10.709  Overall: -21.493 
2A: -13.434 
 2B: -8.058 
-9.96 5.566 
 
Binding Energy* 42.112 Overall: 298.502 
2A: 298.874  
2B: 303.651 
110.386 -1404.36 
 
% ID to 
corresponding 
domain in target 
PfHopTPR1:  
39.84% 
HsHopTPR2AB: 
46.36% 
PfHopTPR2AB: 
36.63% 
 PfHopTPR2B: 
 49.61% 
 HsHopTPR2B:      
45.61% 
 HsHsp90: 61.00% 
 PfHsp90: 36.00% 
 
Reference (Scheufler et al., 
2000) 
(Schmid et al., 
2012) 
(Schmid et al., 2012) (Schmid et al., 
2012) 
*In terms of Rosetta energy scores. See Chapter 4 for explanation of how the binding and interaction 
energies were calculated. 
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Table 3.2: Single structure template summary. 
 
 
 
 
 
 
 
 
 
 
3.3.2 Template Analysis for TPR structures 
Template 2LLV 2LLW 4GCO 
Organism S. cerevisiae S. cerevisiae C. elegans 
Hop Domain Chain A: ScDP1 
 
Chain A: ScDP2 Chain A: CeTPR2B 
Structure 
Determination 
Solution NMR 
Average of 21 Models 
 
Solution NMR 
Average of 21 Models 
XRD 
Resolution N/A N/A 1.60 Å 
R-Value N/A N/A 0.179 
R-Free N/A N/A 0.219 
Modeller’s  
N-DOPE Z 
-1.680 2.405 -2.168 
Rosetta Energy 182.126 24781.403 -95.861 
Minimised   
N-DOPE Z 
-2.279 -0.398 -2.189 
Minimised Rosetta 
Energy 
-140.029 4137.759 -352.763 
% ID to corresponding 
domain in target 
HsHopDP1: 31.17% 
PfHopDP1: 24.32% 
 
HsHopDP2: 40.23% 
PfHopDP2: 33.33% 
 
PfHopTPR2B: 49.11% 
Reference (Schmid et al., 2012) (Schmid et al., 2012) (Osipiuk et al., 2012) 
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Table 3.3: Percentage identity for various domains to be modelled from yeast templates 
in human and P.falciparum. 
Yeast 
Template 
Human P. falciparum Human and 
P.falciparum 
TPR1 34.68% 36.00% 39.84% 
DP1 31.17% 24.32% 22.64% 
TPR2 46.36% 36.63% 42.69% 
DP2 40.23% 33.33% 36.78% 
 
3.3.2.1 Template for Modelling TPR1 
The first functional domain of Hop is the TPR1 region. A single, high quality structure for 
this region (in human Hop) in complex with HsHsp70-GPTIEEVD C-terminal motif was used 
to model this region in PfHop (Scheufler et al., 2000). This crystal structure has excellent 
resolution (1.6Ǻ) with low overall R-value and R-free scores. 
 
Figure 3.1: A) MetaMQAPII rendition of chain A 1ELW B) MetaMQAPII rendition of 
minimised 1ELW chain A. 
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Figure 3.2: Ramachandran plots for A) 1ELW and B) minimised 1ELW.Black triangles 
and squares represent amino acids in the “Favoured” regions, Orange. Triangles and squares 
represent amino acids in the “allowed” regions. 
From Table 3.1, and Figure 3.1, it was seen that the overall beta-factor scores as well as the 
Rosetta energy for the minimised version of 1ELW were lower. However, the original version 
of the template still had the lowest N-DOPE Z score and Ramachandran plots (Figure 3.2) 
indicated that the original and the minimised structures were of equal quality. 
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3.3.2.2 Templates for Modelling HopTPR2A&B in Complex with C-terminal Partner 
Peptides 
The third and fourth functional domains of Hop are the TPR2AB regions. Two high quality 
structures for this region (in yeast Hop) in complex with ScHsp90-MEEVD and ScHsp70-
PTVEEVD C-terminal motifs were used to model this region in both P. falciparum and 
human Hop (Schmid et al., 2012). 3UQ3 is a relatively good quality structure (resolution of 
2.6Ǻ) derived through XRD of ScHopTPR2A&B in complex with 5 residues of ScHsp90 C-
terminal motif (MEEVD) and three residues of ScHsp70 C-terminal motif (EVD).  
While the well characterised “double carboxylate binding clamp” appears to interact primarily 
with the last four residues of partner protein i.e. EEVD, the interactions described above 
cannot discriminate between the C-terminal motifs of Hsp70 and Hsp90 and additional 
contacts are made with residues upstream of  the EEVD motif  (Scheufler et al., 2000). 
Previous studies (in humans) have shown that these contacts are important; the C-terminal 
heptamer motif (GPTIEEVD) of Hsc70 will bind to TPR1 with the same affinity as the 
complete C-terminal domain of Hsp70/Hsc70, but the C-terminal tetramer motif  (EEVD)  
resulted in a sharp drop in the affinity of TPR1 for Hsp70. Additionally an extension of this 
motif (IEEVD) to match the length of the Hsp90 (MEEVD) peptide, still bound with 
significantly weaker affinity than the heptamer peptide (Scheufler et al., 2000). 
Similar studies in yeast published earlier in 2012 show that the TPR2A domain possesses a 
hydrophobic pocket to accommodate the methionine in MEEVD of Hsp90 as observed in the 
structure of 3UQ3. TPR2B lacks this pocket but contains a selective binding cavity for the 
threonine in PTVEEVD in Hsp70, although, the peptide backbone has to adopt an 
energetically unfavourable helical turn to bind at this position. As TPR1 is so similar to 
TPR2B in humans (as established in Chapter 2), it is logical to assume that the same 
improved interaction with longer C-terminal peptide is true for TPR2B. For this reason the 
additional template, 3UPV, representing the yeast TPR2B region in complex with a longer 
Hsp70 C-terminal peptide (PTVEEVD) than that available in 3UQ3 (EVD), was used in 
combination with 3UQ3 to create homology models of human and P. falciparum 
HopTPR2A&B with longer C-terminal Hsc70 and Hsp70 motifs. 
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Figure 3.3: A) MetaMQAPII rendition of chain A 3UQ3 B) MetaMQAPII rendition of 
minimised 3UQ3 chain A. 
 
MetaMQAPII analysis identifies several problematic regions in both the original 3UQ3 
structure and the minimised version (red and orange regions, Figure 3.3). One of these regions 
is the tyrosine residue of the “REY clamp” within the linker (arrows, Figure 3.3 and see also 
Figure 3.4).  
 
As discussed earlier in the chapter, unusual features naturally occurring within a template/ 
true native structure can affect the accuracy of a minimised model, as these unusual features 
(such as energetically unfavourable interactions) tend to be “smoothed out”. There is good 
evidence to suggest that Hop possesses such a feature (see Chapter 1 and Chapter 2). This 
involves the completely conserved “REY clamp” residues which function as the rigid linker 
that forces TPR2AB into an S-shaped conformation (Schmid et al., 2012). In yeast, the 
importance of the interactions between these residues was demonstrated by mutating the 
arginine that positions the rigid linker (Schmid et al., 2012). This mutation affected correct 
folding of glucocorticoid receptor (GR) and thus GR activity was reduced to about 55%. This 
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rigid linker is thought to be formed through cation-π packing of the arginine side chain 
against the aromatic ring of the tyrosine (Figure 3.4 A). These residues are further stabilized 
via hydrogen bond formation between glutamine and both arginine and tyrosine. The structure 
of this linker was further validated through analysis of the X-ray crystallography data, 
revealing that electron density of the linker region between the two TPR2AB domains is 
structurally well defined (Schmid et al., 2012).  
 
 
Figure 3.4: The REY clamp residues (stick representation; TYR390, GLU421 and 
ARG425) for MetaMQAPII rendition of chain A 3UQ3 A) Before minimisation B) After 
minimisation. The orange dashes indicate polar contacts predicted between the three residues 
in PyMOL. 
 
From Table 3.1, it can be seen that the N-DOPE Z score and Rosetta energy for the minimised 
version of 3UQ3 is lower. The overall MetaMQAPII scores for both models indicate that 
some regions are improved while others are degraded with minimisation (see Figure 3.3). 
This is the case for the linker region displayed in Figure 3.4. An intra-protein interaction 
calculator within the PIC webserver was used to validate the existence of the REY clamp 
interactions in templates and models as well as their minimised counterparts. Visualisation of 
polar contacts within PyMOL (dotted orange lines, Figure 3.4) indicates a loss of these 
important interactions between these three residues within the REY clamp through 
reorientation of the tyrosine residue (i.e. presenting a different rotamer), while analysis of 
interactions predicted by the Protein Interaction Calculator (PIC, discussed in Chapter 4) see 
Table 3.4, indicates a total loss of interaction. These REY clamp interactions were also used 
as an indicator of model quality and assessed as such in all relevant templates and models. 
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Table 3.4: Intra-protein interactions calculated by the PIC webserver pertaining to the 
residues with the REY clamp. The final column represents interactions between any of the 
three REY residues with any non-REY residue in the structure. 
 
 
Main-Side 
chain 
Interactions 
Side-Side 
chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
Interactions 
Non intra-
REY 
interaction
s 
3UQ3 
2 x ARG-
TYR 
1 x TYR-GLU 
2 x ARG-TYR 
3 x ARG-GLU 
1 x GLU-ARG 
1 x TYR-
ARG 
0 
Minimised 0 0 0 0 0 
 
 
Figure 3.5: Ramachandran plots for A) 3UQ3 and B) minimised 3UQ3. Black -triangles 
and squares represent amino acids in the “Favoured” regions, Orange. Triangles and squares 
represent amino acids in the “allowed” regions. 
A Ramachandran plot (Figure 3.5) indicates that both the original structure and the minimised 
structure are roughly of equal quality. As described above, to create models in complex with 
longer Hsp/Hsc70 C-terminal peptide, a second template (3UPV) was aligned to the first used 
to model the TPR2B region.  
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Figure 3.6: A) MetaMQAPII rendition of 3UPV. B) MetaMQAPII rendition of 
minimised 3UPV. 
 
Figure 3.7: Ramachandran plots for A) 3UPV and B) minimised 3UPV. Black triangles 
and squares represent amino acids in the “Favoured” regions, Orange. Triangles and squares 
represent amino acids in the “allowed” regions. 
From Table 3.1, it can be seen that the N-DOPE Z score and Rosetta energy for the minimised 
version of 3UPV is lower. However, the overall METAMQAPII scores for both models 
indicate that there is degradation of quality with minimisation, particularly for the secondary 
structure of the C-terminal peptide of Hsp70 (see Figure 3.6). Ramachandran plots show that 
the original structure is of very high quality (all residues in the “favoured” regions) and that 
minimisation moves a single residue (PHE312) from the “favoured” to the “allowed” region 
(see Figure 3.7). 
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3.3.2.3 Templates for Modelling the ScHsp90 M and C Domains in Complex with HopTPR2 
Schmid et al. (2012) and (Lee et al., 2012) have suggested that as the affinity of Hop for 
Hsp90 is much higher than that of the Hsp90 C-terminal peptide. There is most likely 
additional binding site/s for Hop in Hsp90, especially considering that the ATPase inhibition 
by Hop also requires an additional interaction site/s (Lee et al., 2012). They thus investigated 
this interaction by docking the ScHop TPR2 fragment (3UQ3, minus C-terminal partner 
peptides) to a low-resolution spin-labled model ScHsp90 M and C domain fragment. Spin 
labelling was done with three single cysteine variants of the ScHsp90-M domain. As ScHsp90 
does not possess cysteine, three serines (at postions 411, SER422, SER456) were mutated to 
cysteine which were then modified via the addition of iodoacetamido-proxyl and reduced with 
ascorbic acid.  The proxyl-modified template of the Hsp90 M and C domain fragment was 
refined with software that back calculates NOE restraints from a crystal structure template 
(Schwieters et al, 2003). The template used to do this was 2CGE, which is a ScHp90 M and C 
domain fragment in complex an ATP analogue and the co-chaperone Sba1 (Ali et al., 2006). 
As such, this complex was not published in the PDB, however the coordinates for this 
structure were kindly provided by the authors (see file ‘hsp90_sti1_clomplex.pdb’, the 
modified cysteine residues are identified as CYM). As a template, the structure presented 
several issues. This structure does not address conformational changes in the overall backbone 
structure of the Hop TPR2 fragment owing to C-terminal peptide binding, versus that 
resulting from alternate Hsp90 binding. The modified CYM residues in the Hsp90 half of the 
complex had to be changed to either cysteine (mutant) or serine (native), owing to constraints 
in the Modeller software, which does not recognise non-standard amino acids. Two of these 
modified CYM residues are in the region where Hsp90 interacts with HopTPR2 (see Figure 
3.8).  
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Figure 3.8: Cartoon representation of Hop TPR2 (magenta) in complex with Hsp90 M 
and C domain (green). The three proxyl modified cysteines are labelled and displayed in 
stick representation (scarlet). CYM411 and 456 are close to the site of interaction with 
TPR2A. 
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Figure 3.9: Stick representation of A) the proxyl modified cysteine (CYM) and B) 
cysteine displayed above the sphere representation of C) CYM and D) cysteine. The 
proxyl group is a cyclic, bulky molecule that may lead to distortion of the native protein 
backbone. 
It was decided that in silico modification of the model would be limited to removing the 
atomic co-ordinates of the proxyl group from the modified cysteines, leaving the template 
model as a cysteine mutant (see Figure 3.9 and file ‘tailess_schimdCYS.pdb’). This is because 
there is less modification of the template than that required to modify to serine (which could 
introduce significant backbone errors). PyMOL predicted no protein-protein polar contacts for 
the three mutant CYS residues in the modified template file, while the PIC predicted a single 
side-side chain hydrogen bond interaction between the sulfur atom of CYS411 (H-bond 
donor) and the second side-chain oxygen of GLU379 in HopTPR2. Both of these atoms were 
detected by alanine scanning and were predicted to contribute favourably to complex 
formation.  
As part of the homology modelling control process, best of 100 self-models were analysed for 
each template. For this template, two self-models were built on the template structure 
‘tailess_schmidCYS’; the sequences for these differed only by the three residues representing 
the native structure (with serine in place of CYM) and the mutant structure (with cysteine in 
place of CYM). It is interesting to note that the best of 100 self-models representing the native 
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Hsp90 had lower N-DOPE Z, Rosetta energy and Cα-RMSD (to the template) scores, than the 
best of 100 representing mutant Hsp90 (see Table 3.5). This demonstrates that just three 
cysteine mutations can noticeably affect overall backbone structure compared to the native 
structure of Hsp90.  
Table 3.5: Comparing native versus mutant self-models of the template 
‘tailess_SchmidCYS’. 
Model 
N-DOPE 
Z 
Rosetta Cα-RMSD 
tailess_schmidCYS.pdb -1.069 199.047 0.000 
tailess_schmidCYS_cysteinecontrol.B99990098.pd
b 
-0.879 1829.022 0.242 
tailess_schmidCYS_serinecontrol.B99990024.pdb -0.905 1777.032 0.209 
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Figure 3.10: A) MetaMQAPII rendition of the Hsp90 half of SchmidCYS. B) 
MetaMQAPII rendition of the minimised Hsp90 half of SchmidCYS. 
For general analysis of the ‘tailess_schmidCYS’ template, it was plain to see from Table 3.1 
that minimisation resulted in marked improvement of the N-DOPE Z and Rosetta energy 
scores. Based on MetaMQAPII scores, the Hsp90 half of the complex shows overall 
improvement with minimisation (see Figure 3.10), which is confirmed by the Ramachandran 
plots for the original and minimised versions of Hsp90 (see Figure 3.11). Minimisation 
reduced the number of residues occupying both the disallowed and allowed phi and psi 
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regions, and increased the percentage of residues within the favoured region from 91.4% to 
93.4%.  
 
 
Figure 3.11: Ramachandran plots for A) Hsp90 half of SchmidCYS, red squares indicate 
residues (VAL311, LEU530, THR533, SER605 and GLU660) occupying disallowed 
regions. B) Minimised Hsp90 half of SchmidCYS, red squares indicate residues 
(VAL311, THR533, SER605 and GLU660) occupying disallowed regions. Black triangles 
and squares represent amino acids in the “Favoured” regions, Orange. Triangles and squares 
represent amino acids in the “allowed” regions. 
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Figure 3.12: MetaMQAPII rendition of the Hop half of SchmidCYS. B) MetaMQAPII 
rendition of the minimised Hop half of SchmidCYS. 
Based on MetaMQAPII representation, the Hop half of the complex appears to decrease in 
quality with minimisation (see Figure 3.12), while Ramachandran plots indicate that both the 
original and minimised versions of Hop are of equal quality (see Figure 3.13). 
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Figure 3.13: Ramachandran plots for A) Hop half of SchmidCYS and B) minimised Hop 
half of SchmidCYS. Black triangles and squares represent amino acids in the “Favoured” 
regions, Orange. Triangles and squares represent amino acids in the “allowed” regions. 
 
Table 3.6: Intra-protein interactions calculated by the PIC webserver pertaining to the 
residues with the REY clamp in the Hop half of SchmidCYS. The final column represents 
interactions between any of the three REY residues with any non-REY residue in the 
structure. 
 
 
Main-Side 
chain 
Interactions 
Side-Side 
chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
Interactions 
Non intra-
REY 
interactio
ns 
Hop half of 
tailess_ 
schmidCYS  
2 x ARG-TYR 
2 x TYR-
GLU 
2 x ARG-
TYR 
3 x ARG-
GLU 
1 x GLU-
ARG 
1 x TYR-ARG 
1 x Ionic 
GLU-
LYS424 
 
1 x Cation-
pi 
TYR-
LYS424 
Minimised 0 0 0 0 0 
 
MetaMQAPII and PIC analysis of the REY clampin the Hop half of SchmidCYS, shows a 
complete degradation of interactions between the three residues (see Figure 3.14 and Table 
3.6) as well as a change in orientation of the tyrosine with respect to glutamine and arginine. 
This is similar to change in the REY clamp displayed in the minimised version of 3UQ3. It is 
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interesting to notice that Table 3.6 and 3.4 show slightly different results, considering that the 
Hop half of SchmidCYS is 3UQ3. This difference in co-ordination of the residues in the REY 
clamp was most probably a result of fine backbone changes that occurred due to docking 
algorithm (and likely several refinement steps) used to create the model in the first place. 
Alternatively, this difference may also have been as a result of fine backbone changes to the 
S-shaped conformation of TPR2A when not bound to both Hsp90 and Hsp70 C-terminal 
peptides or when bound to Hsp90 M and C domain. As there was slightly more interactions 
between the REY clamp residues in Table 3.6, this may indicate that alternate binding to 
Hsp90 M and C domains actually stabilises or promotes the S-shaped conformation of the 
TPR2 domain when in the multi-chaperone complex, a conclusion arrived at elsewhere in the 
literature (Cheung-Flynn et al., 2003; Schmid et al., 2012; Southworth & Agard, 2011). 
 
 
Figure 3.14: The REY clamp residues (stick representation; TYR390, GLU421 and 
ARG425) for MetaMQAPII rendition of chain B SchmidCYS. A) Before minimisation 
and B) after minimisation. The orange dashes indicate polar contacts predicted between the 
three residues in PyMOL. 
Recently, two NMR structures of C. elegans N-terminal Hop TPR regions in isolation were 
published to the PDB (Osipiuk et al., 2012). Owing to initial difficulties in modelling PfHop 
TPR2 in complex with PfHsp90 M and C domains, several multi template combinations were 
explored. One of these structures from CeHop (4GCO, with high similarity to the TPR2B 
region in PfHop), in combination with the “tailess_schmidCYS”template, yielded the best 
homology models. Based on the analysis of several pilot models of PfHop in complex with 
PfHsp90, the TPR2B region adopts a wider range of conformations than does the TPR2A 
region. The slightly better model produced with the inclusion of 4GCO as a template may 
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account for small conformational changes that better reflect the PfTPR2B in complex with 
Hsp90 while not bound to C-terminal peptide of Hsp70. This is because in this structure, 
3UQ3 is not represented in complex with the C-terminal peptides of Hsp70 and Hsp90,  with 
which its structure was originally determined, while the structure for 4GCO was determined 
unbound to C-terminal peptide (Osipiuk et al., 2012). This is speculative and it is possible that 
the model quality was increased simply because 4GCO is a better quality template (see Table 
3.2) than 3UQ3 (see Table 3.1). However, it is curious to note that 3UPV, which has similar 
template quality to 4GCO (see Table 3.1), did not yield models of comparable quality in place 
of 4GCO. It is more likely as a result of subtle sequential or structural features that are shared 
by invertebrates and protozoans but not by fungi, such as motif 9 (olive green, Figure 2.6), 
discussed in Chapter 2.  
 
Figure 3.15: A) MetaMQAPII rendition of 4GCO. B) MetaMQAPII rendition of the 
minimised 4GCO template. 
Overall analysis, shows that 4GCO was an excellent template structure that minimisation did 
little to improve on (see respective N-DOPE Z and Rosetta energy scores, Table 3.2). 
MetaMQAPII analysis shows that there was almost no change of 4GCO with minimisation 
(Figure 3.15); while Ramachandran plot analysis indicated that the minimised and original 
versions of the template were of equal quality (Figure 3.16). 
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Figure 3.16: Ramachandran plots for A) 4GCO and B) minimised 4GCO.Black triangles 
and squares represent amino acids in the “Favoured” regions, Orange. Triangles and squares 
represent amino acids in the “allowed” regions. 
3.3.2.4 Template Analysis for DP Structures 
 
As seen from Table 3.1, the average of 21 NMR models used to model DP1 in HsHop and 
PfHop was of high quality, with low N-DOPE Z and Rosetta energy scores, both before and 
after minimisation. This was because DP1 appeared to have a very rigid structure and all 21 
models were in good agreement, so the average was well represented with the data (see Figure 
1.5, Chapter 1). It was for this reason that the DP1 regions in both PfHop and HsHop were 
modelled based on a minimised average of the 21 models in 2LLV.  
 
For DP2, however, there was slightly weaker agreement of the models (see Figure 1.5, 
Chapter 1). This disagreement was thought to explain the functionality of DP2 as a cleft that 
helps stabilize client protein, and the models seem to represent the range from most open to 
most closed conformation of DP2 (Schmid et al., 2012). A different approach was used to 
select a working template, as the average structure of all 21 models had very high N-DOPE Z 
and Rosetta energy scores, and even minimisation of the average yielded a poor model (Table 
3.2). Based on the assumption that the minimised average is a good proxy for the native, 
unbound, solution state of DP2 (the rationale for this is explained in detail in Chapter 4), a 
single model out of the 21 was selected based on how well it was structurally aligned to the 
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minimised average. The model selected was that representing state 9 in PDB entry 2LLW (see 
Figure 3.17). 
 
 
Figure 3.17:  Selecting a representative template for DP2. A) All 21 models in 2LLW are 
superposed and represented in cartoon (cyan), with the exception of B) the minimised average 
of all models (scarlet) and state 9 (navy).  
 
It was satisfying to note that the selected state had the lowest N-DOPE Z score (-2.166) of all 
21 models. It also appears that the minimised average makes a good proxy for the native and 
unbound solution state of DP2, as it represented the most closed (globular) conformation state 
of 2LLW. As discussed in Chapter 1, this closed conformation is most likely because of 
shielding of the hydrophobic residues in the centre of the protein (see Figure 1.8.D, Chapter 
1) that may assist in interaction with Hsp70’s client protein. 
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Figure 3.18: A) MetaMQAPII rendition of the average structure of 2LLV B) 
MetaMQAPII rendition of the minimised average structure of 2LLV. 
MetaMQAPII analysis of both the average and minimised average structure of both 2LLV 
(Figure 3.19) and 2LLW (Figure 3.18 A and B) indicated that the structures are slightly 
degraded with refinement in certain regions while other regions are improved. The 
MetaMQAPII scores for state 9 indicated poorer model quality (Figure 3.19), which was 
surprising considering that the N-DOPE Z and Rosetta energy scores (-2.166 and 83.419, 
respectively) for state 9 are drastically lower than that of the average and minimised average 
structures (see Table 3.1).  
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Figure 3.19: A) MetaMQAPII rendition of the average structure of 2LLW. B) 
MetaMQAPII rendition of the minimised average structure of 2LLW. C) MetaMQAPII 
rendition of the state 9 of 2LLW. 
 
  
 
 95 
3.3.3 Homology Modelling Summary 
 
Table 3.7 below summarises the energy scores for the best of 100 self-models built for each 
template. This was a form of control to test the efficacy of the homology modelling process. 
For almost all self-models built, the N-DOPE Z-scores are very close to that of the original 
templates (see Tables 3.1 and 3.2) and are in general very good models (N-DOPE Z > 1).The 
exceptions are the two SchmidCYS models, which have significantly lower N-DOPE Z scores 
than the original template (the reasons for this are discussed in Section 3.4.3) and the 3UQ3 
self-model, which has a relatively large Cα-RMSD score compared to its original template. 
This is likely as a result of problems in modelling the constrained linker region (discussed in 
Section 3.3.2.2 See also Section 2.6.8, in Chapter 2) that is responsible for the S-shaped 
backbone conformation in the structure of TPR2. 
Table 3.7: Energy scores for best of 100 self-models built for each template. 
Model 
N-DOPE 
Z 
Rosetta 
Energy 
Cα-
RMSD 
4GCO_mod_control.B99990013.pdb -1.973 46.339 0.146 
tailess_schmidCYS_cysteinecontrol.B99990098.pdb -0.879 1829.022 0.242 
tailess_schmidCYS_serinecontrol.B99990024.pdb -0.905 1777.032 0.209 
1ELW_mod_control.B99990017.pdb -2.3243 -105.552 0.126 
2LLV_average_control.B99990072.pdb -1.677 471.713 0.269 
2LLW1_state009_control.B99990020.pdb -2.147 250.841 0.320 
3uq3_TPR2ab_control.B99990073.pdb -1.304 5.464 0.873 
 
Table 3.8 summarises the energy scores for the best of 100 models built for each species, and, 
if the case, the minimised version of that model. These are ultimately the final products of 
Chapter 3. The files for these structures have been provided in the supplementary data 
provided on disk and their validation has been described in Sections 3.3.3.1 and 3.3.3.2. 
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Table 3.8: Energy scores for best of 100 models built for each species domain or 
interaction. 
* Alternate PfHsp70-x C-terminal binding complexes. 
It is important to note that the four models with an “N” in the file name, are the models 
created to simulate the interactions between TPR regions in HsHop interacting with the 
alternate C-terminal motif present in the Hsp70 variant, PfHsp70-x, that is transported to the 
erythrocyte cytosol (as discussed in Chapter 1, Section 1.7 and Chapter 4, Section 4.5). These 
validation for these models is not discussed owing to time constraints, however their quality is 
very similar to that of their normal counterparts (i.e. TPR domains in complex with  Hsp70-
1), as the models differ by one or two residues. 
 
  
Model 
N-DOPE 
Z 
Rosetta 
Energy 
Cα-RMSD 
Minimised_PfHopTPR1.B99990036_1.pdb -2.432 -361.134 6.926 
PfHopTPR1N.B99990050.pdb* -2.135 261.725 6.768 
HsHopTPR1N.B99990001.pdb* -2.342 -69.055 0.103 
HsTPR2ab2yeast.B99990013.pdb -0.919 980.277 10.984 
HsTPR2ab2N.B99990083.pdb* -0.976 774.873 10.938 
PfTPR2ab2yeast.B99990014.pdb -1.056 1248.952 7.180 
PfTPR2ab2N.B99990061.pdb* -1.072 1109.672 7.028 
MinimisedHscomplex_07_1.pdb -1.095 -1600.531 5.850 
MinimisedPfMulti_102.pdb -0.824 -1625.737 15.991 
PfDP1.B99990060.pdb -0.786 604.815 11.490 
PfDP2009.B99990003.pdb -2.029 446.246 0.490 
HsDP1.B99990080.pdb -1.623 485.168 9.265 
HsDP2.B99990038.pdb -2.343 62.263 5.879 
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3.3.3.1 Model Validation for Complexes Involving TPR Motifs 
 
Just as for the templates, the best models were evaluated in terms of N-DOPE Z scores, 
Rosetta energies, Cα-RMSD scores, MetaMQAPII scores, Ramachandran plots and important 
structural features. A good overview of the quality of homology models was critical for 
understanding the limitations of these models, in order to correctly interpret results in later 
protein-protein interaction studies. 
3.7.1 Analysing models involved in HopTPR1:Hsp70 interactions  
Table 3.9: Energy scores for top 10 PfHopTPR1:Hsp70-GPTVEEVD complex models. 
Models are listed in order of decreasing N-DOPE Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
1ELW_mod.pdb -2.569 -257.680 0.000 
Minimised_PfHopTPR1.B99990036_1.pdb -2.432 -361.134 6.926 
PfHopTPR1.B99990036.pdb -2.117 247.527 6.876 
PfHopTPR1.B99990029.pdb -2.106 203.831 6.834 
PfHopTPR1.B99990060.pdb -2.091 280.568 6.770 
PfHopTPR1.B99990030.pdb -2.071 245.246 6.871 
PfHopTPR1.B99990021.pdb -2.067 194.782 6.911 
PfHopTPR1.B99990027.pdb -2.061 277.793 6.817 
PfHopTPR1.B99990095.pdb -2.060 422.257 6.929 
PfHopTPR1.B99990087.pdb -2.057 286.809 6.871 
PfHopTPR1.B99990005.pdb -2.047 292.081 6.751 
PfHopTPR1.B99990055.pdb -2.039 306.761 6.807 
 
From Table 3.9, it is easy to see that the overall model quality for the top 10 models is high 
(N-DOPE Z<<< -0.5).The Cα-RMSD score is slightly increased after minimisation, reducing 
the backbone similarity of the model to the template. This is a small trade-off for a better 
quality model and hence, both the original and the refined models were used for further 
analysis. 
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Figure 3.20: Ramachandran plots for PfTPR1 model 36. A) Original model plot. B) 
Minimised model plot. Black triangles and squares represent amino acids in the “Favoured” 
regions, Orange. Triangles and squares represent amino acids in the “allowed” regions. 
 
Figure 3.21: A) MetaMQAPII rendition of chain A for PfTPR1 model 36. B) 
MetaMQAPII rendition of minimised PfTPR1 model 36. 
Refinement of the PfTPR1 model 36 returns the lower N-DOPE Z and Rosetta energy score, 
at the cost of moving a single residue (ASP73) from the “favoured” to the “allowed” region in 
the Ramachandran plot (Figure 3.20). However, MetaMQAPII analysis indicates overall 
improvement with minimisation (Figure 3.21). 
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3.3.3.2 Analysing Models Involved in Hsp90:HopTPR2A&B:Hsp70 Interactions 
In the next few pages, the assessment results of the best of the Hsp90:HopTPR2A&B:Hsp70 
complex models in human Hop are discussed. 
Table 3.10: Energy scores for the top 10 HsHsp90-MEEVD:HsHopTPR2AB:HsHsp70-
PTIEEVD complex models. Models are listed in order of decreasing DOPE-Z scores. 
 
From Table 3.8, it is easy to see that the overall model quality for the top 10 models of the 
HsHsp90-MEEVD:HsHopTPR2AB:HsHsp70-PTIEEVD complex is acceptable (N-DOPE Z< 
-0.5). Minimisation of the HsTPR2ab2yeast model 13 returns the lower Cα-RMSD, N-DOPE 
Z and Rosetta Energy scores, at the cost of moving an equal amount of residues from the 
“favoured” to the “allowed” region, and vice versa in the Ramachandran plot (Figure 3.22).   
Model 
N-DOPE 
Z 
Rosetta 
Energy 
Cα-
RMSD 
Template 1: 3UPV_modH.pdb -2.376 -159.663 9.272 
Template 2: 3uq3_TPR2ab.pdb -1.562 -229.453 0.000 
Minimised_HsTPR2ab2yeast.B99990013_1.pdb -1.253 -728.822 10.847 
HsTPR2ab2yeast.B99990013.pdb -0.919 980.277 10.984 
HsTPR2ab2yeast.B99990038.pdb -0.915 1104.424 10.863 
HsTPR2ab2yeast.B99990046.pdb -0.886 1168.660 11.027 
HsTPR2ab2yeast.B99990027.pdb -0.855 1314.817 11.846 
HsTPR2ab2yeast.B99990010.pdb -0.840 1450.146 11.488 
HsTPR2ab2yeast.B99990067.pdb -0.834 1023.708 10.816 
HsTPR2ab2yeast.B99990080.pdb -0.831 1103.644 11.479 
HsTPR2ab2yeast.B99990048.pdb -0.828 1037.730 11.247 
HsTPR2ab2yeast.B99990034.pdb -0.826 1430.663 11.347 
HsTPR2ab2yeast.B99990091.pdb -0.824 1121.761 10.872 
HsTPR2ab2yeast.B99990082.pdb -0.821 1173.126 11.192 
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Figure 3.22: Ramachandran plots for HsTPR2ab model 13. A) general plot before 
minimisation. B) General plot after minimisation. Red squares indicate residues 
(GLN251 and ASN253) occupying disallowed regions. Black triangles and squares 
represent amino acids in the “Favoured” regions, Orange triangles and squares represent 
amino acids in the “allowed” regions. 
This is a small trade-off for a better quality model and hence, the minimised model would 
preferably have been used for further analysis. MetaMQAPII analysis indicates that there are 
a lot of regions in the model that appear to degrade with minimisation and there are very few 
regions that display improvement (Figure 3.23). 
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Figure 3.23: A) MetaMQAPII rendition of chain A and C HsTPR2ab model 13. B) 
MetaMQAPII rendition of minimised HsTPR2ab2yeast model 13 chain A and C. 
Unfortunately, in spite of increased overall model quality, the minimisation step disrupted an 
important feature of the TPR2 domain: the interactions between the three residues of the REY 
clamp (TYR130, GLU161 and ARG165). Both PIC intra-protein analysis (Table 3.11) and 
PyMOL (see Figure 3.24) failed to detect sufficient interactions between these three residues 
in the minimised model. This is an indication that for this region of the model, model quality 
is poor. 
 
 
 
 
 
 
 102 
Table 3.11: Intra-protein interactions calculated by the PIC webserver pertaining to the 
residues within the REY clamp in HsTPR2ab2yeast model 13. The final column represents 
interactions between any of the three REY residues with any non-REY residue in the 
structure. 
 
 
Main-Side 
chain 
Interaction
s 
Side-Side 
chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
Interactions 
Non intra-
REY 
interactions 
HsTPR2ab-
2yeast 
model 13 
0 
2 x TYR-
GLU 
3 x ARG-
TYR 
1 x GLU-
ARG 
1 x TYR-
ARG 
1 x Cation-pi 
TYR-ARG127  
Minimised 0 0 
1 x GLU-
ARG 
0 
1 x Main-Side 
ALA129-TYR  
 
 
Figure 3.24: The REY clamp residues (stick representation; TYR130, GLU161 and 
ARG165) in chain A of HsTPR2ab model 13. A) MetaMQAPII rendition before 
minimisation. B) MetaMQAPII rendition after minimisation. The orange dashes indicate polar 
contacts predicted between the three residues.  
 
In the next few pages, the assessment results of the best of the Hsp90:HopTPR2A&B:Hsp70 
complex models in P. falciparum Hop are discussed. 
From Table 3.12, below, it is easy to see that the overall model quality for the top 10 models 
ofPfHsp90-MEEVD:PfHopTPR2AB:PfHsp70-PTVEEVDis acceptable (N-DOPE Z< -0.5). 
The Cα-RMSD score is increased after minimisation, reducing the backbone similarity of the 
model to the template. 
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Table 3.12: Energy scores for top 10 PfHsp90-MEEVD:PfHopTPR2AB:PfHsp70-
PTVEEVD complex models. Models are listed in order of decreasing DOPE-Z scores. 
Model 
N-DOPE 
Z 
Rosetta 
Energy 
Cα-
RMSD 
Template1: 3UPV_mod.pdb -2.176 -130.692 7.582 
Template 2: 3uq3_TPR2ab.pdb -1.473 -212.989 0.000 
Minimised_PfTPR2ab2yeast.B99990014_1.pdb -1.383 -717.198 7.376 
PfTPR2ab2yeast.B99990014.pdb -1.056 1248.952 7.180 
PfTPR2ab2yeast.B99990022.pdb -1.052 1324.550 7.236 
PfTPR2ab2yeast.B99990098.pdb -1.042 1180.747 7.146 
PfTPR2ab2yeast.B99990027.pdb -1.028 1039.171 7.210 
PfTPR2ab2yeast.B99990018.pdb -1.025 1222.645 7.414 
PfTPR2ab2yeast.B99990011.pdb -1.012 1265.783 7.155 
PfTPR2ab2yeast.B99990090.pdb -1.011 1495.175 7.463 
PfTPR2ab2yeast.B99990017.pdb -1.003 1287.585 7.537 
PfTPR2ab2yeast.B99990046.pdb -0.993 1371.101 7.237 
PfTPR2ab2yeast.B99990032.pdb -0.986 1612.909 7.536 
PfTPR2ab2yeast.B99990031.pdb -0.985 1221.850 7.120 
 
Refinement through minimisation of the PfTPR2ab2yeast Model 14 returns the lower N-
DOPE Z and Rosetta energy scores, and restores several residues from the “favoured” to the 
“allowed” regions, and the single residue in the disallowed (or “outlier”) to the “allowed” 
region in the Ramachandran plot (Figure 3.25). The Cα-RMSD score is increased after 
minimisation, reducing the backbone similarity of the model to the template. 
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Figure 3.25: Ramachandran plots for PfTPR2ab2yeast model 14. A) General plot before 
minimisation. Red square indicates residue ILE181 occupying a disallowed region B) General 
plot after minimisation. Black triangles and squares represent amino acids in the “Favoured” 
regions, Orange triangles and squares represent amino acids in the “allowed” regions. 
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Figure 3.26: A) MetaMQAPII rendition of chain A and C PfTPR2ab2yeast model 14. B) 
MetaMQAPII rendition of minimised PfTPR2ab model 14 chain A and C. 
Additionally, in spite of increased overall model quality, the minimisation step again 
disrupted the interactions between the three residues of the REY clamp (TYR130, GLU161 
and ARG165). Both PIC intra-protein analysis (Table 3.13) and PyMOL (see Figure 3.27) 
failed to detect sufficient interactions between these three residues in the minimised model. 
This is an indication that for this region of the model, model quality is poor. This is too large 
a trade-off for a better quality model and hence, the original model was used for further 
analysis.  
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Table 3.13: Intra-protein interactions calculated by the PIC webserver pertaining to the 
residues within the REY clamp PfTPR2ab2yeast model 14. The final column represents 
interactions between any of the three REY residues with any non-REY residue in the 
structure. 
 
 
Main-Side 
chain 
Interactions 
Side-Side 
chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
Interactions 
Non intra-
REY 
Interactions 
PfTPR2ab-
2yeast  
model 14 
2 x ARG-
TYR 
2 x TYR-
GLU 
2 x ARG-
TYR 
3 x ARG-
GLU 
1 x GLU-
ARG 
1 x TYR-
ARG 
3 x Ionic 
1 x GLU-
ARG164 
1 x ASP132 - 
ARG 
1 x HIS139 - 
GLU 
Minimised 
2 x ARG-
TYR 
2 x ARG-
GLU 
1 x GLU-
ARG 
0 
4 x Side-Side 
3 x ARG164-
GLU 
1 x ARG-
HIS139 
3 x Ionic 
1 x GLU-
ARG164 
1 x ASP132 - 
ARG 
1 x HIS139 - 
GLU 
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Figure 3.27: The REY clamp residues (stick representation; TYR130, GLU161 and 
ARG165) in chain A of PfTPR2ab model 14. A) MetaMQAPII rendition before 
minimisation. B) MetaMQAPII rendition after minimisation. The orange dashes indicate polar 
contacts predicted between the three residues.  
In the next few pages, the assessment results for the best of the Hsp90:HopTPR2 complex 
models in human Hop are discussed. 
Table 3.14: Energy scores for top 10 HsHsp90M&Cdomains:HsHopTPR2 complex. 
Models are listed in order of decreasing DOPE-Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
tailess_schmidCYS.pdb -1.069 -161.600 0.000 
MinimisedHscomplex_07_1.pdb -1.095 -1600.531 5.850 
Hs_complex_single.B99990007.pdb -0.668 2950.236 2.648 
Hs_complex_single.B99990029.pdb -0.658 3464.726 2.648 
Hs_complex_single.B99990084.pdb -0.649 3002.862 2.650 
Hs_complex_single.B99990085.pdb -0.640 3058.365 2.652 
Hs_complex_single.B99990074.pdb -0.628 3003.778 2.650 
Hs_complex_single.B99990027.pdb -0.623 3157.533 2.627 
Hs_complex_single.B99990080.pdb -0.606 3117.747 2.641 
Hs_complex_single.B99990054.pdb -0.605 3465.792 2.653 
Hs_complex_single.B99990006.pdb -0.604 3114.043 2.632 
Hs_complex_single.B99990008.pdb -0.597 3529.762 2.625 
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The overall model quality for the top 10 HsHsp90M&Cdomains:HsHopTPR2 complex 
models was acceptable (N-DOPE Z < -0.5). For general analysis of the 
HsHsp90M&Cdomains:HsHopTPR2 complex model 07, it was plain to see from Table 3.14 
that minimisation resulted in drastic improvement of the N-DOPE Z and Rosetta energy 
scores, however, the Cα-RMSD score was also increased. 
 
 
Figure 3.28: Ramachandran plots for the Hsp90 half of HsComplex model 07. A) 
General plot before minimisation.  Red squares indicate residues (VAL37, MET77, GLU256, 
LEU257, ASP260, ASP359 and ASP386) occupying disallowed regions. B) General plot after 
minimisation. Red squares indicate residues (VAL37, PHE58, MET77, LEU257, ASP260 and 
ASP359) occupying disallowed regions. Black triangles and squares represent amino acids in 
the “Favoured” regions, Orange. triangles and squares represent amino acids in the “allowed” 
regions. 
 
Based on MetaMQAPII scores, the Hsp90 half of the complex showed overall improvement 
with minimisation (see Figure 3.29), which was confirmed by the Ramachandran plots for the 
original and minimised versions of Hsp90 (see Figure 3.28). Minimisation reduced the 
number of residues occupying both the disallowed and allowed phi and psi regions, and 
increased the percentage of residues within the favoured region from 93.7% to 95.5%.  
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Figure 3.29: A) MetaMQAPII rendition of chain A HsComplex model 07. B) 
MetaMQAPII rendition of minimised chain A HsComplex model 7. 
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Based on MetaMQAPII representation, the Hop half of the complex appeared to decrease 
slightly in quality with minimisation (see Figure 3.29), while Ramachandran plots indicated 
that the minimised version of Hop was of better quality (see Figure 3.30). Minimisation 
halved the number of residues occupying the allowed phi and psi regions, and increased the 
percentage of residues within the favoured region from 95.8% to 97.9%. This is almost the 
expected value (98%) for a native model. 
 
 
Figure 3.30: Ramachandran plots for the Hop half of HsComplex model 07. A) General 
plot before minimisation. B) General plot after minimisation. Black triangles and squares 
represent amino acids in the “Favoured” regions, Orange triangles and squares represent 
amino acids in the “allowed” regions. 
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Figure 3.31: A) MetaMQAPII rendition of chain B HsComplex model 07. B) 
MetaMQAPII rendition of minimised chain B HsComplex model 07. 
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Table 3.15: Intra-protein interactions calculated by the PIC webserver pertaining to the 
residues with the REY clamp within the Hop half ofHsTPR2: HsHsp90 model 14. The 
final column represents interactions between any of the three REY residues with any non-
REY residue in the structure. 
 
 
Main-Side 
chain 
Interactions 
Side-Side 
chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
Interactions 
Non intra-
REY 
interactions 
Hop half of 
HsTPR2: 
HsHsp90 
model 14 
2 x ARG-
TYR 
2 x TYR-
GLU 
2 x ARG-
TYR 
3 x ARG-
GLU 
1 x GLU-
ARG 
1 x TYR-
ARG 
1 x Ionic 
1 x GLU-
LYS562 
1 x Cation-Pi 
1 x TYR-
LYS562 
Minimised 
1 x ARG-
TYR 
2 x TYR-
GLU 
3 x ARG-
TYR 
 
2 x GLU-
ARG 
1 x TYR-
ARG 
2 x M-S: 
2 x ARG-
LEU533  
3 x S-S: 
1 x LYS562-
GLU 
2 x ARG-
GLU537 
3 x Ionic: 
1 x GLU536-
ARG 
1 x GLU537-
ARG 
1 x GLU-
LYS562 
 
PyMOL and PIC analysis of the REY clamp showed almost no degradation of interactions 
between the three residues (see Figure 3.32 and Table 3.15). Therefore, based on the 
conservation of the orientation of the tyrosine residue, as well as the cation-π interactions and 
several hydrogen bonds, the minimised model was of preferable quality and was used for 
subsequent studies on protein-protein interactions in Chapter 4. 
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Figure 3.32: The REY clamp residues (stick representation) in chain B HsComplex 
model 7. A) MetaMQAPII rendition before minimisation. B) MetaMQAPII rendition after 
minimisation. The orange dashes indicate polar contacts predicted between the three residues. 
In the next few pages, the assessment results for the best of the Hsp90:HopTPR2 complex 
models in P.falciparum Hop are discussed. 
Table 3.16: Energy scores for top 10 PfHsp90M&Cdomains:PfHopTPR2 complex 
models. Models are listed in order of decreasing DOPE-Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
Template 1: 4GCO_mod -2.168 -95.861 N/A 
Template 2: tailess_schmidCYS.pdb -1.069 -161.600 0.000 
MinimisedPfMulti_102.pdb -0.824 -1625.737 15.991 
Pfmulti.B99990102.pdb -0.423 4140.058 15.627 
Pfmulti.B99990077.pdb -0.409 4228.389 15.636 
Pfmulti.B99990056.pdb -0.392 4259.119 15.618 
Pfmulti.B99990059.pdb -0.389 3754.028 15.612 
Pfmulti.B99990036.pdb -0.375 4770.000 15.577 
Pfmulti.B99990075.pdb -0.353 4427.120 15.595 
Pfmulti.B99990019.pdb -0.346 4512.396 15.614 
Pfmulti.B99990063.pdb -0.343 4042.399 15.587 
Pfmulti.B99990041.pdb -0.342 4174.044 15.604 
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For general analysis of the PfHsp90M&Cdomains:PfHopTPR2 complex model 102, it was 
plain to see from Table 3.16 that minimisation resulted in drastic improvement of the DOPE-
Z and Rosetta energy scores, while the Cα-RMSD score was only increased by a small 
fraction.  
 
 
Figure 3.33: Ramachandran plots for the Hsp90 half of PfComplex model 102. A) 
General plot before minimisation.  Red squares indicate residues (VAL37, ASN79, THR243, 
ASN266, ASN374, SER378 and ASP398) occupying disallowed regions. B) General plot 
after minimisation. Red squares indicate residues (VAL37, THR243, LYS261, ASN266, 
ASN374 and ASP398) occupying disallowed regions. Black triangles and squares represent 
amino acids in the “Favoured” regions, Orange triangles and squares represent amino acids in 
the “allowed” regions. 
 
Ramachandran plots for the original and minimised versions of Hsp90 (see Figure 3.33) 
showed that minimisation reduced the number of residues occupying both the disallowed and 
allowed phi and psi regions, and increased the percentage of residues within the favoured 
region from 93.4% to 95.1%. Based on MetaMQAPII scores, the Hsp90 half of the complex 
showed overall improvement with minimisation (see Figure 3.34). 
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Figure 3.34: A) MetaMQAPII rendition of chain A Pfmulti model 102. B) MetaMQAPII 
rendition of minimised chain A Pfmulti model 102. 
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Based on MetaMQAPII representation, the Hop half of the complex appeared to improve 
slightly in quality with minimisation (see Figure 3.35), which was confirmed with 
Ramachandran plots indicating that the minimised version of Hop is of better quality (see 
Figure 3.36).  
 
Figure 3.35: A) MetaMQAPII rendition of chain B Pfmulti model 102 B) MetaMQAPII 
rendition of minimised chain B Pfmulti model 102. 
 
Minimisation moved the single residue in the disallowed region to its preferred region and 
dramatically reduced the number of residues occupying the allowed phi and psi regions, 
which increased the percentage of residues within the favoured region from 94.4% to 98.8%. 
This is greater than the expected value (98%) for a native model. 
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Figure 3.36: Ramachandran plots for the Hop half of Pfmulti model 102. A) General plot 
before minimisation. . Red square indicates residue ILE594 occupying a disallowed region. B) 
General plot after minimisation. Black triangles and squares represent amino acids in the 
“Favoured” regions, Orange triangles and squares represent amino acids in the “allowed” 
regions. 
 
PyMOL and PIC analysis of the REY clamp showed a small degree of degradation in 
interaction between the three residues, and again a change in orientation of the tyrosine (see 
Figure 3.37 and Table 3.17). However, based on the conservation of the Cation-π interaction 
and several hydrogen bonds, this was a small trade-off; the minimised model was of 
preferable quality and was used for subsequent studies on protein-protein interactions in 
Chapter 4. 
 
 
 
 
 
 
 
 
 
Table 3.17: Intra-protein interactions calculated by the PIC webserver pertaining to the 
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residues with the REY clamp. The final column represents interactions between any of the 
three REY residues with any non-REY residue in the structure. 
 
 
Main-Side 
chain 
Interactions 
Side-Side 
chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
Interactions 
Non intra-
REY 
interactions 
Hop half of 
PfTPR2: 
PfHsp90 
model 102 
2 x ARG-
TYR 
2 x TYR-
GLU 
2 x ARG-
TYR 
1 x ARG-
GLU 
1 x GLU-
ARG 
1 x TYR-
ARG 
1 x S-S: 
1 x ARG-
HIS549  
3 x Ionic: 
1 x ASP542-
ARG 
1 x GLU-
ARG574 
1 x HIS549-
GLU 
Minimised 
1 x ARG-
TYR 
2 x ARG-
GLU 
2 x GLU-
ARG 
1 x TYR-
ARG 
1 x Ionic 
1 x HIS549-
GLU 
 
 
 
Figure 3.37: The REY clamp residues (stick representation) in chain B Pfmulti model 
102. A) MetaMQAPII rendition before minimisation. B) MetaMQAPII rendition after 
minimisation. The orange dashes indicate polar contacts predicted between the three residues. 
 
 
 
 
3.3.3.3 Model Analysis for DP Structures 
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The models built for the DP structures are validated in the same way as the complex models, 
but are only analysed and compared in brief. This is primarily because there is very little 
understanding on the role of these domains in Hop functioning. 
Table 3.18: Energy scores for top 10 HsDP1 models. Models are listed in order of 
decreasing N-DOPE Z scores. Models are listed in order of decreasing DOPE-Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
Minimised_2LLV_average_1.pdb -2.279 -140.029 0.000 
Minimised_ HsDP1.B99990080_1.pdb -1.765 650.570 9.489 
HsDP1.B99990080.pdb -1.623 485.168 9.265 
HsDP1.B99990094.pdb -1.546 663.021 9.271 
HsDP1.B99990084.pdb -1.499 634.739 9.234 
HsDP1.B99990031.pdb -1.494 706.112 9.457 
HsDP1.B99990062.pdb -1.490 641.174 9.214 
HsDP1.B99990036.pdb -1.488 717.452 9.213 
HsDP1.B99990008.pdb -1.487 654.019 9.217 
HsDP1.B99990073.pdb -1.461 811.782 9.498 
HsDP1.B99990022.pdb -1.436 617.179 9.261 
HsDP1.B99990089.pdb -1.425 620.153 9.406 
 
The overall model quality for the top 10 HsHopDP1 models was acceptable (N-DOPE Z < -
1.0). For general analysis of the HsHopDP1 model 80, it was plain to see from Table 3.18 that 
minimisation resulted in only minor improvement of the N-DOPE Z and Rosetta energy 
scores; however, the Cα-RMSD score was increased. Based on MetaMQAPII scores, the 
model showed overall degradation with minimisation (see Figure 3.38), which was confirmed 
by the Ramachandran plots for the original and minimised versions of HsHopDP1 model 80 
(see Figure 3.39). Minimisation reduced the number of residues occupying allowed phi and 
psi regions, and increased the percentage of residues within the favoured region from 90.7% 
to 92.0%.  
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Figure 3.38: A) MetaMQAPII rendition of HsDP1 model 80 B) MetaMQAPII rendition 
of minimised HsDP1 model 80. 
 
 
Figure 3.39: Ramachandran plots for HsDP1 model 80. A) General plot before 
minimisation. Red square indicates residue ASP37 occupying a disallowed region. B) General 
plot after minimisation. Red square indicates residue ASP28 occupying a disallowed region. 
Black triangles and squares represent amino acids in the “Favoured” regions, Orange triangles 
and squares represent amino acids in the “allowed” regions. 
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Table 3.19: Energy scores for top 10 PfDP1 models. Models are listed in order of 
decreasing N-DOPE Z scores. Models are listed in order of decreasing DOPE-Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
Minimised_2LLV_average_1.pdb -2.279 -140.029 0.000 
Minimised_PfDP1.B99990066_1.pdb -1.140 -140.555 12.356 
PfDP1.B99990066.pdb -0.707 398.247 11.675 
PfDP1.B99990016.pdb -0.665 615.473 11.349 
PfDP1.B99990024.pdb -0.631 623.253 11.441 
PfDP1.B99990082.pdb -0.628 632.107 11.183 
PfDP1.B99990007.pdb -0.617 640.611 11.236 
PfDP1.B99990094.pdb -0.614 352.044 11.537 
PfDP1.B99990061.pdb -0.614 364.981 11.632 
PfDP1.B99990003.pdb -0.608 333.015 11.357 
PfDP1.B99990048.pdb -0.597 452.358 11.255 
PfDP1.B99990018.pdb -0.595 333.345 11.276 
 
The overall model quality for the top 10 PfHopDP1 models was acceptable (N-DOPE Z < -
5.0). For general analysis of the PfHopDP1 model 66, it was plain to see from Table 3.19 that 
minimisation resulted in dramatic improvement of the N-DOPE Z and Rosetta energy scores; 
however, the Cα-RMSD score was increased. Based on MetaMQAPII scores, the model 
showed overall improvement with minimisation (see Figure 3.40), which was confirmed by 
the Ramachandran plots of the original and minimised versions of Hsp90 (see Figure 3.41). 
Minimisation moved the single residue in the disallowed region to its preferred region, 
reduced the number of residues occupying allowed phi and psi regions, and increased the 
percentage of residues within the favoured region. 
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Figure 3.40: A) MetaMQAPII rendition of PfDP1 model 66 B) MetaMQAPII rendition 
of minimised PfDP1 model 66. 
 
 
Figure 3.41: Ramachandran plots for PfDP1 model 66. A) General plot before 
minimisation. Red square indicates residue ASP58 occupying a disallowed region. B) General 
plot after minimisation. Black triangles and squares represent amino acids in the “Favoured” 
regions, Orange triangles and squares represent amino acids in the “allowed” regions. 
DP1 is only clearly defined by conserved motifs in fungal, plant and certain invertebrate 
species, as was discussed in Chapter 2. Mammalian and monotreme Hop sequences are so 
well conserved it was difficult to discern whether DP1 was conserved as a single domain, but 
meme analysis identified at least the C-terminal end of DP2, TPR2A and the corresponding 
linker between the two domains as a single motif (see Figure 2.6, Chapter 2). If Hop does 
indeed possess a recognisable DP1 domain, it is significantly different from that in ScHop, 
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which would explain why the HsHop models are of average quality. However, it is highly 
doubtful that protozoan species possess a recognisable DP1 domain, as was concluded in 
Chapter 2. This is most likely the reason why the PfDP1 models are of relatively low quality 
and these models must be treated with speculation as to their validity. If DP1 is conserved, it 
may only be conserved in the structural sense, which may be difficult to confirm with 
homology models.  
 
Table 3.20: Energy scores for top 10 HsDP2 models. Models are listed in order of 
decreasing N-DOPE Z scores. Models are listed in order of decreasing DOPE-Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
2LLW1_state009.pdb -2.166 83.419 0.000 
Minimised_HsDP2.B99990072_1.pdb -3.123 -164.081 5.623 
HsDP2.B99990072.pdb -2.302 485.168 5.822 
HsDP2.B99990007.pdb -2.286 663.021 5.899 
HsDP2.B99990086.pdb -2.271 634.739 5.817 
HsDP2.B99990084.pdb -2.251 706.112 5.860 
HsDP2.B99990059.pdb -2.249 641.174 5.831 
HsDP2.B99990095.pdb -2.238 717.452 5.847 
HsDP2.B99990045.pdb -2.219 654.019 5.825 
HsDP2.B99990061.pdb -2.217 811.782 5.871 
HsDP2.B99990076.pdb -2.214 617.179 5.801 
HsDP2.B99990014.pdb -2.211 620.153 5.844 
 
The overall model quality for the top 10 HsHopDP2 models was excellent (N-DOPE Z <<< -
1.0). For general analysis of the HsHopDP2 model 78, it was plain to see from Table 3.20 that 
minimisation resulted in dramatic improvement of the N-DOPE Z, Cα-RMSD and Rosetta 
energy scores. Based on MetaMQAPII scores, the model showed overall improvement with 
minimisation (see Figure 3.42), which was confirmed by the Ramachandran plots for the 
original and minimised versions of Hsp90 (see Figure 3.43). Minimisation moved the single 
residues in the disallowed and allowed regions to their preferred region, resulting in 100% of 
residues occupying their favoured regions. 
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Figure 3.42: A) MetaMQAPII rendition of HsDP2 model 72 B) MetaMQAPII rendition 
of minimised HsDP2 model 72. 
 
 
 
Figure 3.43: Ramachandran plots for HsDP2 model 78. A) General plot before 
minimisation. Red square indicates residue SER5 occupying a disallowed region. B) General 
plot after minimisation. Black triangles and squares represent amino acids in the “Favoured” 
regions, Orange triangles and squares represent amino acids in the “allowed” regions. 
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Table 3.21: Energy scores for top 10 PfDP2 models. Models are listed in order of 
decreasing N-DOPE Z scores. Models are listed in order of decreasing DOPE-Z scores. 
Model N-DOPE Z Rosetta Energy Cα-RMSD 
2LLW1_state009.pdb -2.166 83.419 0.000 
Minimised_PfDP2009.B99990003_1.pdb -2.341 -124.597 0.568 
PfDP2009.B99990003.pdb -2.029 446.246 0.490 
PfDP2009.B99990070.pdb -2.009 348.074 0.643 
PfDP2009.B99990082.pdb -1.972 382.159 0.586 
PfDP2009.B99990013.pdb -1.946 352.044 0.527 
PfDP2009.B99990071.pdb -1.939 364.981 0.674 
PfDP2009.B99990047.pdb -1.919 333.015 0.474 
PfDP2009.B99990048.pdb -1.918 452.358 0.858 
PfDP2009.B99990073.pdb -1.916 333.345 0.510 
PfDP2009.B99990079.pdb -1.913 327.039 0.839 
PfDP2009.B99990028.pdb -1.912 224.762 0.478 
 
The overall model quality for the top 10 PfHopDP2 models was excellent (N-DOPE Z <<< -
1.0). For general analysis of the PfHopDP2 model 03, it was plain to see from Table 3.21 that 
minimisation resulted in slight improvement of the N-DOPE Z and Rosetta energy scores; 
however, the Cα-RMSD score was increased. Based on MetaMQAPII scores, the model 
showed some degradation with minimisation (see Figure 3.42), which was contradicted by the 
Ramachandran plots for the original and minimised versions of PfHopDP2 model 03 (see 
Figure 3.43). Minimisation moved the single residue in the allowed regions to its preferred 
region, resulting in 100% of residues occupying their favoured regions. 
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Figure 3.44: A) MetaMQAPII rendition of PfDP2009 model 03 B) MetaMQAPII 
rendition of minimised PfDP2009 model 03. 
 
 
 
Figure 3.45: Ramachandran plots for PfDP2 model 03. A) General plot before 
minimisation. B) General plot after minimisation.  
Based on the overall quality of all the DP models, it is clear that DP2 was far more accurately 
modelled than DP1, and in both cases the human models are superior to the P. falciparum 
ones. From Chapter 2, it was clear that DP2 is the most well conserved region in the Hop 
protein and may even be recognised as a conserved domain in other proteins, such as the XPC 
binding domain. This is most likely the reason for the production of good quality DP2 models 
for both species. The HsDP2 sequence shares higher identity with the yeast target than does 
PfDP2, resulting in better quality models for the human species.  
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3.4 Evaluation of Structures in Terms of Sequence Information 
Both phylogenetic and MSA studies indicate that there are regions of similarity and difference 
in Hop across all eukaryote species analysed. This information was important for two reasons; 
firstly, human and P. falciparum models of the various domains were constructed based on 
yeast templates and it was important to take into account the differences in sequence and 
conserved domain organisation between templates and targets. To highlight these differences, 
the motif results for the three species of interest were aligned to their respective crystal 
structures, NMR structures and homology models in Figures 3.46 - 3.48. 
 
Figure 3.46: HsHop structures coloured and aligned to their corresponding motifs from 
Figure 2.6 (Chapter 2). 
 
Figure 3.47: ScHop structures coloured and aligned to their corresponding motifs from 
Figure 2.6 (Chapter 2). 
 
Figure 3.48: PfHop structures coloured and aligned to their corresponding motifs from 
Figure 2.6 (Chapter 2). 
From these figures it seems that PfHop (Figure 3.48) is more similar to ScHop (Figure 3.47) 
with regards to domain organisation and that HsHop (Figure 3.46) is distinctly differently 
organised with respect to conserved domains. This motif structuring shared by vertebrates and 
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particularly within the mammals, does not necessarily mean that human hop is structured in a 
radically different way to Sc- and PfHop, and is most likely an artefact of the excellent 
conservation of Hop within the vertebrates, and MEME was simply positioning the motifs 
over the most well conserved regions within these species.  
This is paradoxical, as when the template is pairwise aligned to the two targets, it turns out 
that ScHop shares higher identity with HsHop (Figure A6.1, Appendix 6) than with PfHop 
(Figure A6.2, Appendix 6) in spite of larger gaps in the alignment. As seen from Appendix 6, 
Figure A6.3, PfHop has higher identity to Hs- than ScHop. Similar scores were recorded from 
pBLAST of PfHop against the human genome to find HsHop (see Appendix 1). 
3.5 Conclusions  
It is clear from this chapter that there are some discrepancies in quality between HsHop and 
PfHop homology models for the various domains. This may be partly as a result of the fact 
that HsHop shares greater sequence identity with the template species than does PfHop. With 
the exception of the structure that was not published to the PDB (‘tailess_schmidCYS’), all 
the templates selected were of good to excellent quality, and in most cases, shared at least 
35% sequence identity with the targets. This was fortuitous, as there are relatively very few 
published structures for the various Hop domains, in complex or otherwise. However, while 
these templates are of good quality, it should not be taken for granted that structures published 
to the PDB (even those associated with publications) are without error and/or beyond 
improvement, as has been demonstrated through the “PDB Redo” project (Joosten, Joosten, 
Murshudov, & Perrakis, 2012). It was for this reason that all templates used were minimised, 
and both the minimised and original structures were analysed and validated as thoroughly as 
the homology models themselves. While the minimised templates were not used for 
homology modelling, this was an important step for understanding the potential negative or 
positive effects of minimisation of Hop structures.  
Owing to time constraints, it was not possible to further validate the templates (those that are 
available) by being carefully compared to their redone versions in the PDBRedo database 
(Joosten et al., 2011). However, a brief scan of the templates currently available on PDBRedo 
(1ELW, 3UQ3 and 3UPV) shows that the basic statistics for those models, such as R-values, 
resolution and R-free values were identical or very close to those published within their 
respective PDB entries. 
 
 129 
Overall, most homology models produced were of acceptable to very good quality. Homology 
models that were already of good quality appeared to be very minimally improved with 
minimisation, and in certain cases minimisation resulted in the degradation of unusual 
features, such as the interactions of the REY clamp. In other cases, such as for poorly scored 
homology models that were built on unsuitable or poor quality templates, minimisation 
appears to greatly improve the quality of these models, with minimal degradation of the REY 
clamp.  
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Chapter 4: Analysis of Binding Energies and Protein-protein 
Interactions 
4.1 Introduction  
Protein-protein interactions are the most important networks maintaining biological functions, 
from protein folding to programmed cell death, and represent a large and important class of 
targets for human therapeutics (Arkin & Wells, 2004; Ma & Nussinov, 2007). Viral and 
bacterial pathogens often rely on critical protein-protein interactions (such as the E1-E2 
interactions in cervical cancer and fibronectin-binding proteins in bacterial infection) to allow 
infection (Arkin and Wells, 2004). Other biologically important processes are the result of 
unnatural protein-protein interactions that can cause disease, such as protein aggregations and 
malfunctioning voltage gated ion-channels in neurodegenerative diseases (Clare, Tate, Nobbs, 
& Romanos, 2000). Therefore, controlling protein-protein interactions has received increasing 
attention in drug target research.  
Earlier this year, PfHop was localised and isolated from the trophozoite (infective) stage of 
the parasite, and characterised in depth, determining that PfHop potentially exists in 
association with PfHsp70 and PfHsp90 (Gitau et al., 2012). While these interactions are only 
thought to be possible in P. falciparum, there is still a lot of experimental work to be done to 
substantiate these interactions existence. The following section endeavours to describe, 
compare and contrast the differences between interactions in the several complexes predicted 
in the previous chapter. This work attempts to go some way toward identifying a means to 
design a selective drug that targets only parasite protein-protein interactions within the 
infected host. 
4.1.1 Protein Interactions Calculator (PIC) and ROBETTA Alanine Scanning 
Webservice (AlaScan) 
The PIC returns a number of interaction descriptions for several interaction types submitted 
per complex model(Tina, Bhadra, & Srinivasan, 2007). To cross-reference these results the 
complexed models were sent to AlaScan (Kortemme & Baker, 2002; Kortemme, Kim, & 
Baker, 2004). AlaScan, whose fundamental principles for calculating the effect on complex 
Rosetta energy by comparing the overall Rosetta energy for residue-by-residue alanine 
mutants, was used as the basis for the script detailed in the next section. All interactions 
reported for an interaction type for each model were summarised numerically in the tables in 
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this section. However, only residues that were detected by AlaScan to be important to 
complex formation were included (by residue identifiers) in the tables (e.g. see Table 4.1). In 
order to determine which interactions and important residues were conserved or analogous, 
the interacting residues were mapped to their respective homology models, which were 
aligned and viewed (see .pse files in the supplementary data) in PyMOL. 
4.2 Methods and Software 
4.2.1 Protein Interactions 
Protein interactions for the various complexes were predicted using the PIC Webserver. These 
results were downloaded and visualised in PyMOL and Discovery Studio Visualiser and 
compared with interactions predicted by these programs. Further, residues that are important 
to complex formation were detected using ROBETTA Alanine Scanning Webserver. Of the 
residues presented in the tables, those that were not involved in analogous interactions (with 
respect to the model being compared) were highlighted in bold. 
4.2.2 Interaction and Binding Energy Calculations 
Binding and interaction energies for the various complexes were calculated both before and 
after minimisation. In the case of models comprising three proteins in complex (e.g. 
Hsp90:TPR2:Hsp70 complexes), both the binding energies for the overall complex and 
unbound (strictly between two proteins) interactions were calculated for each complex. 
Both interaction (∆I) and binding energies (∆∆E) were calculated with a script written for the 
purpose (See Appendix 6, Section D). Binding energies were calculated with the same 
standard score function used to calculate the Rosetta energy scores in PyRosetta based on a 
basic equation used by others (Kajander et al., 2009): 
∆∆E = E (AB) - ∆E (A) - ∆E (B) 
 
∆E represents the energy required to convert an unbound proteinfrom its bound conformation 
to it solution-state conformation, i.e. A* to A as in Figure 4.1. The custom script assumes that 
simplyrepacking of the rotamers or minimisation of the entire protein is sufficient to convert 
an unbound proteinfrom its bound conformation to it solution-state conformation. The 
interaction energy between proteins A and B is the change in energy for the process of A* and 
B* forming a complex (energy changes as a result of the presence of the other partner): 
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∆I = E (AB) - E (A) - E (B) 
 
Since the Rosetta score does not scale with any physical units and is not an actual physical 
energy, neither the physical interaction energy, nor the physical binding energy calculated by 
the script is an accurate energy value, however, the difference in scores was interpreted 
qualitatively. Greater scores indicate poorer binding/affinities, while lower scores indicate 
better binding/ affinities. 
 
 
Figure 4.1: Simplified diagram illustrating the energies of interaction and binding 
involved in protein-protein interactions. 
Another limitation of the approach detailed here, is that of statistical representation of the 
average binding energies. Ideally, most forms of refinement or minimisation are based on 
random sampling of a conformation space, they need to be iterative. With several rounds of 
minimisation, some feature of the model, such as overall energy score, converges at a global 
energy minimum. In other words, the minimised model ends up in a specific conformation 
more often than in others (this process has been implemented in more professionally used 
software and was discussed in clearer detail in Chapter 3, Sections 3.1.2 and 3.1.4). 
Unfortunately, owing to time limitation, this feature could not be incorporated into the script 
detailed in Appendix 2, Section D. Thus, all binding energy values reported in Section 4.5 of 
this chapter must be treated with caution as they are not representative of a mean value. This 
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limitation does not apply to interaction energy (no minimisation needs to take place to 
calculate interaction energy, as described previously); hence its inclusion in the study as a 
form of control.   
 
4.3 Results & Discussion  
4.3.1 Analyses of Templates 
This section deals with interactions found within the templates used for homology modelling, 
and how minimisation affected or disrupted those interactions. This overview assisted with 
understanding both the advantages and disadvantages of minimisation. 
Table 4.1: Comparison of the interacting residues in both the original and refined 
versions of 1ELW (i.e HsHopTPR1 complexed to HsHsc70-1 C-terminal peptide 
GPTIEEVD). 
Model Method Hydrophobic 
interactions 
Main-Side Chain 
Interactions 
Side-Side Chain 
Hydrophobic 
Interactions 
Ionic 
Interactions 
Original PIC 8 13 2 5 
 Interacting 
residues 
found in 
AlaScan 
A, LEU15, 
TYR27, PHE84. 
C; VAL8, ILE6 
A; LYS8, ASN12, 
ASN43, LYS73, 
ARG77. C; ASP12, 
GLU10, GLU9 
A; LYS73. C; 
ASP12 
A; LYS73, 
ARG77. C; 
ASP12, GLU10, 
GLU9 
Minimised PIC 9 13 3 5 
 Interacting 
residues 
found in 
AlaScan 
A, LEU15, 
TYR27, PHE84. 
C; VAL8, ILE6 
A; LYS8, ASN12, 
ASN43, ARG77. C; 
ASP12, GLU10, 
GLU9 
A; LYS50, LYS73, 
SER76. C; 
ASP12, GLU10, 
GLU9 
A; LYS50, 
LYS73, ARG77. 
C; ASP12, 
GLU10, GLU9 
 
 
From Table 4.1, it’s clear to see that the minimised structure displayed more interactions than 
the original. However it is only the additional side-chain to side-chain hydrophobic interaction 
that was detected by alanine scanning. It also appears that LYS50 replaces the ARG77 for its 
role in one of the ionic interactions. The original analysis of this template described the 
“dicarboxylatebinding clamp” residues as make the largest favourable contributions to the 
stability of both peptide complexes (Kajander et al., 2009). The binding residues that were 
reported to contribute most significantly are LYS8, LYS73, and ASN43 as well as one 
conserved arginine, ARG77 as was found for both the original and minimised versions of this 
template. Alanine scanning suggested that LYS8, LYS73, and ASN43 contributions to 
interaction were not changed with minimisation; however ARG77 contributed more 
favourably in the minimised version. It has been suggested that this residue originally 
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contributes unfavourably because of a large desolvation penalty associated with burying this 
residue at the interface (Kajander et al., 2009). In the unminimised structure, SER76 is 
predicted to be the residue that contributes most favourably to the interaction by alanine 
scanning, however it was not predicted to participate in any interaction by the PIC. In the 
minimised structure, alanine scanning predicted that this residue contributed a lot less 
favourably to the interaction and paradoxically was also predicted by the PIC to participate in 
an ionic interaction.  
 
Table 4.2: Comparison of the interacting residues in both the original and refined 
versions of 3UQ3 for the TPR2A region only (i.e  ScHopTPR2A complexed to ScHsp-90 
C-terminal peptide MEEVD). 
Model Method Hydrophobic 
interactions 
Main-side 
chain 
Interactions 
Side-Side 
Chain 
Interactions 
Ionic 
Interactions 
Aromatic 
sulphur 
Interaction 
Original PIC 4 12 12 2 1 
 Interacting 
residues 
found in 
AlaScan 
A; 273TYR, 
285TYR. B; 
MET706, 
VAL709 
A; LYS266, 
ASN270, 
TYR273, 
ASN300, 
ARG341, 
GLU307. B; 
GLU707, 
GLU708, 
ASP710 
A; ARG276, 
LYS337, 
ARG341, 
ASN344. B; 
MET706, 
GLU707, 
ASP710 
A; ARG276, 
LYS337, B; 
MET706, 
GLU707, 
A; TYR273. 
B; MET706. 
Minimised PIC 4 10 11 6 0 
 Interacting 
residues 
found in 
AlaScan 
A; 273TYR. B; 
MET706, 
VAL709 
A; LYS266, 
TYR273, 
ASN300, 
ARG341, 
GLU307. B; 
GLU707, 
GLU708, 
ASP710 
A; LYS337, 
ARG341, 
ASN344. B;  
GLU707, 
ASP710 
A; LYS337, 
ARG341, 
LYS374. B;  
GLU707, 
GLU708, 
ASP710 
N/A 
 
As can be seen from Table 4.2, it’s clear to see that minimisation of 3UQ3 resulted in fewer 
interactions between TPR2A and the Hsp90 C-terminal peptide, and fewer still of the residues 
involved in these interactions were detected by alanine scanning to be important to complex 
formation. However, the minimised version did possess more ionic interactions than the 
unminimised version. The residues that contributed most significantly to interaction are the 
“carboxylate binding clamp” residues LYS266, LYS337 and ASN300, in both the original 
and minimised versions.  
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Most importantly, minimisation resulted in the loss of the aromatic sulfur interaction between 
TYR273 in HsHop and MET706 in Hsp90 that is thought to assist HsHop in distinguishing 
between HsHsp90 and HsHsc70 C-terminal peptide binding (Kajander et al., 2009). Alanine 
scanning indicates that minimisation causes both these amino acids to contribute less 
favourably to the interaction. This clearly reaffirmed that minimisation deteriorated this 
template complex, and would likely deteriorate the complex and quality of homology models 
built on this template.  
Kajander et al (2009) noted that when the structures of TPR1 and TPR2A domains in 
complex with their C-terminal peptides are aligned, the Hsp70-peptide was in a conformation 
that could not fit in into a binding cavity in TPR2A, as it does into the TPR1 binding cavity. 
This specificitydisplayed by TPR2A is mainly as a result of the bulky methionine of Hsp90C-
terminal MEEVD peptide better filling a cavity in the TPR2A convex surface than the 
corresponding isoleucine in the Hsp70 C-terminal GPTIEEVD peptide (Kajander et al., 2009; 
Schmid et al., 2012). 
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Table 4.3: Comparison of the interacting residues in both the original and refined 
versions of 3UQ3 for the TPR2B region only. (i.e ScHopTPR2B complexed to ScHsp-70 
C-terminal peptide EVD). 
Model Method Hydrophobic 
interactions 
Main-Side Chain 
Interactions 
Side-Side Chain 
Hydrophobic 
Interactions 
Ionic 
Interactions 
Original PIC 3 7 0 2 
 Interacting 
residues 
found in 
AlaScan 
A; PHE407, 
TYR419. C; 
VAL709 
A; ARG400, 
ASN435, ARG469. 
C; ASP710 
N/A A; LYS404, 
ARG469. C; 
ASP710 
Minimised PIC 3 5 3 2 
 Interacting 
residues 
found in 
AlaScan 
A; PHE407, 
TYR419. C; 
VAL709 
A; ARG400, 
ASN435. C; 
ASP710 
A; ARG465. C; 
ASP710 
A; ARG465, 
ARG469. C; 
GLU708, 
ASP710 
 
It is clear to see from Tables 4.3 and 4.4 (representing the ScHop TPR2B half of 3UQ3 and 
3UPV, respectively) that there is some discrepancy between the number of interactions 
reported for both models, even though the interactions being represented are essentially the 
same (that of ScHop TPR2B in complex ScHsp70 C-terminal peptide), and were produced by 
the same authors, in the same manner, in the same species (Schmid et al., 2012). The most 
obvious reason for this is that the C-terminal fragment bound in 3UQ3 is EVD whereas the C-
terminal fragment bound in 3UPV is PTIEEVD. There are two other possible reasons for 
these differences. The first is that it is possible that TPR2 may bind Hsp70 C-terminal peptide 
less strongly after binding Hsp90 C-terminal peptide owing to conformational changes in the 
S-shaped backbone. It is also likely that more interactions are detected in 3UPV as this model 
was of higher resolution (1.60 Å) than 3UQ3 (2.60 Å) and was a more accurate representation 
of the native structure. 
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Table 4.4: Comparison of the interacting residues in both the original and refined 
versions of 3UPV. (i.e ScHopTPR2B complexed to ScHsp-70 C-terminal peptide 
PTIEEVD). 
Model Method Hydrophobic 
interactions 
Main-Side Chain 
Interactions 
Side-Side Chain 
Hydrophobic 
Interactions 
Ionic 
Interactions 
Original PIC 3 11 9 4 
 Interacting 
residues 
found in 
AlaScan 
A; PHE273, 
TYR285. B; 
VAL655 
A; ARG266, 
ASN301, 
ARG335, 
GLU371. B; 
THR651, ASP656, 
GLU654 
A; LYS308, 
ARG331, 
GLU371. B; 
THR651, 
GLU653, 
ASP656 
A; LYS308, 
ARG331, 
ARG335. B; 
GLU654, 
GLU653, 
ASP656 
Minimised PIC 4 10 5 4 
 Interacting 
residues 
found in 
AlaScan 
A; PHE273, 
TYR285. B; 
VAL652, 
VAL655 
A; ASN301, 
ARG335, 
GLU371. B; 
THR651,  
GLU654, ASP656 
A; ARG335, 
GLU371. B; 
THR651, 
ASP656 
A; LYS308, 
ARG331, 
ARG335. B; 
GLU654, 
GLU653, 
ASP656 
 
The minimisation of SchmidCYS model, depicting TPR2 (unbound to Hsp90 and Hsp70 C-
terminal peptides) in complex with Hsp90 M and C domains, resulted in a large increase in 
interactions as well as the number of interacting residues involved in complex formation (see 
Table 4.5).  There was only one Main-Main hydrophobic interaction loss. This is likely as a 
result of the method of producing this template (discussed in Chapter 3, Section 3.4.3). The 
docking of these two proteins with each other was rigid and relaxation of the side chain 
rotamers introduced more points of interaction. 
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Table 4.5: Comparison of the interacting residues in both the original and refined 
versions of SchmidCYS (i.e  ScHopTPR2 complexed to ScHsp-90 M and C domains). 
Model Method Hydro-
phobic 
interaction 
Main-Main 
chain 
interaction 
Main-side 
chain 
Interaction 
Side-Side 
Chain 
Interaction 
Ionic 
Interaction 
Cation-Pi 
interaction 
Original PIC 3 1 6 11 10 1 
 Interacting 
residues 
found in 
AlaScan 
A; TRP300 
B; VAL416 
A; THR462 
B; THR368 
A; ASN298, 
LYS449, B; 
LEU443, 
ARG376, 
SER445 
A; CYS411, 
GLU446, 
ASP452, 
GLU453, 
GLU412, 
ASP302, B; 
LYS417, 
LYS383, 
LYS380, 
ARG376, 
LYS337, 
GLU379 
A; GLU287, 
ASP302, 
GLU412, 
ASP452, 
GLU453, 
ASP459, 
GLU466, B; 
ASP370, 
HIS366, 
LYS337, 
ARG376, 
LYS380, 
LYS383, 
LYS417, 
A; TRP300 
B; ARG436 
Mini-
mised 
PIC 4 0 18 16 14 1 
 Interacting 
residues 
found in 
AlaScan 
A; TRP300 
B; VAL416, 
LEU440 
N/A A; ASN298, 
LYS449, 
MET464, 
TRP300, 
ASN298, B; 
LEU443, 
SER445, 
ARG367, 
ARG376, 
LEU443 
A; CYS411, 
GLU415, 
GLU412, 
GLU446, 
GLU287, 
ASP302, 
GLU301, 
MET464, 
TRP300,  B; 
LYS417, 
LYS424, 
LYS383, 
LYS380, 
LYS333,  
GLU448, 
ARG367, 
ARG376, 
GLU379 
A; GLU287, 
GLU301, 
ASP302, 
GLU412,   
GLU453, 
ASP459, 
GLU466, 
ARG326,  B; 
GLU448, 
LYS333, 
HIS366, 
ARG376, 
LYS380, 
LYS383, 
LYS417, 
LYS424 
A; TRP300 
B; ARG436 
 
 
 
 
  
 
 139 
4.3.2: Protein-Protein Surface Interactions and Characterisation 
Table 4.6: Comparison of the interacting residues in the refined PfHopTPR1 Model (36) 
and its human homolog 1ELW. 
Model Method Hydrophobic 
interactions 
Main-Side Chain 
Interactions 
Side-Side Chain 
Hydrophobic 
Interactions 
Ionic 
Interactions 
1ELW_mod PIC 8 13 2 5 
 Interacting 
residues 
found in 
AlaScan 
A, LEU15, 
TYR27, PHE84. 
C; VAL8, ILE6 
A; LYS8, ASN12, 
ASN43, LYS73, 
ARG77. C; ASP12, 
GLU10, GLU9 
A; LYS73. C; 
ASP12 
A; LYS73, 
ARG77. C; 
ASP12, 
GLU10, GLU9 
Minimised 
PfHopTPR1. 
B99990036.pdb 
PIC 6 13 0 2 
 Interacting 
residues 
found in 
AlaScan 
A; PHE18, B; 
PRO123, 
VAL125, 
VAL128 
A; ASN15, ASN46, 
ARG80 B; 
GLU126, GLU127, 
ASP129 
N/A B; ASP129 
Conserved PIC 3 9 N/A 1 
Aligned PIC 3* 9**  N/A 1 
*However, there is also a displaced PHE57 (undetected by alanine scanning) in P.falciparum, in the 
same region as PHE84 in 1ELW (but on adjacent helix) performing the same function. 
** No LYS interactions in P. falciparum model confirmed by AlaScan 
 
From Table 4.6, it is evident that there are several differences between homologous P. 
falciparum and H. sapiens TPR1:Hsp70 C-terminal complexes. The active sites of both 
proteins have several aligned interactions, i.e. those interactions of the same type occurring 
between different residues (or same residues but different atoms) that align in both species’ 
structures. There are slightly fewer conserved interactions, i.e. those interactions of the same 
type occurring between identical residues (and atoms) that align on both species’ structures.  
  
 
 140 
As is discussed by Scheufler, et al (2000) most of the direct hydrogen bonding interactions 
from the TPR1 region are to the Hsp70 C-terminal peptide backbone. PIC results show that 
the same is true for the the PfHop model. It was previously concluded that this meant that 
TPR1:Hsp70 C-teminal complex formation did not rely on sequence-specific features of the 
Hsp70 peptide in the human complex (Scheufler et al., 2000). However, in-silico alanine 
scanning of the complex indicated that mutation of any of the Hsp70 peptide residues in both 
complexes indicated that all the residues in –IEEVD in HsHsp70 and –VEEVD in PfHsp70 
result in complex destabilisation for both species when mutated to alanine (Table 4.6).  
In the human complex, ARG77 of TPR1 plays a key role in binding the backbone of the 
peptide. Its guanidinium group makes three direct hydrogen bonds with the carbonyls of 
GLU9 and VAL10 in the EVD C-terminal (Scheufler et al., 2000). In PfHop, in the aligned 
position, ARG80 is only making two direct hydrogen bonds with the residue homologous to 
HsHop GLU9, which is to the carbonyl of GLU127.  An additional hydrogen bond to the 
carbonyl of GLU9 is mediated by a tightly bound water molecule positioned by LYS50 in 
TPR1 in human (Scheufler et al., 2000). Neither the PIC nor AlaScan programs detected this 
LYS50-GLU9 interaction in 1ELW; however, it was detected by these programs in the 
refined version of this structure (see Table 4.1). Owing to the fact that all waters are removed 
from the template prior to homology modelling and that the homologous residue in 
P.falciparum is SER53, it is not surprising that an aligned interaction was not predicted by the 
PIC. However, alanine scanning results indicated that mutation of the SER53 to alanine may 
result in complex disruption, indicating that the residue in this position is important. This 
highlights the necessity of using more than one method to analyse individual residue 
interactions in complex models. 
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Figure 4.2: 1ELW (green) aligned to minimised PfTPR1 model 36 (pink) and visualised 
in PyMOL, showing the “carboxylate clamp” residues (stick representation) interacting 
with the C-terminal -EEVD of Hsp70/Hsc70 (cartoon representation). 
 
Importantly, the highly conserved “carboxylate clamp” (Scheufler et al., 2000), is present in 
both the human and malarial complex (Figure 4.2). In the P.falciparum model, the PIC 
predicts ionic protein interactions for LYS11 and LYS76 to ASP129 however; alanine 
scanning does not predict that these lysines are critical to complex stabilisation hence their 
exclusion form the Table 4.6. For the homologous interaction in humans, LYS8 and LYS73 to 
Hsc70’s ASP12, alanine scanning predicts that the mutation of these lysines to alanine will 
destabilise the complex. 
 
 
 
 
 
 
 
 
 142 
Table 4.7: Comparison of the interacting residues in the PfHopTPR2A model 71 and the 
homologous HsHopTPR2a model 13. 
Model Method Hydrophobic 
interactions 
Main-side 
chain 
Interactions 
Side-Side 
Chain 
Interactions 
Ionic 
Interactions 
Aromatic 
sulphur 
Interaction 
HsTPR2A13 PIC 4 14 9 5 1 
 Interacting 
residues 
found in 
AlaScan 
A; TYR12, 
TYR24, B; 
MET264, 
VAL267 
A; LYS5, 
ASN9, TYR12, 
ASN40, 
GLU47, 
LYS77, 
ARG81, B; 
GLU265, 
GLU266, 
ASP268 
A; LYS15, 
THR36, 
LYS77, 
ARG81, 
ASN84, B; 
MET264, 
GLU265, 
ASP268, 
A; LYS5, 
LYS77, ARG81, 
B; GLU265, 
GLU266, 
ASP268 
A; TYR12, B; 
MET264 
PfTPR2A14 PIC 4 10 3 2 1 
 Interacting 
residues 
found in 
AlaScan 
A; TYR12, 
TYR24. B; 
MET245, 
VAL248 
A; ASN9, 
TYR12, 
ASN40, 
GLU47, 
ARG81,  B; 
GLU246, 
GLU247, 
ASP249 
A; LYS15, 
LYS77, 
ARG81, B; 
MET245, 
GLU246, 
ASP249 
A; LYS77, 
ARG81 B; 
ASP249, 
GLU246, 
A; TYR12. B; 
MET245. 
Conserved PIC 4 10 3 2 1 
Aligned PIC 4 10 3 2 1 
 
From Table 4.7, it is evident that there are very small differences between homologous P. 
falciparum and H. sapiens TPR2A:Hsp90 C-terminal complexes. Generally, the human 
complex has more sites of interaction and all the active sites of P. falciparum are identical to 
their aligned human interactions. It is also clear to see from Figure 4.3, that all the carboxylate 
binding clamp residues in both species are in very similar orientations for complex formation. 
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Figure 4.3: Comparing interaction sites in HsTPR2B model 13 (green) aligned to 
PfTPR2B model 14 (pink) and visualised in PyMOL. The “carboxylate binding-clamp” 
residues (stick representation) are interacting with the C-terminal -MEEVD of Hsp90 (cartoon 
representation). 
 
Figure 4.4: Comparing interaction sites in HsTPR2B model 13 (green) aligned to 
PfTPR2B model 14 (pink) and visualised in PyMOL. The interacting residues (stick 
representation) interacting with the C-terminal -PTIEEVD of HsHsc70 and the C-terminal -
PTVEEVD of PfHsp70, respectively (cartoon representation). 
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Table 4.8: PIC results comparing binding residues in human and malarial 
TPR2B:Hsp70-PTVEEVD complexes. 
Model Method Hydrophobic 
interactions 
Main-side 
chain 
Interactions 
Side-Side 
Chain 
Interactions 
Ionic 
Interactions 
Aromatic 
sulphur 
Interaction 
HsTPR2B13 PIC 4 5 1 4 0 
 Interacting 
residues 
found in 
AlaScan 
A; PHE147, 
TYR159, B; 
ILE271, 
VAL274 
A; ARG209, 
ASN175 C; 
GLU273, 
THR270, 
ASP275 
A; LYS182, C; 
GLU272, 
A; LYS182, LYS 
205, ARG209 
C; GLU272, 
GLU273 
ASP275 
N/A 
PfTPR2B14 PIC 3 8 1 4 0 
 Interacting 
residues 
found in 
AlaScan 
A; PHE147, 
TYR159, 
ALA178* C;  
VAL255 
A; LYS140, 
ASN175, 
ARG209. C; 
THR251, 
GLU254, 
ASP256 
A; LYS182, C; 
GLU253, 
A; LYS182, 
ARG 205, 
ARG209 C; 
GLU253, 
GLU254, 
ASP256 
N/A 
Conserved PIC 3 1 1 4 N/A 
Aligned PIC 3 5** 1 4 N/A 
*ALA178 in P.falciparum detected by alanine scanning, but human homolog ALA178 is not. 
**There are four bonds in P. falciparum from NH1 of ARG209 to O of THR251 and GLU254, but for 
human, there is an analogous interaction occurring from NH2 of ARG209 to O of THR270 and 
GLU273. 
 
From Table 4.8, it is evident that there are very small differences between homologous P. 
falciparum and H. sapiens TPR2B:Hsp70 C-terminal complexes. As shown in Figure 4.4, the 
assembly of interacting residues are very similar, with the exception of the variability at the 
LYS205 and ARG204 position. Generally, the complexes have an equal amount of 
interactions and again, almost all the active site interactions of P. falciparum are identical to 
their aligned human interactions. In the few cases where interactions are not identical, there 
are aligned interactions occurring between identical residues, but different side chain nitrogen 
groups become the H-bond donor.  
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Table 4.9: PIC results comparing binding residues in human and malarial Hsp90-M&C-
domains:HopTPR2 complexes. 
Model Method Hydrophobic 
interactions 
Main-side 
chain 
Interactions 
Side-Side 
Chain 
Interactions 
Ionic 
Interactions 
Cation-Pi 
interactions 
Minimised 
HsComplex 
model 7 
PIC 3 3 11 6 1 
 Interacting 
residues 
found in 
AlaScan 
A; TRP26 B; 
MET554, 
TYR578, 
LEU586 
A; LYS20, 
ASN24, 
TRP26, B; 
THR558, 
LEU581 
A; GLU13, 
GLU138, 
ASP185, 
ARG189 B; 
GLN514, 
ARG525, 
LYS555 
A; GLU13, 
ASP28, 
LYS137, 
GLU138, 
LYS141, 
GLU179, B; 
LYS518, 
ARG525, 
LYS555 
A; TRP26 B; 
ARG574 
Minimised 
Pfmulti 
model 102 
PIC 4 5 8 7 0 
 Interacting 
residues 
found in 
AlaScan 
TYR26 B; 
TYR569, 
ALA589, 
LEU590, 
LEU593 
A; LYS26, 
ALA25, TYR26, 
ASN192 B; 
ARG519, 
LYS566, 
ASP570, 
GLU595 
A; ASN13, 
ASP141, 
ASP181, 
LYS182 B; 
ARG519, 
LYS526, 
ARG530, 
GLU533, 
LYS567 
A; ASP28, 
ASP141, 
ASP181, 
GLU191, 
LYS182, 
ASP226 B; 
ARG519, 
ARG522, 
LYS526, 
ARG530, 
LYS526, 
ARG530, 
GLU533, 
LYS567 
N/A 
Conserved PIC 0 0 0 1 0 
Aligned PIC 1 1 2 3 0 
Region of Occurrence Only TPR2B 
and Hsp90M 
Primarily 
TPR2B and 
Hsp90M 
Primarily 
Linker, TPR2A 
and Hsp90C 
Primarily 
Linker, TPR2A 
and Hsp90C 
Only Linker 
and Hsp90C 
 
The convex binding sites on HsHop TPR2 in complex with the HsHsp90 M and C domains 
share almost no conservation of interactions (in terms of interacting residues) to their 
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counterparts in PfHop TPR2 in complex with PfHsp90 M and C domains and a relatively 
small percentage of those interactions were even aligned (see Table 4.9). The only interaction 
that was conserved between the two species was an ionic interaction (bold italics, Table 4.9) 
between ASP28 (in both species Hsp90 C domain) and a lysine (LYS555 and LYS567 in 
HsHop TPR2 and PfHop TPR2, respectively). Additionally, alanine scanning identified more 
residues integral to complex formation in P. falciparum than in human Hop. 
 
Figure 4.5: HsTPR2A model 13 (green) and PfTPR2A model 14 (pink) and visualised in 
PyMOL, showing the interacting residues (stick representation) interacting with the 
Hsp90 C and M domains (blue and red for human and P. falciparum, respectively). 
The regions in which interaction was observed as well as the numbers of each interaction 
type, however, seemed to be well conserved (see Table 4.9 and Figure 4.5). Overall it was 
plain to see that this interaction is important to complex formation in both species; however 
the interacting residues showed far more variability than the interacting residues on the 
concave surfaces of TPR1 and TPR2A&B. 
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4.4 Binding Energies of Several Complexes  
4.4.1 TPR1 Complexes 
Table 4.10 shows that the comparative interaction and binding energies in TPR1 complexes 
are higher in the PfHop model, indicating the PfTPR1 domain has lower affinity for the C-
terminal motif of its Hsp70 partner than does the HsTPR1 domain for its respective Hsc70 
partner. With regards to cross-species binding of HsHop to Hsp70-x GPTVEEVN C-terminal 
motif, it is ambiguous as to which species has the higher affinity for Hsp70-x, as the 
interaction energy for the HsHop complex is higher, while the overall binding energy is 
lower.  
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Table 4.10: Binding energy summary for single template complex models. 
Template Rosetta Energies 
  H. sapiens  P. falciparum 
1ELW Chain A and 
C 
Human 
One Complex 
- TPR1:GPTIEEV
D 
 One Complex 
- TPR1:GPTVEEV
D 
XRD 
Scheufler et 
al., 2000 
TPR1 Motif 
- 1.60 
- 0.180 
- 0.215 
Template: 1ELW_mod 
 
 PfHopTPR1 model 36 
 
 
Interaction 
Energy:  
-10.709 Interaction 
Energy:  
-4.515 
Binding 
Energy:   
42.112 Binding 
Energy:   
299.633 
 -  -  -  
1ELW Chain A and 
C 
Human 
One Complex 
- TPR1:GPTVEEV
N 
 One Complex 
- TPR1:GPTVEEV
N 
XRD 
Scheufler et 
al., 2000 
TPR1 Motif 
- 1.60 
- 0.180 
- 0.215 
HsHopTPR1N model 1  PfHopTPR1N model 50 
 
 
Interaction 
Energy:  
7.791 Interaction 
Energy:  
-4.91 
Binding 
Energy:   
208.804 Binding 
Energy:   
349.301 
M&C Domain Hsp90 
& HopTPR2 
Yeast 
One complex 
 
 None 
Docked 
Spin-
Labelled 
complex 
Schmid et 
al., 2012 
TPR2AB 
(Convex) 
 Hs_complex_single model 7 
 
                      N/A  
 
 
 
 
Interaction 
Energy:  
-21.402 
Binding 
Energy:   -195.339 
 
What is also important to note is that the overall affinity of HsHopTPR1 for its Hsc70-1 C-
terminal motif is much greater than for the PfHsp70-x motif, so this motif may be out 
competed for binding in the red blood cell cytoplasm. Interestingly, overall affinity of 
PfHopTPR1 for its Hsp70-1 C-terminal motif is greater than for the PfHsp70-x motif, so this 
motif may be outcompeted for binding within the parasite cytoplasm. 
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4.4.2 TPR2 Complexes 
The comparative interaction and binding energies in TPR2 models are higher in both P. 
falciparum HopTPR2:Hsp70-1:Hsp90 and HopTPR2:Hsp70-x:Hsp90 complexes (see Table 
4.11). This indicates the PfTPR2A&B C-terminal binding domains have lower affinity for 
both C-terminal motifs of its Hsp70 and Hsp90 partners than does the HsTPR2 domain for its 
respective Hsc70 and Hsp90 partners. In all models, the HopTPR2A has stronger affinity for 
its Hsp90 C-terminal motif partner than does the TPR2B domain for its Hsp70-1 partner. This 
is consistent with both recent and older findings, both in vitro (Scheufler et al., 2000; Schmid 
et al., 2012) and insilico (Kajander et al., 2009). 
What is interesting to note is that in HsHop, all TPR regions complexed to their respective 
motifs have lower binding energies than their P. falciparum counterparts. However, the 
interaction and binding energy are lower for the P. falciparum complex between HopTPR2 
and Hsp90 M and C domains (Table 4.11), than for the human counterpart (Table 4.10).  
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Table 4.11: Binding energy summary for multi template complex models. 
 
 
 
 
Templates Homology Models – Best DOPE-Z Score of 100  
A B H. sapiens  P. falciparum 
M&C Domain Hsp90 & 
HopTPR2 
And 4GCO C. elegans 
None 
 
 One complex 
 
Spin-labelled 
Scheufler et 
al., 2000 
TPR2 
Chain A 
TPR2B 
N/A  Pfmulti model 102 
Interaction Energy:  -24.59 
Binding Energy:   -282.631 
3UQ3 Chain A, B and C 
3UPV Chain A and B 
Yeast 
Two complexes 
- TPR2A:MEEVD 
- TPR2B:PTIEEVD 
-  Two complexes 
- TPR2A:MEEVD 
- TPR2B:PTVEEVD 
XRD 
Schmid et al., 
2012 
TPR2AB 
Motifs 
- 2.60 
- 0.222 
- 0.279 
HsTPR2ab2yeast  model 13 
 
PfTPR2ab2yeast model 61 
 
 2A 2B  2A 2B 
Interaction 
Energy:  
-7.746 8.996 
Interaction 
Energy:  
-6.533 41.979 
Binding 
Energy:   
-3640.731 -3620.463 
Binding 
Energy:   
628.2 653.952 
Overall 
Interaction 
Energy: 
1.25 
Overall 
Interaction 
Energy: 
35.446 
Overall 
Binding 
Energy: 
-3624.447 
Overall 
Binding 
Energy: 
652.644 
3UQ3 Chain A, B and C 
3UPV Chain A and B 
Yeast 
Two complexes 
- TPR2A:MEEVD 
- TPR2B:PTVEEVN 
-  Two complexes 
- TPR2A:MEEVD 
- TPR2B:PTVEEVN 
XRD 
Schmid et al., 
2012 
TPR2AB 
Motifs 
- 2.60 
- 0.222 
- 0.279 
Top Model: 
HsTPR2ab2N  model 83 
 Top Model: 
PfTPR2ab2N model14 
 
 
 2A 2B  2A 2B 
Interaction 
Energy:  
-9.813 25.603 
Interaction 
Energy:  
8.717 93.106 
Binding 
Energy:   
45.657 81.834 
Binding 
Energy:   
627.293 707.019 
Overall 
Interaction 
Energy: 
15.79 
Overall 
Interaction 
Energy: 
101.822 
Overall 
Binding 
Energy: 
78.653 
Overall 
Binding 
Energy: 
721.523 
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4.5 Correlating Sequential and Structural Features with Interaction Sites 
Analysis of most of the MEME motifs, particularly those describing fungal and protozoan 
sequences (discussed in Chapter 2, see also Appendix 1), indicated a periodicity of conserved 
residues at approximately every third or fourth site. As this is roughly the periodicity of an 
alpha-helix turn, it was suspected that this periodicity of conservation reflected conserved 
surfaces in the Hop structure. To investigate this, conserved residue sites identified in fungal 
and protozoan motifs were mapped to the corresponding sites on the PfHop structures 
discussed in Chapters 3 and 4.  
Using motifs 2, 9 and 10 from the twenty motif search (i.e. that discussed in Chapter 2), the 
residues with bit scores higher than 3 were mapped to the minimised PfTPR1 model 36, and 
displayed as a surface. Interestingly the concave surface is very well conserved and is almost 
completely mapped with these well conserved (bit score > 3) regions (see Figure 4.6 A). 
The convex surface of PfTPR1 is less well conserved, however there are two blocks of well 
conserved sites (block B1 & B2, Figure 4.6 C2) that map two “patches” of the convex surface 
(region B1 and B2, Figure 4.6 B). TPR1 is thought to interact with other proteins by means 
other than the concave binding site residues in the human model (Scheuflur et al, 2000; 
Kajander et al, 2009), and may also work in concert with the DP2 domain to stabilise the 
interaction between Hsp70 bound to client when in complex in the yeast model (Schmid et al, 
2012). It is possible that these “patches” of conserved residues on the convex side of TPR1 
could identify these as yet uncharacterised regions of interaction in Hop TPR1. Only further 
experimental studies may confirm this.  
To the author’s knowledge, this is the first reported instance of using MEME results to 
identify conserved surface features and relate them to structures in this way. This may turn 
out to be a useful method for examining the suspected conserved and functional features of 
protein structures in the future.  
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Figure 4.6: Residues with a bit score > 3 in Minimised PfTPR1 model 36 (chain A) 
selected and displayed as surface in PyMOL. A) The concave surface of the TPR1 domain 
(green alpha-carbon wireframe model) with the cartoon representation (black) of PfHsp70-1 
C-terminal motif. B) The convex surface (cyan alpha-carbon wireframe model). B1 and B2 
correspond to 2 stretch of well conserved residues and are highlighted in C2. C1) Motif 10 
from Figure 2.6. C2) Motif 2 from Figure 2.6. C3) Motif 9 from Figure 2.6. 
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Figure 4.7: Residues with a bit score > 2.5 in Pfmulti model 102 (chain B) selected and 
displayed as surface in PyMOL. A) The convex surface of the TPR2A&B domain (green 
alpha-carbon ribbon) with the stick and surface representation (orange) of Hsp90 binding 
residues. 1A and 1B correspond to 2 stretches of well conserved residues and are highlighted 
in D3. B) The concave surface of TPR2A. B) The concave surface of TPR2B. D1) Motif 10 
from Figure 2.6, representing the N-terminal region of TPR2A. D2) Motif 4 from Figure 2.6, 
representing the middle of TPR2A. D3) Motif 1 from Figure 2.6, representing the C-terminal 
of TPR2A, linker helix and TPR2B regions. 
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Using motifs 1, 4 and 10 from the twenty motif search, the residue sites with a bit score 
higher than 2.5 were mapped to the Hop half of Pfmulti model 102 (chain B), and displayed 
as surface (Figure 4.7). Not surprisingly, the concave surfaces of TPR2A and for TPR2B were 
well conserved and were almost completely mapped with these well conserved (bit score > 
2.5) regions. At a bit score of greater than 3, only four of the residues in PfHop that bind 
PfHsp90 M and C Domains in Pfmulti model 102 (ARG530, TYR569, ALA589 and 
LEU593) are represented. These are all residues identified by alanine scanning to be 
important to complex formation (Table 4.9). At a bit score of greater than 2.5, a further four 
residues (ARG522, ASP570, LEU590 and GLU595) involved in the interaction are 
represented. Again these are all residues identified by alanine scanning to be important for 
complex formation (Table 4.9). 
 
4.6 Conclusions 
The primary conclusions of this chapter are two-fold; firstly, as discussed in Chapter 3, 
minimisation can severely impact the structure of models and secondly, that the concave 
interaction sites in the TPR domains are marginally better conserved than the convex 
interacting sites. From Section 4.3, it is observed that when a model (or template) is of low 
quality it appears that minimisation introduces new points of interaction and alanine scanning 
detects greater numbers residues that are important to the interaction. However, when the 
model (or template) is of sufficient quality not to warrant minimisation, there is either a small 
loss or gain in interactions. If a model is of good quality, it is probably advantageous to leave 
it alone, as minimisation will result in the risk of introducing bias toward a certain 
conformation (as discussed in Chapter 3, Section 3.1.4). If a model is of low quality, it may 
well be with the risk of introducing bias in order to identify a wider range of interaction sites. 
Similar refinement advantages and disadvantages have been discussed elsewhere in the 
literature (Tastan Bishop & Kroon, 2012; Vyas et al., 2012). 
Overall, from Section 4.4, it is clear that the concave binding site interactions and residues 
(primarily the “carboxylate binding clamp” residues) are exceptionally well conserved 
between the two human and P. falciparumHop sequences. In fact, Section 4.6 suggests that 
the entire concave surface of the TPR domain in general is extremely well conserved. In 
contrast, Section 4.4 also shows that the convex surfaces of the TPR2 domains involved in 
complex formation with the Hsp90 M and C domains display much more variability in 
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residue composition between the two species. However, the sites of interaction remain the 
same. This would be the more plausible protein-protein interaction site to target with selective 
drugs in order to combat malaria.  
Section 4.5 dealt with the question of whether there is potential for a cross-species protein 
complex to form, as discussed in Chapter 1, Sections 1.2 and 1.9. However it also allowed 
generalisations to be made about differences in protein affinities between each species. 
Overall, it appears that the human complexes have lower interaction and binding energies 
than do the P. falciparum complexes, with the exception of the TPR2:Hsp90 M and C domain 
complex, where the interaction and binding energies are slightly lower in P. falciparum than 
in human complexes. This is reflected in Table 4.9, which shows that this complex has a 
higher number of interactions (and residues favourably involved in interaction) in P. 
falciparum than in human. 
It has long been known that P. falciparum can annex and manipulate the host cell’s proteins 
for growth (Charpian et al, 2009). With regards to cross-species protein complex formation to 
occur, it is possible that PfHsp70-x may interact with human Hop. The results from Section 
4.5.2 seem to support the likelihood of this interaction. The interaction and binding energies 
in the PfHopTPR2B:PfHsp70-x models are higher in P. falciparum than in the human 
HsHopTPR2B:PfHsp70-x complex, indicating that HsHop has a higher affinity for PfHsp70-x 
C-terminal peptide than PfHop, allowing PfHop to be outcompeted for binding in the host cell 
cytoplasm. Additionally, overall affinity of PfHopTPR1 for its Hsp70-1 C-terminal motif is 
greater than for the PfHsp70-x motif, so this motif may also be outcompeted for binding 
within its native parasite cytoplasm. 
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Chapter 5: Summary and Implications of Research 
5.1 Project Results in Brief 
It was clear from Chapter 2 that phylogeny-wide MSA shows good conservation of the Hop 
protein across all sequences analysed. Phylogenetic analysis at both the protein and gene 
level, while disagreeing on the order of outgroups, indicates that there is distinct grouping of 
Hop sequences into several units; vertebrate and invertebrate, fungal and protozoan. Overall, 
the most well conserved region of Hop is the DP2 region, indicating that this domain may 
have a more important functional role than previously thought. Future research efforts will 
need to focus on the experimental characterisation of this region.  
On the other hand, the DP1 domain and linker region connecting DP1 and TPR2A domain 
appears to be the least well conserved region in the protein. MSA analysis of this area in the 
protein suggests this is the region of most insertions and deletions. Because the DP1 domain 
possesses no recognisable “DP” repeats and the long linker contains no proline repeats in the 
apicomplexan taxa (particularly in the Plasmodium genus), it is probable that this region will 
form a structurally and functionally distinct domain that is unique to this taxa (in comparison 
to all other taxa) and has yet to be characterised experimentally in PfHop. The production of 
poor quality models of PfDP1 discussed in Chapter 3 only reinforces this conclusion.  
With regards to the TPR domains in all species, and apart from the lysine/arginine variability 
in the “carboxylate binding clamp residues” of TPR2B, the binding site residues for the 
concave surfaces (in fact, the whole concave surfaces) of the 3 TPR motifs domains are 
highly conserved across all taxa. The production of good to excellent quality models of 
human and P.falciparum TPR domains (in complex with their respective C-terminal peptide 
partners) discussed in Chapter 3 again reinforce this conclusion. In contrast, the convex 
surface residues of TPR2A&B that are involved in the interactions that allow Hop to bind 
Hsp90 in on surface regions of the M and C domains are less conserved between HsHop and 
PfHop. However, the sites of these interacting residues appear to be well conserved. Any 
further research that aims to find drugs that target Hop protein-protein interactions would 
likely have the most success targeting this interaction between PfHop and PfHsp90. 
Chapter 4 suggests that HsHop TPR domains bind their C-terminal peptides more strongly 
than do PfHop TPR domains. This could be advantageous for chemotherapeutic drugs that 
target these concave surface TPR interactions, as it is possible that HsHop TPR interactions 
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will be less easily disrupted than their P. falciparum counterparts. While this is an interesting 
and exciting result, there were several limitations on the way these results were obtained (as 
discussed in Section 4.2). Further in-silico and experimental research will need to focus on 
simulating the physiological conditions in which these interactions take place in the 
uninfected human host cell, the parasite cell and the infected cell in the trophozoite stage.  
Additionally, Chapter 4 provides evidence for the possibility of cross-species protein-protein 
interactions. While both HsHop and PfHop have lower affinities for the alternative PfHsp70-x 
C-terminal motif discussed in Chapters 1 and 4, HsHop has a greater affinity for the peptide 
than does PfHop. Again the validity of these results will need to be explored under simulated 
or experimental physiologically appropriate conditions. If it is found that such interactions do 
exist between P. falciparum and human Hsp and chaperone proteins within the infected host, 
this information would lead to exciting new protein interactions and biochemical pathways for 
drug development, so this idea definitely needs to be explored further. 
5.2 Novel Approaches Used in this Project 
According to the the author’s current knowledge, the methods of comparing MEME/MAST 
block diagrams according to the phylogeny of the sequences used (Chapter 2), as well as 
using MEME sequence logos to identify conserved surface features and map them to 
structures (Chapter 4) are novel ways of using the MEME software. This may turn out to be a 
useful method for examining the suspected conserved and functional features of protein 
structures as well as the validation of protein trees (or even gene trees) in the future. 
5.3 Hop as a Potential Drug Target 
Overall this project addressed its aims of determining whether the PfHop protein and its role 
in other protein interactions would make a suitable drug target. The simple answer is yes. In 
reality, there is a lot that still needs to be understood about P. falciparum’s mechanism of 
growth within the infected host’s red blood cell. A good summary of the most up to date 
research on trafficking of malarial proteins was recently published by Deponte et al (2012). 
However, this report mentions Hop only briefly and otherwise there is very little information 
available on the role of PfHop within the parasite as well as HsHop within the mature 
erythrocyte environment.  
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5.4 Project Expansion 
There is much scope for the expansion of this project. While Hop in general has only been 
studied intensively for a relatively short period of time (approximately 10 years), it has been 
implicated in a very large number of pathways of interest to research in several high-impact 
diseases. These are thoroughly discussed in Chapter 1. There is no official collective 
publication on how vast the network of this protein as yet. Hop is clearly a small protein, but 
part of a big interaction network which is currently of a lot of interest to several aspects of 
disease research. Most high profile proteins or pathways are researched as such. However, 
each research group will tend to focus on their own separate pathways of interactions within 
their field of interest. While this is standard practise, it might be wise to change this paradigm 
of research to one that is at least peripherally aware of all the other interactions a particular 
group’s protein of interest is involved in, both in other species and other cell types in the same 
species.   
One method of reaching this holistic view of all interactions pertaining to a protein or class of 
proteins is already currently being developed. A bioinformatics PhD student, G. Salazar, 
based in Cape Town, is currently working on a user-friendly interface that visualises protein-
protein interactions in a networked “bubble” viewer. The current prototype, which has been 
built using information on protein-protein interactions between multiple Mycobacterium 
tuberculosis proteins of interest to TB research and can be viewed here: 
http://biosual.cbio.uct.ac.za/biosual/tests/pinv/pinv.html. The author of this tool also 
documents the development of work in a blog, available here: 
http://biosual.blogspot.com/2013/01/biosual-viewer-first-prototype.html. Personal 
communication with this author at a conference earlier this year revealed that future aimsof 
the project involved outside parties being able to upload information into the network tool, 
and create their own networks. 
It is for this reason that there the next step in the current work is a collaboration to combine 
this tool with a repository of information on Hop (and later, all Hsp proteins) protein-protein 
interactions, in various species as well as various organ and cell types. It would be available 
online as a user-friendly tool available to all those seeking information on current Hop 
research. In order to build on this experimentally, the role of Hop within P. falciparum should 
be more thoroughly characterised and the existence of HsHop within the mature red blood cell 
needs to confirmed, in order to design experiments that build on the current work’s results. 
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Ideally, there needs to be attempts to create models of the full length structure of Hop in 
human yeast and P. falciparum, both in solution-state and in complexed conformations.  
It may be possible to use the BUNCH assembly (computational assembly of several 
experimentally produced domain structures, and the linker region sequences) approach used 
by Romano et al (2009) to produce an accurate, full length working structure of HsHop. 
Analyses in Chapter 2 showed that (between XRD models of TPR1 and TPR2A, the probable 
polyproline II helix in the linker between mammalian DP1 and TPR2A, Cryo-EM models of 
TPR2A&B, and the homology models presented in this project) there are approximately only 
10 residues in the linker between TPR2B and DP2 for HsHop that have not been mapped to a 
structure. Unfortunately, this approach would not be as feasible with PfHop. This is because 
the DP1 and long linker region have not been structurally or functionally characterised yet 
and its role in the formation of the Hsp chaperone complex as not been nearly as well 
described or investigated as that for yeast and human. 
 
  
 
 160 
References  
Abbas-Terki, T., Donzé, O., Briand, P.-A., & Picard, D. (2001). Hsp104 interacts with Hsp90 
cochaperones in respiring yeast. Molecular and Cellular Biology, 21, 7569–7575. 
Accelrys Software Inc., Discovery Studio Modeling Environment, Release 3.5, San Diego: 
Accelrys Software Inc., 2007. 
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Molecular 
Biology of the Cell. (S. Gibbs, Ed.) (4th ed., p. 1463). New York: Taylor & Francis 
Group. 
Albanèse, V., Yam, A. Y., Baughman, J., Parnot, C., & Frydman, J. (2006). Systems analyses 
reveal two chaperone networks with distinct functions in eukaryotic cells. Cell 124, 75-
88. 
Ali, M.M., Roe, S.M., Vaughan, C.K., Meyer, P., Panaretou, B., Piper, P.W., Prodromou, C., 
Pearl, L.H. (2006). Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone 
complex. Nature. 440(7087), 1013-7. 
Altschul, S. F., Gish, W., Miller, W., Myers, E., & Lipman, D. J. (1990). Basic Local 
Alignment Search Tool. Journal of Molecular Biology, 215, 403–410. 
Altschul, S. F., Madden, T. L., Schäffer, a a, Zhang, J., Zhang, Z., Miller, W., & Lipman, D. 
J. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search 
programs. Nucleic Acids Research, 25(17), 3389–402. 
Americo, T. A., Chiarini, L. B., & Linden, R. (2007). Signaling induced by hop/STI-1depends 
on endocytosis. Biochemical and Biophysical Research  Communications. 358, 620-625. 
Arkin, M. R., & Wells, J. a. (2004). Small-molecule inhibitors of protein-protein interactions: 
progressing towards the dream. Nature reviews. Drug discovery, 3(4), 301–17.  
Bailey, T L, & Gribskov, M. (1998). Combining evidence using p-values: application to 
sequence homology searches. Bioinformatics (Oxford, England), 14(1), 48–54. 
Bailey, Timothy L, Boden, M., Buske, F. a, Frith, M., Grant, C. E., Clementi, L., Ren, J., et al. 
(2009). MEME SUITE: tools for motif discovery and searching. Nucleic Acids Research, 
37(Web Server issue), W202–8.  
Bailey, Timothy L., & Charles, E. (1994). Fitting a mixture model by expectation 
maximization to discover motifs in biopolymers. Proceedings of the Second 
International Conference on Intelligent Systems for Molecular Biology (pp. 28–36). 
Menlo Park, California: AAAI Press. 
Baugh, E. H., Lyskov, S., Weitzner, B. D., & Gray, J. J. (2011). Real-time PyMOL 
visualization for Rosetta and PyRosetta. PloS One, 6(8), e21931.  
Beaumont, M. a, & Rannala, B. (2004). The Bayesian revolution in genetics. Nature reviews. 
Genetics, 5(4), 251–61.  
Benner, S. a. (2001). Natural progression. Nature, 409(6819), 459.  
Berman, H. M., Henrick, K., & Nakamura, H. (2003). Announcing the worldwide Protein 
Data Bank. Nature Structural Biology, 10(12), 98. 
Berman, J., Westbrook, Z., Feng, G., Gilliland, T. N., Bhat, H., Weissig, I. N., Shindyalov, P. 
E., et al. (2000). The Protein Data Bank. Nucleic Acids Research, 28, 235–242. 
 
 161 
Birkholtz, L., Joubert, F., Neitz, A. W. H., & Louw, A. I. (2003). Comparative properties of a 
three-dimensional model of Plasmodium falciparum ornithine decarboxylase. Proteins, 
50(3), 463–473. 
Boniecki, M., Rotkiewicz, P., Skolnick, J., & Kolinski, A. (2003). Protein fragment 
reconstruction using various modeling techniques. Journal of Computer-aided Molecular 
Design, 17(11), 725–38. 
Brayton, K. a, Lau, A. O. T., Herndon, D. R., Hannick, L., Kappmeyer, L. S., Berens, S. J., 
Bidwell, S. L., et al. (2007). Genome Sequence of Babesia bovis and Comparative 
Analysis of Apicomplexan Hemoprotozoa. PLoS Pathogens, 3(10), 1401–1013.  
Charpian, S., Przyborski, J. M., & Strasse, K. V. F. (2008). Protein Transport Across the 
Parasitophorous Vacuole of Plasmodium falciparum: Into the Great Wide Open, Traffic 
(8), 157–165.  
Chaudhury, S., Lyskov, S., & Gray, J. J. (2010). PyRosetta: a script-based interface for 
implementing molecular modeling algorithms using Rosetta. Bioinformatics (Oxford, 
England), 26(5), 689–91.  
Chen, S., Prapapanich, V., Rimerman, R. A., Honoré, B., and Smith, D. F. (1996). 
Interactions of p60, a mediator of progesterone receptor assembly, with heat shock 
proteins Hsp90 and Hsp70. The Journal of Molecular Endocrinology. 10, 682-693. 
Chen, S., and Smith, D. F. (1998). Hop as an adaptor in the heat shock protein 70 (Hsp70) and 
hsp90 chaperone machinery. The Journal of Biological Chemistry. 273, 35194-35200. 
Cheung-Flynn, J., Roberts, P. J., Riggs, D. L., & Smith, D. F. (2003). C-terminal sequences 
outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential 
binding to Hsp90. The Journal of Biological Chemistry, 278(19), 17388–94.  
Clare, J., Tate, S., Nobbs, M., & Romanos, M. (2000). Voltage-gated sodium channels as 
therapeutic targets. Drug discovery today, 5(11), 506–520. 
Coitinho, A. S., Lopes, M. H., Hajj, G. N. M., Rossato, J. I., Freitas, A. R., Castro, C. C., 
Cammarota, M., et al. (2007). Short-term memory formation and long-term memory 
consolidation are enhanced by cellular prion association to stress-inducible protein 1. 
Neurobiology of Disease, 26(1), 282–290.  
Corena, P., VanEkeris, L., Salazar, M. I., Bowers, D., Fiedler, M. M., Silverman, D., Tu, C., 
et al. (2005). Carbonic anhydrase in the adult mosquito midgut. The Journal of 
Experimental Biology, 208(Pt 17), 3263–73.  
Daniel, S., Bradley, G., Longshaw, V. M., Söti, C., Csermely, P., & Blatch, G. L. (2008). 
Nuclear translocation of the phosphoprotein Hop (Hsp70/Hsp90 organizing protein) 
occurs under heat shock, and its proposed nuclear localization signal is involved in 
Hsp90 binding. Biochimica et Biophysica Acta, 1783(6), 1003–14.  
DeLano, W.L. (2002)The PyMOL Molecular Graphics System. DeLano Scientific, San 
Carlos, CA, USA. 
Deponte, M., Hoppe, H.C., Lee, M.C., Maier, A.G., Richard, D., Rug, M., Spielmann, T., 
Przyborski, J.M. (2012). Wherever I may roam: protein and membrane trafficking in P. 
falciparum-infected red blood cells. Molecularand Biochemical Parasitology, 186(2), 
95-116. 
Do, C. B., & Batzoglou, S. (2008). What is the expectation maximization algorithm? Nature 
Biotechnology, 26(8), 897–9.  
 
 162 
Donnelly, A. C., Zhao, H., Reddy Kusuma, B., & Blagg, B. S. J. (2010). Cytotoxic sugar 
analogues of an optimized novobiocin scaffold. Medical Chemistry Communications, 
1(2), 165.  
Eiben, C. B., Siegel, J. B., Bale, J. B., Cooper, S., Khatib, F., Shen, B. W., Stoddard, B. L., et 
al. (2012). Increased Diels-Alderase activity through backbone remodeling guided by 
Foldit players. Nature Biotechnology, 130, 190–192. 
Eramian, D., Eswar, N., Shen, M.-Y., & Sali, A. (2008). How well can the accuracy of 
comparative protein structure models be predicted? Protein Science, 17(11), 1881–93.  
Erlich, R. B., Kahn, S. A., Avia, F. L., Martins, R. A. P., Linden, R., Chiarini, L. B., Martins, 
V. R., et al. (2007). STI1 Promotes Glioma Proliferation Through MAPK and PI3K 
Pathways. GLIA, 55, 1690–1698.  
Eswar, N., Eramian, D., Webb, B., Shen, M.-Y., & Sali, A. (2008). Protein structure modeling 
with MODELLER. Methods in Molecular Biology (Clifton, N.J.), 426, 145–59.  
Eustace B. K. & Jay D. G. (2004). Extracellular roles for the molecular chaperone, hsp90. 
Cell Cycle, 3, 1098-1100.. 
Figueireido, M. (2002). Unsupervised Learning of Finite Mixture Models. Transactions on 
Pattern Analysis and Machine Intelligence, 24(3), 381–396. 
Flom, G., Weekes, J., Williams, J. J., & Johnson, J. L. (2006). Effect of mutation of the 
tetratricopeptide repeat and asparatate-proline 2 domains of Sti1 on Hsp90 signaling and 
interaction in Saccharomyces cerevisiae. Genetics 172, 41-51. 
Giordano, A., Whyte, P., Harlow, E., Jr., B. R. F., Beach, D., & Draetta, G. (1989). A 60 kd 
cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected 
cells. Cell, 58(5), 981 – 990. 
Gitau, G. W., Mandal, P., Blatch, G. L., Przyborski, J., & Shonhai, A. (2012). 
Characterisation of the Plasmodium falciparum Hsp70-Hsp90 organising protein 
(PfHop). Cell Stress & Chaperones, 17(2), 191–202.  
Grigorieff, N. & Harrison, S.C. (2011).  Near-atomic resolution reconstructions of icosahedral 
viruses from electron cryo-microscopy. Current Opinion in Structural Biology, 21(2), 
265-73. 
Gromov, P. S., & Celis, J. (1991). Identification of Two Molecular Chaperons (HSX70 , 
HSC70) in Mature Human Erythrocytes. Experimental Cell Research, 195, 556–559. 
Harrison, C. J., & Langdale, J. a. (2006). A step by step guide to phylogeny reconstruction. 
The Plant Journal : for Cell and Molecular biology, 45(4), 561–72.  
Hatherley, R. (2012). In Silico Characterisation of the Four Canonical Plasmodium 
falciparum 70 kDa Heat Shock Proteins. MScby Coursework / Thesis. Rhodes 
University. 
Honoré, B., Leffers, H., Madsen, P., Rasmussen, H. H., Vandekerckhove, J., & Celis, J. E. 
(1992). Molecular cloning and expression of a transformingsensitive human protein 
containing the TPR motif and sharing identity to the stress-inducible yeast protein STI1. 
The Journal of Biological Chemistry, 267, 8485-8491. 
Horibe, T., Kohno, M., Haramoto, M., Ohara, K., & Kawakami, K. (2011). Designed hybrid 
TPR peptide targeting Hsp90 as a novel anticancer agent. Journal of Translational 
Medicine, 9(1), 8.  
 
 163 
Johnson, M., Zaretskaya, I., Raytselis, Y., Merezhuk, Y., McGinnis, S., & Madden, T. L. 
(2008). NCBI BLAST: a better web interface. Nucleic Acids Research, 36(Web Server 
issue), W5–9.  
Jones, D. T., Taylor, W. R., & Thornton, J. M. (1992). The rapid generation of mutation data 
matrices from protein sequences. Computer Applications in the Biosciences,8(3), 275–
82. 
Joosten, R. P., Joosten, K., Cohen, S. X., Vriend, G., & Perrakis, A. (2011). Automatic 
rebuilding and optimization of crystallographic structures in the Protein Data Bank. 
Bioinformatics (Oxford, England), 27(24), 3392–8. 
Joosten, R. P., Joosten, K., Murshudov, G. N., & Perrakis, A. (2012). PDB_REDO: 
constructive validation, more than just looking for errors. Acta Crystallographica. 
Section D, Biological Crystallography, 68(4), 484–96.  
Kajander, T., Sachs, J. N., Goldman, A., & Regan, L. (2009). Electrostatic interactions of 
Hsp-organizing protein tetratricopeptide domains with Hsp70 and Hsp90: computational 
analysis and protein engineering. The Journal of Biological Chemistry, 284(37), 25364–
74.  
Kamionka, M., & Feigon, J. (2004). Structure of the XPC binding domain of hHR23A reveals 
hydrophobic patches for protein interaction. Protein Science, 13, 2370–2377.  
Katoh, K., Kuma, K., Toh, H.  & Miyata, T,. (2005) MAFFT Version 5: improvement in 
accuracy of multiple sequence alignment. Nucleic Acids Research, 33(2), 511-8.  
Katoh, K. &Toh, H. (2008) Recent developments in the MAFFT multiple sequence alignment 
program. Briefings in Bioinformatics, 9,276-285. 
Kerfeld, C., & Scott, K. M.(2011). Using BLAST to teach “E-value-tionary” concepts. PLoS     
Biology, 9(2), e1001014.  
Kersey, P. J., Lawson, D., Birney, E., Derwent, P. S., Haimel, M., Herrero, J., Keenan, S., et 
al. (2010). Ensembl Genomes: extending Ensembl across the taxonomic space. Nucleic 
Acids Research, 38(Database issue), D563–9.  
Khatib, F., Cooper, S., Tyka, M. D., Xu, K., Makedon, I., Popovic, Z., Baker, D., et al. 
(2011). Algorithm discovery by protein folding game players. Proceedings of the 
National Academy of Sciences of the United States of America, 108(47), 18949–53.  
Kortemme, T., & Baker, D. (2002). A simple physical model for binding energy hot spots in 
protein-protein complexes. Proceedings of the National Academy of Sciences of the 
United States of America, 99(22), 14116–21.  
Kortemme, T., Kim, D. E., & Baker, D. (2004). Computational Alanine Scanning of Protein-
Protein Interfaces. Science STKE, pl2.Krause, P. J. (2003). Babesiosis Diagnosis and 
Treatment. Vector-borne and Zoonotic Diseases, 3(1), 45–51. 
Krishnamoorthy, B., & Tropsha, a. (2003). Development of a four-body statistical pseudo-
potential to discriminate native from non-native protein conformations. Bioinformatics, 
19(12), 1540–1548.  
Külzer, S., Charnaud, S., Dagan, T., Riedel, J., Mandal, P., Pesce, E.R. Blatch, G.L., Crabb, 
B.S., Gilson, P.R. & Przyborski, J.M. (2012). Plasmodium falciparum-encoded exported 
hsp70/hsp40 chaperone/co-chaperone complexes within the host erythrocyte. Cellular 
Microbiology, 14(11), 1784–1795. 
 
 164 
Kumar, R., Musiyenko, A., & Barik, S. (2003). The heat shock protein 90 of Plasmodium 
falciparum and antimalarial activity of its inhibitor, geldanamycin. Malaria Journal, 2, 
30.  
Kumar, S., Tamura, K., & Nei, M. (1994). MEGA: Molecular Evolutionary Genetics Analysis 
software for microcomputers. Computational and Applied Bioscience, 10(2), 189 – 191. 
Kunicki, J. B., Petersen, M. N., Alexander, L. D., Ardi, V. C., McConnell, J. R., & McAlpine, 
S. R. (2011). Synthesis and evaluation of biotinylated sansalvamide A analogs and their 
modulation of Hsp90. Bioorganic & Medicinal Chemistry letters, 21(16), 4716–9.  
Kyte, J., & Doolittle, R. F. (1982). A Simple Method for Displaying the Hydropathic 
Character of a Protein. Journal of Molecular Biology, 157(1), 105 – 132. 
Papadopoulos, J.S. & Agarwala, R.(2007).COBALT: constraint-based alignment tool for 
multiple protein sequences. Bioinformatics, 23(9), 1073-1079. 
Pare, J.M., Tahbaz, N., López-Orozco, J., LaPointe, P., Lasko, P. & Hobman, T.C. (2009). 
Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-
bodies. Molecular Biology of the Cell, 20(14), 3273-84. 
Lassle, M., Blatch, G. L., Kundra, V., Takatori, T., & Zetter, B. R. (1997). Stress-inducible, 
Murine Protein mSTI1. The Journal of Biological Chemistry, 272(3), 1876–1884. 
Lazaridis, T., & Karplus, M. (1998). Discrimination of the native from misfolded protein 
models with an energy function including implicit solvation. Journal of Molecular 
Biology, 288(3), 477–87.  
Lazaridis, T., & Karplus, M. (1999). Effective energy function for proteins in solution. 
Proteins, 35(2), 133–52. 
Leaver-Fay, A., Tyka, M., Lewis, S. M., Lange, O. F., Thompson, J., Jacak, R., Kaufman, K. 
W., et al. (2011). Chapter nineteen – Rosetta3: An Object-Oriented Software Suite for 
the Simulation and Design of Macromolecules. Methods in Enzymology, 487, 545–574. 
Lee, C.-T., Graf, C., Mayer, F. J., Richter, S. M., & Mayer, M. P. (2012). Dynamics of the 
regulation of Hsp90 by the co-chaperone Sti1. The EMBO Journal, 90, 1–11.  
Li H. (2006) Constructing the TreeFam database. PhD thesis, the Institute of Theoretical 
Physics, Chinese Academy of Science.Li, H., Coghlan, A., Ruan, J., Coin, L. J., Hériché, 
J.-K., Osmotherly, L., Li, R., et al. (2006). TreeFam: a curated database of phylogenetic 
trees of animal gene families. Nucleic Acids Research, 34(Database issue), D572–80.  
Li, H., & Durbin, R. (2007). Incorporating speices phylogeny in the reconstruction of gene 
trees. Current Challenges and Problems in Phylogenetics. An Isaac Newton Workshop 
Proceedings by The Wellcome Trust Sanger Institute. 
Lima, F. R. S., Arantes, C. P., Muras, A. G., Nomizo, R., Brentani, R. R., & Martins, V. R. 
(2007). Cellular prion protein expression in astrocytes modulates neuronal survival and 
differentiation. Journal of Neurochemistry, 103(6), 2164–76.  
Lin, K., May, A. C. W. & Taylor, W. R. (2002). Threading using neural nEtwork (TUNE): 
the measure of protein sequence-structure compatibility., Bioinformatics 18(10), 1350–
1357. 
Longshaw, V. M., Chapple, J. P., Balda, M. S., Cheetham, M. E., & Blatch, G. L. (2004). 
Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell 
cycle kinases. Journal of Cell Science, 117(Pt 5), 701–10.  
 
 165 
Lopes, M. H., Hajj, G. N., Muras, A. G., Mancini, G. L., Castro, R. M., Ribeiro, K. C., 
Brentani, R. R., Linden, R., and Martins, V. R. (2005). Interaction of cellular prion and 
stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct 
signaling pathways. Journal of Neuroscience, 25, 11330-11339. 
Lovell, S.C., Davis, I.W., Arendall, W.B. 3rd, de Bakker, P.I., Word, J.M., Prisant, M.G., 
Richardson, J.S., Richardson, D.C. (2003). Structure validation by Calpha geometry: 
phi,psi and Cbeta deviation. Proteins, 450, 437–450. 
Luthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-
dimensional profiles. Nature, 365, 83–85. 
Lyskov, S., & Gray, J. J. (2008). The RosettaDock server for local protein-protein docking. 
Nucleic Acids Research, 36(Web Server issue), W233–8.  
Ma, B., & Nussinov, R. (2007). Trp / Met / Phe Hot Spots in Protein-Protein Interactions: 
Potential Targets in Drug Design. Current Topics in Medicinal Chemistry, 7(10), 999–
1005. 
Martins, V. R., Graner, E., Garcia-Abreu, J., de Souza, S. J., Mercadante, A. F., & Veiga, S. 
S., Zanata, S. M., Neto, V. M., and Brentani, R. R. (1997). Complementary hydropathy 
identifies a cellular prion protein receptor. Nature Medicine, 3, 1376–1382. 
MATLAB R2009a, The MathWorks Inc., Natrick, MA, 2009. 
Matts, R. L., Dixit, A., Peterson, L. B., Sun, L., Voruganti, S., Kalyanaraman, P., Hartson, S. 
D., et al. (2011). Elucidation of the Hsp90 C-terminal inhibitor binding site. ACS 
Chemical Biology, 6(8), 800–7.  
Mehrpour, M., Esclatine, A., Beau, I. & Codogno, P. (2010). Overview of macroautophagy 
regulation in mammalian cells. Cell Research, 20(7), 748-62. 
Melo, F., & Feytmans, E. (1998). Assessing Protein Structures with a Non-local Atomic 
Interaction Energy. Journal of Molecular Biology, 277, 1141–1152. 
Misura, K. M. S., & Baker, D. (2005). Progress and challenges in high-resolution refinement 
of protein structure models. Proteins, 59(1), 15–29.  
Nicolet, C. M., & Craig, E. A. (1989). Isolation and Characterization of STIJ , a Stress-
Inducible Gene from Saccharomyces cerevisiae, 9(9), 3638–3646. 
Odunuga, O. O., Longshaw, V. M., & Blatch, G. L. (2004). Hop: more than an Hsp70/Hsp90 
adaptor protein. BioEssays: News and Reviews in Molecular, Cellular and 
Developmental Biology, 26(10), 1058–68.  
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006). How many drug targets are 
there? Nature Reviews. Drug Discovery, 5(12), 993–6.  
Pasini, E. M., Kirkegaard, M., Salerno, D., Mortensen, P., Mann, M., & Thomas, A. W. 
(2008). Deep coverage mouse red blood cell proteome: a first comparison with the 
human red blood cell. Molecular & Cellular Proteomics: MCP, 7(7), 1317–30.  
Pawlowski, M., Gajda, M. J., Matlak, R., & Bujnicki, J. M. (2008). MetaMQAP: a meta-
server for the quality assessment of protein models. BMC Bioinformatics, 9, 403.  
Pei, J. (2008). Multiple protein sequence alignment. Current opinion in structural biology, 
18(3), 382–6.  
Price, M. N., Dehal, P. S., & Arkin, A. P. (2008). FastBLAST: homology relationships for 
millions of proteins. PloS one, 3(10), e3589.  
 
 166 
Pruitt, K. D., & Maglott, D. R. (2001). RefSeq and LocusLink: NCBI gene-centered 
resources. Nucleic Acids Research, 29(1), 137–40. 
Roffé, M., Beraldo, F. H., Bester, R., Nunziante, M., Bach, C., Mancini, G., Gilch, S., et al. 
(2010). Prion protein interaction with stress-inducible protein 1 enhances neuronal 
protein synthesis via mTOR. Proceedings of the National Academy of Sciences of the 
United States of America, 107(29), 13147–52.  
Romano, S. a, Cordeiro, Y., Lima, L. M. T. R., Lopes, M. H., Silva, J. L., Foguel, D., & 
Linden, R. (2009). Reciprocal remodeling upon binding of the prion protein to its 
signaling partner hop/STI1. FASEB Journal: Official Publication of the Federation of 
American Societies for Experimental Biology, 23(12), 4308–16.  
Ruan, J., Li, H., Chen, Z., Coghlan, A., Coin, L. J. M., Guo, Y., Hériché, J.-K., et al. (2008). 
TreeFam: 2008 Update. Nucleic Acids Research, 36(Database Issue), D735–D740.  
Sakudo, A., Lee, D. C., Li, S., Nakamura, T., Matsumoto, Y., Saeki, K., Itohara, S., Ikuta, K., 
& Onodera, T. (2005). PrPc cooperates with STI1 to regulate SOD activity in PrPc-
deficient neuronal cell line. Biochemistry and Biophysics Research Communications, 
328, 14-19. 
Sali, A., & Blundell, T. L. (1993). Comparative Protein Modelling by Satisfaction of Spatial 
Restraints. Journal of Molecular Biology, 234, 779–815. 
Scheufler, C., Brinker, A., Bourenkov, G., Pegoraro, S., Moroder, L., Bartunik, H., Hartl, F. 
U., et al. (2000). Structure of TPR domain-peptide complexes: critical elements in the 
assembly of the Hsp70-Hsp90 multichaperone machine. Cell, 101(2), 199–210.  
Schmid, A. B., Lagleder, S., Gräwert, M. A., Röhl, A., Hagn, F., Wandinger, S. K., Cox, M. 
B., et al. (2012). The architecture of functional modules in the Hsp90 co-chaperone 
Sti1/Hop. The EMBO Journal, 31, 1506–1517.  
Schwieters, C.D., Kuszewski, J.J., Tjandra, N., Clore, G.M. (2003) The Xplor-Nih NMR 
molecular structure determination package. Journal of Magnetic Resonance,160, 65–73. 
Searls, D. B. (2003). Pharmacophylogenomics: genes, evolution and drug targets. Nature 
reviews. Drug Discovery, 2(8), 613–23.  
Shen, M.-Y., & Sali, A. (2006). Statistical potential for assessment and prediction of protein 
structures. Protein Science, 15(11), 2507–24.  
Shonhai, A. (2010). Plasmodial heat shock proteins: targets for chemotherapy. FEMS 
Immunology and Medical Microbiology, 58(1), 61–74.  
Sims, J. D., McCready, J., & Jay, D. G. (2011). Extracellular heat shock protein (Hsp)70 and 
Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration 
and invasion. PloS One, 6(4), e18848.  
Siwach, P., Sengupta, S., Parihar, R., & Ganesh, S. (2011). Proline repeats, in cis- and trans-
positions, confer protection against the toxicity of misfolded proteins in a mammalian 
cellular model. Neuroscience Research, 70(4), 435–41. 
Smith, C. (2003). Hitting the target. Nature Reviews, 422, 341–347.  
Smith, D. F., Sullivan, W. P., Marion, T. N., Zaitsu, K., Madden, B., Mccormick, D. J., & 
Toft, D. O. (1993). Identification of a 60-kilodalton stress-related protein, p60, which 
interacts with hsp90 and hsp70. Molecular and Cellular Biology, 13(2), 869–76. 
 
 167 
Southworth, D. R., & Agard, D. a. (2011a). Client-loading conformation of the Hsp90 
molecular chaperone revealed in the cryo-EM structure of the human Hsp90:Hop 
complex. Molecular Cell, 42(6), 771–81. 
Southworth, D. R., & Agard, D. a. (2011b). Client-loading conformation of the Hsp90 
molecular chaperone revealed in the cryo-EM structure of the human Hsp90:Hop 
complex. Molecular Cell, 42(6), 771–81. 
Subramanian, A. R., Kaufmann, M., & Morgenstern, B. (2008). DIALIGN-TX: greedy and 
progressive approaches for segment-based multiple sequence alignment. Algorithms for 
Molecular Biolog , 3, 6.  
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011). MEGA5 : 
Molecular Evolutionary Genetics Analysis Using Maximum Likelihood , Evolutionary 
Distance , and Maximum Parsimony Methods. Molecular Biology and Evolution, 28(10), 
2731–2739.  
Tastan Bishop, A. O., De Beer, T. A. P., & Joubert, F. (2008). Protein homology modelling 
and its use in South Africa. South African Journal Of Science, 104, 2–6. 
Tastan Bishop, Ö., & Kroon, M. (2011). Study of protein complexes via homology modeling , 
applied to cysteine proteases and their protein inhibitors. Journal of Molecular 
Modelling. 17, 3163 - 3172. 
Tilley, L., Dixon, M. W. , & Kirk, K. (2011). The Plasmodium falciparum-infected red blood 
cell. The International Journal of Biochemistry & Cell Biology, 43(6), 839–42.  
Tina, K. G., Bhadra, R., & Srinivasan, N. (2007). PIC: Protein Interactions Calculator. 
Nucleic Acids Research, 35(Web Server issue), W473–6.  
Tyka, M. D., Keedy, D. A., André, I., Dimaio, F., Song, Y., Richardson, D. C., Richardsonb, 
J. S., et al. (2011). Alternate states of proteins revealed by detailed energy landscape 
mapping. Journal of Molecular Biology, 405(2), 607–618.  
van Der Spuy, J., Kana, B. D., Dirr, H. W., & Blatch, G. L. (2000). Heat shock cognate 
protein 70 chaperone-binding site in the co- chaperone murine stress inducible protein 1 
maps to within three consecutive tetratricopeptide repeat motifs. Biochemical Journal, 
345, 645-651. 
Vyas, V.K., Ukawala, R.D., Ghate, M. &Chintha, C. (2012) Homology modeling a fast tool 
for drug discovery: Current perspectives. The Indian Journal of Pharmaceutical 
Sciences, 74(1), 1-17. 
Wallner, B., & Elofsson, A. (2006). Identification of correct regions in protein models using 
structural , alignment, and consensus information. Protein Science, 15, 900–913.  
Wang, T.-H., Chao, A., Tsai, C.-L., Chang, C.-L., Chen, S.-H., Lee, Y.-S., Chen, J.-K., et al. 
(2010). Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian 
cancer promotes cancer cell proliferation. Molecular &Cellular Proteomics, 9(9), 1873–
84.  
Weiss, M. J., & Dos Santos, C. O. (2009). Chaperoning erythropoiesis. Blood, 113(10), 2136–
44.  
Whelan, S., & Goldman, N. (2001). A general empirical model of protein evolution derived 
from multiple protein families using a maximum-likelihood approach. Molecular 
Biology and Evolution, 18(5), 691–9. 
WHO: Global Malaria Programme. (2011). World malaria report: 2011 (p. 248). Geneva. 
 
 168 
Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: interactive web service for the 
recognition of errors in three-dimensional structures of proteins. Nucleic acids research, 
35(Web Server issue), W407–10. 
Williamson, M. P. (1994). The structure and function of proline-rich regions in proteins. The 
Biochemical Journal, 297(Pt 2), 249–60. 
Wu, S., & Zhang, Y. (2007). LOMETS: a local meta-threading-server for protein structure 
prediction. Nucleic Acids Research, 35(10), 3375–82.  
Yi, F., Zhu, P., Southall, N., Inglese, J., Austin, C. P., Zheng, W., & Regan, L. (2009). An 
AlphaScreen-based high-throughput screen to identify inhibitors of Hsp90-cochaperone 
interaction. Journal of Biomolecular Screening, 14(3), 273–81.  
Zanata, S. M., Lopes, M. H., Mercadante, A. F., Hajj, G. N. M., Chiarini, L. B., Nomizo, R., 
Freitas, A. R. O., et al. (2002). Stress-inducible protein 1 is a cell surface ligand for 
cellular prion that triggers neuroprotection. EMBO, 21(13), 3307–3316. 
Zemla, A., Venclovas, Č., Moult, J., & Fidelis, K. (2002). Processing and evaluation of 
predictions in CASP4. Proteins, 45(5), 13–21. 
Zhang, T., Li, Y., Yu, Y., Zou, P., Jiang, Y., & Sun, D. (2009). Characterization of celastrol 
to inhibit hsp90 and cdc37 interaction. The Journal of Biological Chemistry, 284(51), 
35381–9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 169 
Appendix 1: Blast Results 
 
Table A1.1: searching for Hop homologs on NCBI pBLAST’s Genome Viewer with the 
protein sequence for gene entry PF3D7_1434300 from PlasmoDB.org 
 
Species Protein ID E-value Score % 
Identity 
Positives Gaps Gene ID Description 
Callithrix 
jacchus 
Length= 586  
XP_002755509.1 
 
2e-107 
 
336 bits 
(861) 
 
212/565 
(38%) 
 
326/565 
(58%) 
 
28/565 
(5%) 
 
GENE ID: 
100409178 STIP1 
 
Predicted stress-
induced-
phosphoprotein 1 
isoform 1 
 
 Homo sapiens 
Length= 565  
NP_006810.1 
 
2e-106 
 
 
333 bits 
(855) 
 
212/565 
(38%) 
 
326/565 
(58%) 
 
28/565 
(5%) 
 
GENE ID: 10963 
STIP1 
stress-induced-
phosphoprotein 1 
Pan troglodytes 
Length= 560 
XP_001163388.1 
 
3e-105 
 
332 bits 
(851) 
 
211/560 
(38%) 
 
324/560 
(58%) 
 
28/560 
(5%) 
 
GENE ID: 451286 
STIP1 
 
PREDICTED: 
stress-induced-
phosphoprotein 1 
isoform 1 
 
Rattusnorvegicus 
Length= 565  
NP_620266.1 
 
1e-107 
 
 
337 bits 
(864) 
 
212/565 
(38%) 
 
327/565 
(58% 
 
28/565 
(5%) 
 
GENE ID: 192277 
Stip1 
stress-induced-
phosphoprotein 1 
Musmusculus 
Length= 565  
NP_058017.1 3e-108 338 bits 
(868 
 
214/565 
(38%) 
 
326/565 
(58%) 
 
28/565 
(5%) 
 
GENE ID: 20867 
Stip1 
 
stress-induced-
phosphoprotein 1 
 
Cricetulusgriseus 
Length= 565  
NP_001233607.1 2e-108 
 
338 bits 
(868) 
 
214/565 
(38% 
 
325/565 
(58%) 
 
28/565 
(5%) 
 
GENE ID: 
100689413 Stip1 
 
stress-induced-
phosphoprotein 1 
 
Ornithorhynchus 
anatinus 
Length= 547  
XP_001511150.1 1e-101 
 
320 bits 
(819) 
 
204/547 
(37%) 
 
308/547 
(56%) 
 
40/547 
(7%) 
 
GENE ID: 
100080264 STIP1 
 
PREDICTED: 
stress-induced-
phosphoprotein 1, 
partial  
 
Ailuropodamelan
oleuca 
Length= 565  
XP_002916718.1 8e-108 
 
337 bits 
(864) 
 
 
214/565 
(38%) 
 
323/565 
(57%) 
 
28/565 
(5%) 
 
GENE ID: 
100475133 
LOC100475133 
 
PREDICTED: 
stress-induced-
phosphoprotein 1-
like  
 
Bostaurus 
Length= 565  
NP_001030569.1 
 
5e-107 
 
335 bits 
(859) 
 
214/565 
(38%) 
 
324/565 
(57%) 
 
28/565 
(5%) 
 
GENE ID: 617109 
STIP1 
 
stress-induced-
phosphoprotein 1 
 
Sus scrofa 
Length= 565  
XP_003353842.1 3e-108 
 
338 bits 
(866) 
 
 
216/565 
(38%) 
 
323/565 
(57%) 
 
28/565 
(5%) 
 
GENE ID: 
100623923 
LOC100623923 
 
PREDICTED: 
stress-induced-
phosphoprotein 1-
like 
 
Xenopus 
(Silurana) 
tropicalis 
Length= 573  
 
NP_989360.1 3e-108 
 
338 bits 
(867) 
 
217/573 
(38%) 
 
325/573 
(57%) 
 
44/573 
(8%) 
 
GENE ID: 394990 
stip1 
 
stress-induced-
phosphoprotein 1  
 
Oreochromisnilot
icus 
Length= 571  
XP_003450486.1 8e-111 
 
345 bits 
(884) 
 
 
215/571 
(38%) 
 
328/571 
(57%) 
 
41/571 
(7%) 
 
GENE ID: 
100696373 
LOC100696373 
 
stress-induced-
phosphoprotein 1-
like 
 
Daniorerio 
Length= 565 
NP_001007767.1 3e-109 
 
341 bits 
(874) 
 
211/565 
(37%) 
 
325/565 
(58%) 
29/565 
(5%) 
 
GENE ID: 493606 
stip1 
 
stress-induced-
phosphoprotein 1  
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Anoliscarolinensi
s 
Length= 566  
 
 
 
XP_003228007.1 1e-112 
 
349 bits 
(896) 
 
216/566 
(38%) 
 
327/566 
(58%) 
 
 
 
30/566 
(5%) 
 
GENE ID: 
100563364 
LOC100563364 
 
PREDICTED: 
stress-induced-
phosphoprotein 1-
like 
Taeniopygia 
guttata 
Length=  528 
XP_002198951.1 5e-18 86.7 35% Coverage 
= 84% 
 
 
 
 GENE ID: 
100229922 
LOC100229922 
 
PREDICTED: 
RNA polymerase 
II associated 
protein 3, partial  
 
Meleagrisgallopa
vo 
Length 665 
 
XP_003202082.1 5e-19 90.1 33% Coverage 
= 76% 
 GENE ID: 
100541433 
LOC100541433 
 
PREDICTED: 
LOW QUALITY 
PROTEIN: RNA 
polymerase II-
associated  
protein 3-like 
 
 
Gallus gallus 
Length 665 
 
XP_418360.3 7e-17 84.0 35% Coverage 
= 84% 
 GENE ID: 420249 
SPAG1 
 
PREDICTED: 
sperm-associated 
antigen 1 
 
Monodelphisdom
estica 
Length=441 
(Marsupial) 
XP_001372931.2 3e-15 
 
78.2 
 
29% 
 
Coverage 
= 90% 
 GENE ID: 
100020424 
LOC100020424 
 
PREDICTED: 
small glutamine-
rich 
tetratricopeptide 
repeat-containing  
protein alpha-like 
 
 
Acyrthosiphon 
pisum 
Length=565  
XP_001950745.1 4e-112 
 
348 bits 
(892) 
 
204/565 
(36%) 
 
319/565 
(56%) 
 
31/565 
(5%) 
 
GENE ID: 
100167947 
LOC100167947 
 
PREDICTED: 
stress-induced-
phosphoprotein 1-
like  
 
Anopheles 
gambiae 
due to problems 
with alignment 
not used 
XP_319365.4 4e-80  257 41% Coverage 
= 80% 
 
 
 GENE ID: 
1279608 
AgaP_AGAP0101
88 
 
AGAP010188-PA 
[Anopheles 
gambiae str. 
PEST] 
 
 
Bombusterrestris 
Length=565  
XP_003402501.1 8e-114 
 
352 bits 
(902) 
 
207/555 
(37%) 
 
324/555 
(58%) 
 
24/555 
(4%) 
 
GENE ID: 
100631059 
cactus-2 
 
 
PREDICTED: 
hypothetical 
protein 
LOC100631059 
Drosophila 
melanogaster 
Length = 490 
NP_477354.1 248 1e-74 51% 
 
86%  GENE ID: 33202 
Hop 
 
Hsp70/Hsp90 
organizing protein 
homolog  
 
 
 
Nasoniavitripenni
s Length=565  
XP_001603429.1 1e-106 
 
333 bits 
(855) 
 
204/569 
(36%) 
 
323/569 
(57%) 
 
32/569 
(6%) 
 
GENE ID: 
100119701 
LOC100119701 
 
PREDICTED: 
stress-induced-
phosphoprotein 1-
like  
 
 
Amphimedonquee
nslandica 
Length=554 
XP_003387638.1 8e-101 
 
318 bits 
(815) 
 
198/564 
(35%) 
 
319/564 
(57%) 
 
20/564 
(4%) 
 
GENE ID: 
100633434 
LOC100633434 
  
PREDICTED: 
Stress-induced 
phosphoprotein 
1-like 
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Cionaintestinalis 
Length=570  
XP_002128875.1 2e-100 
 
317 bits 
(813) 
 
 
197/570 
(35%) 
 
314/570 
(55%) 
 
 
 
37/570 
(6%) 
 
 
GENE ID: 
100181490 
LOC100181490 
 
PREDICTED: 
similar to Stress-
induced-
phosphoprotein 1 
(STI1)  
(Hsc70/Hsp90-
organizing 
protein) (Hop) 
 
Saccoglossuskow
alevskii 
Length=310 
XP_002733893.1 3e-75 
 
244 bits 
(622) 
 
127/315 
(40%) 
 
203/315 
(64%) 
 
8/315 
(3%) 
 
GENE ID: 
100374768 
LOC100374768 
 
PREDICTED: 
stress-induced-
phosphoprotein 1 
(Hsp70/Hsp90-
organizing  
protein)-like  
 
Hydra 
magnipapillata 
Length=534 
 
XP_002160503.1 8e-97 
 
307 bits 
(787) 
 
195/560 
(35%) 
 
308/560 
(55%) 
 
 
28/560 
(5%) 
 
GENE ID: 
100203295 
LOC100203295 
 
 
PREDICTED: 
similar to stress-
induced-
phosphoprotein 1 
(Hsp70/Hsp90-
organizing  
protein), partial 
 
Caenorhabditisel
egans 
Length=320 
 
NP_503322.1 2e-73 
 
240 bits 
(612) 
 
126/316 
(40%) 
 
205/316 
(65%) 
 
8/316 
(3%) 
 
GENE ID: 178587 
sti-1 
 
Protein STI-1 
Caenorhabditisbr
iggsae 
Length=320 
 
XP_002634443.1 5e-72 
 
236 bits 
(601) 
 
126/316 
(40%) 
 
203/316 
(64%) 
 
Gaps = 
8/316 
(3%) 
 
GENE ID: 
8576439 
CBG04457 
 
Hypothetical 
protein 
CBG04457 
 
Babesiabovis 
Length=546 
 
XP_001611358.1 0.0 
 
 
546 bits 
(1407) 
273/553 
(49%) 
 
394/553 
(71%) 
 
 
12/553 
(2%) 
 
GENE ID: 
5479603 
BBOV_III002230 
 
tetratricopeptide 
repeat domain 
containing protein  
Cryptosporidium 
parvum 
[Iowa II] 
Length=326 
 
XP_001388209.1 6e-131 
 
387 bits 
(994) 
 
183/318 
(58%) 
 
251/318 
(79%) 
 
0/318 
(0%) 
 
GENE ID: 
3373446 
cgd2_1850 
 
stress-induced 
protein sti1-like 
protein 
Leishmaniabrazili
ensis[MHOM/BR
/75/M2904] 
Length=547 
 
XP_001562145.1 9e-110 
 
341 bits 
(875) 
 
209/563 
(37%) 
 
320/563 
(57%) 
 
26/563 
(5%) 
 
GENE ID: 
5413050 
LBRM_08_0880 
 
 
stress-induced 
protein sti1 
 
 
Leishmania 
major[strain 
Friedlin] 
Length=546 
 
XP_001681140.1 7e-118 
 
362 bits 
(929) 
 
214/563 
(38%) 
 
 
326/563 
(58%) 
 
 
 
27/563 
(5%) 
 
 
GENE ID: 
5649395 
LMJF_08_1110 
 
 
stress-induced 
protein sti1 
 
Leishmaniainfant
um[JPCM5] 
Length=546 
 
XP_001463435.1 2e-118 
 
363 bits 
(933) 
 
 
215/563 
(38%) 
 
326/563 
(58%) 
 
27/563 
(5%) 
 
GENE ID: 
5066714 
LINJ_08_1020 
 
stress-induced 
protein sti1 
Plasmodium 
berghei[strain 
ANKA] 
Length=559 
 
XP_677465.1 0.0 
 
880 bits 
(2275) 
 
462/564 
(82%) 
 
519/564 
(92%) 
 
5/564 
(1%) 
 
GENE ID: 
3426000 
PB000909.03.0 
 
 
hypothetical 
protein 
 
Plasmodium 
chabaudichabaud
i 
Length=559 
 
XP_745506.1 0.0 
 
 
 
880 bits 
(2273) 
 
460/564 
(82%) 
 
519/564 
(92%) 
 
5/564 
(1%) 
 
 
GENE ID: 
3498629 
PC000814.02.0 
 
hypothetical 
protein 
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Plasmodium 
falciparum  
[3D7] 
Length=564 
 
XP_001348498.1 0.0 
 
1144 bits 
(2959) 
 
564/564 
(100%) 
 
 
564/564 
(100%) 
 
 
0/564 
(0%) 
 
 
GENE ID: 811906 
PF14_0324 
 
Hsp70/Hsp90 
organizing 
protein, putative 
Theileriaparva[st
rain Muguga] 
Length=540 
 
XP_763615.1 0.0 
 
532 bits 
(1371) 
 
286/554 
(52%) 
 
 
393/554 
(71%) 
 
18/554 
(3%) 
 
GENE ID: 
3499840 
TP03_0587 
 
hypothetical 
protein 
 
 
Trypanosomabruc
eibrucei[strain  
927/4 
GUTat10.1] 
Length=550 
 
XP_844966.1 4e-110 
 
 
342 bits 
(877) 
205/562 
(36%) 
316/562 
(56%) 
21/562 
(4%) 
 
 
GENE ID: 
3657403 
Tb927.5.2940 
 
stress-induced 
protein sti1 
 
 
Plasmodium 
yoelii 
yoelii[17XNL] 
Length=559 
 
 
XP_731105.1 0.0 
 
882 bits 
(2278 
 
463/564 
(82%) 
 
520/564 
(92%) 
 
5/564 
(1%) 
 
GENE ID: 
3830331 
PY03138 
 
 
stress-induced 
protein Sti1  
 
Aspergillusniger[
CBS 513.88] 
Length=580 
XP_001395168.2 1e-83 
 
273 bits 
(699) 
 
187/584 
(32%) 
 
 
304/584 
(52%) 
 
34/584 
(6%) 
 
GENE ID: 
4985429 
ANI_1_116104 
 
 
heat shock protein 
STI1 
 
Saccharomyces 
cerevisiae[S288c] 
Length=589 
 
NP_014670.1 2e-97 
 
310 bits 
(793) 
 
 
203/593 
(34%) 
 
316/593 
(53%) 
 
46/593 
(8%) 
 
 
GENE ID: 854192 
STI1 
 
Sti1p  
 
Oryzasativa[Japo
nica Group] 
Length=578 
 
NP_001047563.1 8e-116 
 
358 bits 
(920) 
 
213/600 
(36%) 
 
328/600 
(55%) 
 
65/600 
(11%) 
 
GENE ID: 
4330134 
Os02g0644100 
 
Os02g0644100 
 
Arabidopsis 
thaliana 
Length=558 
 
NP_001031620.1 5e-121 
 
372 bits 
(954) 
 
218/572 
(38%) 
 
334/572 
(58%) 
 
29/572 
(5%) 
 
GENE ID: 826849 
AT4G12400 
 
putative stress-
inducible protein 
 
Aspergillusclavat
us[NRRL 1] 
Length=581 
 
XP_001272361.1 1e-81 
 
268 bits 
(686) 
 
188/585 
(32%) 
 
297/585 
(51%) 
 
35/585 
(6%) 
 
GENE ID: 
4704565 
ACLA_065690 
 
heat shock protein 
(Sti1), putative  
 
Trichophytonrubr
um[CBS 118892] 
Length=578 
 
XP_003232880.1 2e-88 
 
286 bits 
(731) 
 
 
202/585 
(35%) 
 
299/585 
(51%) 
 
37/585 
(6%) 
 
GENE ID: 
10372247 
TERG_06870 
 
heat shock protein 
STI1  
 
 
Theileriaannulata
[strain Ankara] 
Length=540 
XP_955292.1 0.0 
 
 
543 bits 
(1398) 
 
280/554 
(51%) 
393/554 
(71%) 
18/554 
(3%) 
 
GENE ID: 
3865063 
TA18515 
 
 
hypothetical 
protein, conserved  
Neosporacaninu
m[Liverpool] 
Length=563 
 
XP_003880293.1 2e-168 
 
493 bits 
(1269) 
 
 
 
268/566 
(47%) 
 
370/566 
(65%) 
 
7/566 
(1%) 
 
GENE ID: 
13446323 
NCLIV_007330 
 
similar to 
uniprot|P15705 
Saccharomyces 
cerevisiae 
YOR027w STI1,  
related  
Neosartoryafisch
eri[NRRL 181] 
Length=582 
 
XP_001262823.1 1e-90 
 
292 bits 
(747) 
191/582 
(33%) 
 
299/582 
(51%) 
 
29/582 
(5%) 
 
GENE ID: 
4589462 
NFIA_114590 
heat shock protein 
(Sti1), putative 
Talaromycesstipit
atus[ATCC 
10500] 
Length=577 
XP_002478770.1 7e-83 272 bits 
(695) 
 
184/586 
(31%) 
296/586 
(51%) 
41/586 
(7%) 
 
GENE ID: 
8108134 
TSTA_090460 
heat shock protein 
(Sti1), putative 
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Penicilliummarne
ffei[ATCC 18224] 
Length=578 
 
XP_002146473.1 4e-84 
 
275 bits 
(703) 
 
182/590 
(31%) 
 
297/590 
(50%) 
 
48/590 
(8%) 
 
GENE ID: 
7024148 
PMAA_070140 
 
heat shock protein 
(Sti1), putative 
 
Paracoccidioides
brasiliensis[possi
bly new species; 
'lutzii', Pb01] 
Length=578 
 
XP_002791265.1 
 
2e-92 
 
298 bits 
(763) 
 
 
 
 
199/579 
(34%) 
 
299/579 
(52%) 
 
 
 
Gaps = 
26/579 
(4%) 
 
GENE ID: 
9094424 
PAAG_06811 
 
 
heat shock protein 
STI1  
 
Schizosaccharom
ycesjaponicus[yF
S275] 
Length=582 
 
XP_002174852.1 1e-96 
 
305 bits 
(781) 
 
200/585 
(34%) 
 
313/585 
(54%) 
 
33/585 
(6%) 
 
GENE ID: 
7052233 
SJAG_03717 
 
chaperone 
activator Sti1  
 
Candida 
tropicalis[MYA-
3404] 
Length=579 
 
XP_002551007.1 2e-97 
 
309 bits 
(792) 
 
198/585 
(34%) 
 
310/585 
(53% 
 
36/585 
(6%) 
 
GENE ID: 
8299626 
CTRG_05305 
 
heat shock protein 
STI1  
 
Saccharomyces 
cerevisiae[S288c] 
Length=589 
*Referred to by 
Schmid et al., 
2012 as strain 
YOR0W287 
 
NP_014670.1 2e-96 
 
310 bits 
(793) 
 
 
 
203/593 
(34%) 
 
316/593 
(53%) 
 
46/593 
(8%) 
 
GENE ID: 854192 
STI1 
 
Sti1p 
 
Pyrenophoratritic
i-repentis[Pt-1C-
BFP] 
Length=576 
 
XP_001940455.1 6e-87 282 bits 
(722) 
 
 
189/581 
(33%) 
 
308/581 
(53%) 
 
Gaps = 
32/581 
(6%) 
 
GENE ID: 
6348424 
PTRG_10123 
 
 
heat shock protein 
STI1 
 
Arthrodermagyps
eum[CBS 
118893] 
Length=578 
 
XP_003175251.1 5e-89 
 
288 bits 
(736) 
 
202/589 
(34%) 
 
303/589 
(51%) 
 
45/589 
(8%) 
 
 
GENE ID: 
10030557 
MGYG_02781 
 
 
heat shock protein 
STI1 
Candida 
albicans[SC5314] 
Length=590 
 
XP_714740.1 4e-88 
 
286 bits 
(732) 
 
 
198/598 
(33%) 
 
304/598 
(51% 
 
51/598 
(9%) 
 
GENE ID: 
3643631 STI1 
 
 
hypothetical 
protein 
CaO19.10702 
 
 
Plasmodium  
knowlesi[strain 
H] 
Length=560 
 
XP_002260669.1 0.0 
 
885 bits 
(2287) 
 
460/564 
(82%) 
 
509/564 
(90%) 
 
4/564 
(1%) 
 
GENE ID: 
7322649 
PKH_131500 
 
hypothetical 
protein, conserved 
in Apicomplexan 
species  
 
 
Verticilliumalbo-
atrum[VaMs.102] 
Length=584 
 
 
XP_002999908.1 4e-87 
 
283 bits 
(724) 
 
195/586 
(33%) 
 
 
296/586 
(51%) 
 
36/586 
(6%) 
 
GENE ID: 
9531727 
VDBG_09948 
 
heat shock protein 
STI1 
 
Lodderomyceselo
ngisporus 
[NRRL YB-4239] 
Length=596 
 
XP_001524727.1 8e-88 
 
285 bits 
(728) 
 
196/600 
(33%) 
 
314/600 
(52%) 
 
49/600 
(8%) 
 
GENE ID: 
5232040 
LELG_03759 
 
heat shock protein 
STI1 
 
Schizosaccharom
ycespombe 
[972h-] 
Length=591 
 
NP_588123.1 3e-92 
 
296 bits 
(757) 
 
 
202/596 
(34%) 
 
302/596 
(51%) 
 
46/596 
(8%) 
 
GENE ID: 
2539474 sti1 
 
chaperone 
activator Sti1 
(predicted) 
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Aspergillusoryzae 
[RIB40] 
Length=579 
 
XP_001825463.1 9e-87 
 
285 bits 
(728) 
 
195/584 
(33%) 
 
300/584 
(51%) 
 
35/584 
(6%) 
 
GENE ID: 
5997558 
AOR_1_950074 
 
shock protein 
STI1  
 
Aspergillusfumiga
tus[A1163] 
Length=585 
 
XP_746746.1 3e-84 
 
278 bits 
(711) 
 
183/559 
(33%) 
 
287/559 
(51%) 
 
29/559 
(5%) 
 
GENE ID: 
3504281 
AFUA_7G01860 
 
 
heat shock protein 
(Sti1)  
 
Aspergillusflavus[
NRRL3357] 
Length=579 
 
XP_002380660.1 1e-87 
 
285 bits 
(728) 
 
195/584 
(33%) 
 
300/584 
(51%) 
 
35/584 
(6%) 
 
GENE ID: 
7914463 
AFLA_071010 
 
heat shock protein 
(Sti1), putative 
 
 
Table A1.2: searching for Hsp90 homologs on NCBI pBLAST’s Genome Viewer with the 
protein sequence from SchmidCYS yeast’s Hsp90 Structure 
Species Seq ID E-value Score % 
Identity 
Positives Gaps Gene ID Description 
Plasmodium 
falciparum [3D7] 
Length=927 
XP_001348591.1 2e-78 
 
261 bits 
(668) 
147/409 
(36%) 
 
255/409 
(62%) 
 
18/409 
(4%) 
 
GENE ID: 
811999 
PF14_0417 
 
HSP90 
Homo sapiens 
Length=854 
 
NP_001017963.2 4e-164 
 
488 
bits(1256) 
244/399 
(61%) 
 
312/399 
(78%) 
 
2/399 
(1%) 
 
GENE ID: 3320 
HSP90AA1 
 
heat shock 
protein HSP 
90-alpha 
isoform 1 
(cytosolic) 
Caenorhabditisele
gans 
Length=702 
 
NP_506626.1 2e-165 
 
485 bits 
(1248) 
 
246/399 
(62%) 
 
308/399 
(77%) 
 
3/399 
(1%) 
 
GENE ID: 
179971 daf-21 
 
Protein DAF-
21 
(Abnormal 
Dauer 
Formation 
protein 21) 
 
Table A1.3: searching for Hsp90 homologs on NCBI pBLAST’s Genome Viewer with the 
protein sequence from XP_001348591.1 (PfHsp90, from Table A1.2) 
Species Seq ID E-value Score % 
Identity 
Positives Gaps Gene ID Description 
Caenorhabditisel
egans 
Length=702 
 
NP_506626.1 2e-79 
 
261 bits 
(668) 
 
143/410 
(35%) 
 
251/410 
(61%) 
 
13/410 
(3%) 
 
GENE ID: 
179971 daf-21 
 
Protein DAF-21 
(Abnormal 
Dauer 
Formation 
protein 21) 
 
Homo sapiens 
Length=854 
 
NP_001017963.2 3e-76 
 
258 bits 
(658) 
 
146/410 
(36%) 
 
246/410 
(60%) 
 
12/410 
(3%) 
 
GENE ID: 3320 
HSP90AA1 
 
heat shock 
protein HSP 90-
alpha isoform 1 
(cytosolic) 
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Appendix 2: Input Code and Scripts 
 
Section 1: Checking Pairwise Sequence Identity Between Each Species in a 
Large Subset of Data. 
 
The following program is a simple checker program written solely for the purpose of 
checking the minimum sequence identity score in a large subset of pairwise sequence data. 
The data is stored in file that was produced by Jalview (see Pairwise_identities.fasta in the 
supplementary data on disk) when calculating the pairwise identity of each of the 60 
sequences that have been locally aligned to each other sequence in the database used in the 
project (See Appendix 4). 
 
This checker file is necessary as the pairwise sequence identity data file can become too large 
to search manually when the sequence dataset becomes very large. For example, in this 
project 60 species sequences were downloaded for use in the multiple sequence analysis. To 
perform a pairwise alignment analysis between all of the sequences in Jalview would result in 
60 x 60 = 3600 pairwise alignments. Because Hop has a sequence length greater than 250 
residues (approximately 520 residues), it was desirable to ascertain whether all sequences 
used in the multiple sequence alignment and phylogenetic studies in Chapter 2 could have 
plausibly been homologs, simply by showing that all sequences used in the analysis shared at 
least 25% sequence identity to all other sequences, putting them in the “Daylight” zone of 
homology detection (Rost, 1999; Venclovas, 2012). 
 
Figure A2.1: Adapted from Venclovas, 2012, Chapter 3, page 58. Detecting Homology is 
done through three methods of increasing complexity level, depending on the degree of 
sequence identity. 
 
 
Finding minimum sequence identity in a large dataset:  pairwise_id_reporter.py. 
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This script was run from the command line as follows: 
 [user@home]$ python pairwise_id_reporter.py  
 
# This is a function that will parse the jalview pairwise identity 
file (.fasta) and add axception where a value id below the user-
specified sequence_ID. 
 
defpair_id_report(FAST,x): 
 
 start = open(FAST, "r") 
 newfile = start.read() 
 stringlist = [] 
 stringlist = newfile.split("\n\nScore = ") 
 
 idlist = [] 
 for k in range(len(stringlist)): 
  stringlist[k] = stringlist[k].split("\n\nPercentage ID = 
") 
 
 for i in range(len(stringlist)): 
  idlist.append(stringlist[i][1]) 
 
 idlist[len(idlist)-1].split("\n\n\n\n") 
 for l in range(len(idlist)): 
  idlist[l] = float(idlist[l]) 
 
 checker = 0 
 for check in range(len(idlist)): 
  if x >idlist[check]: 
   checker += 1 
  else: 
   checker = checker 
  
 if checker > 0: 
  return "%i out of %i alignment identities are below 
Percentage Identity Threshold %i%%" %(checker,len(idlist),x)  
 else: 
  return "All of %i alignment identities are above 
Percentage Identity Threshold %i%%" %(len(idlist),x) 
 
# Here the user inserts the file name to be searched and the minimum 
Pairwise Identity level sought. 
 
printpair_id_report('Pairwise_identities.fasta',25) 
 
#Script written by Crystal-Leigh Clitheroe (03-03-2012). 
 
 
 
 
Section 2: Creating Alignment Files (.pir Extensions) and Modeling Scripts 
(.py Extensions) for Modeller. 
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Modeller requires three important files to create models; an alignment file (.pir), a template 
file (.pdb) and a command script that runs Modeller functions using Python code (.py), all 
within the same folder. In Section A of this appendix the production of models from three 
types of templates is discussed and file and modeling sample scripts are provided. All 
modeling scripts are based on and modified from templates provided in the Modeller manual. 
 
2-1) The first example script is for creating a model from a single chain template. 
 
Example for a single chain alignment file: DP1.pir 
 
>P1;2LLV_average_control 
sequence:2LLV_average_control:1:A:70::: : 0.00: 0.00 
QPDLGLTQLFADPNLIENLKKNPKT 
SEMMKDPQLVAKLIGYKQN-PQAIGQDLFTDPRLMTIMATLMGVDLN* 
 
>P1;2LLV_average 
structureX:2LLV_average:127:A: 197::: : 0.00: 0.00 
QPDLGLTQLFADPNLIENLKKNPKT 
SEMMKDPQLVAKLIGYKQN-PQAIGQDLFTDPRLMTIMATLMGVDLN* 
 
The template and target sequence must always align exactly and the alignment ends with “*” 
for both sequences. Only standard amino acids can be used in Modeller so if the template 
model contains non-standard amino acids, one will have to try change them to their standard 
forms (if possible, it is better to write to the authors of this template for their advice on 
modifications) or find another template.  
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Example of modeling script for single chain file using template 2LLV_average.pdb: 
single_chain_make.py 
 
This script was run from the command line as follows: 
 [user@home]$ python single_chain_make.py 
 
# This script requires Modeller version 9.10 to run 
# Homology modeling by the automodel and MyModel class 
 
frommodeller import *    # Load standard Modeller 
classes 
frommodeller.automodel import *  # Load the automodel class 
 
log.verbose()   # request verbose output 
env = environ()   # create new MODELLER environment to build the 
models 
 
# directories for input atom files 
env.io.atom_files_directory = '.' 
 
a = automodel(env, 
alnfile = 'DP1.pir',     # alignment filename 
knowns = '2LLV_average',   # codes of the templates 
sequence = '2LLV_average_control')  # code of the target 
 
#Index Model/s 
a.starting_model= 1 
a.ending_model = 100 
 
 
# Thorough MD optimization: 
a.md_level = refine.very_slow 
 
a.make() 
 
Notice the names of the template structure and the target sequence is identical in each file. 
Notice also the blue highlighting in the DP1.pir file. For the template, the numbering of the 
residues can merely be 1 no matter how long the model chain will be. However the template 
numbering must reflect the exact numbering in the template.pdb file. This numbering will 
change if one trims the ends of their template. 
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2-2) The next example script is for creating a model from a multi chain template. 
 
 
Example for a multi-chain alignment file: 3uq3_TPR2ab.pir 
 
>P1;3uq3_TPR2ab_control 
sequence:3uq3_TPR2ab_control:1:A:249:B:C: : 0.00: 0.00 
ADKEKAEGNKFYKARQFDEAIEHYNKAWELH-KDITYLNNRAAAEYEKGEYETAI 
STLNDAVEQGREMRADYKVISKSFARIGNAYHKLGDLKKTIEYYQKSLTEHRTADILTKL 
RNAEKELKKAEAEAYVNPEKAEEARLEGKEYFTKSDWPNAVKAYTEMIKRAPEDARGYSN 
RAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAVKEYASALETLDAARTKDA 
EVNNGSSAR/MEEVD/EVD* 
 
>P1;3uq3_TPR2ab 
structureX:3uq3_TPR2ab:262:A: 504:B:C: : 0.00: 0.00 
ADKEKAEGNKFYKARQFDEAIEHYNKAWELH-KDITYLNNRAAAEYEKGEYETAI 
STLNDAVEQGREMRADYKVISKSFARIGNAYHKLGDLKKTIEYYQKSLTEHRTADILTKL 
RNAEKELKKAEAEAYVNPEKAEEARLEGKEYFTKSDWPNAVKAYTEMIKRAPEDARGYSN 
RAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAVKEYASALETLDAARTKDA 
EVNNGSSAR/MEEVD/EVD* 
 
 
Notice again the regions in the .pir file that are highlighted. Each of the chains is separated by 
a backslash and the new chain names are inserted between the colon symbols following the 
last residue number of chain A. There is no need to number the residues for subsequent 
chains. Other than that, the modeling script that accompanies the multi-chain template and 
model takes an identical format to that of the single-chain script: 
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Example of modeling script for single chain file using template 3uq3_TPR2ab.pdb: 
multi_chain_make.py 
 
This script was run from the command line as follows: 
 [user@home]$ python multi_chain_make.py 
 
# This script requires Modeller version 9.10 to run 
# Homology modeling by the automodel and MyModel class 
 
frommodeller import *    # Load standard Modeller 
classes 
frommodeller.automodel import *  # Load the automodel class 
 
log.verbose()    # request verbose output 
env = environ()    # create a new MODELLER environment to 
build in 
 
# directories for input atom files 
env.io.atom_files_directory = '.' 
 
 
a = automodel(env, 
alnfile = 'PfTPR2ab.pir',     # alignment filename 
knowns = '3uq3_TPR2ab',    # codes of the templates 
sequence = '3uq3_TPR2ab_control')   # code of the target 
 
#Index Model/s 
a.starting_model= 1 
a.ending_model = 100 
 
# Thorough MD optimization: 
a.md_level = refine.very_slow 
 
a.make() 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2-3) The next example script is for creating a model from multiple, multi chain 
templates. 
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Example for a multi-template alignment file: 3uq3_TPR2ab_multitemp.pir 
 
>P1;PfTPR2ab2yeast 
sequence:PfTPR2ab2yeast:1:A:249:B:C: : 0.00: 0.00 
ADKEKAEGNKFYKARQFDEAIEHYNKAWELH-KDITYLNNRAAAEYEKGEYETAI 
STLNDAVEQGREMRADYKVISKSFARIGNAYHKLGDLKKTIEYYQKSLTEHRTADILTKL 
RNAEKELKKAEAEAYVNPEKAEEARLEGKEYFTKSDWPNAVKAYTEMIKRAPEDARGYSN 
RAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAVKEYASALETLDAARTKDA 
EVQQGSSAR/MEEVD/PTVEEVD* 
 
>P1;3uq3_TPR2ab 
structureX:3uq3_TPR2ab:262:A: 504:B:C: : 0.00: 0.00 
ADKEKAEGNKFYKARQFDEAIEHYNKAWELH-KDITYLNNRAAAEYEKGEYETAI 
STLNDAVEQGREMRADYKVISKSFARIGNAYHKLGDLKKTIEYYQKSLTEHRTADILTKL 
RNAEKELKKAEAEAYVNPEKAEEARLEGKEYFTKSDWPNAVKAYTEMIKRAPEDARGYSN 
RAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAVKEYASALETLDAARTKDA 
EVNNGSSAR/MEEVD/----EVD* 
 
>P1;3UPV_mod 
structureX:3UPV_mod:261:A: 370:B:: : 0.00: 0.00 
------------------------------------------------------- 
------------------------------------------------------------ 
-------------------KAEEARLEGKEYFTKSDWPNAVKAYTEMIKRAPEDARGYSN 
RAAALAKLMSFPEAIADCNKAIEKDPNFVRAYIRKATAQIAVKEYASALETLDAARTKDA 
EVNNGSSAR/-----/PTVEEVD* 
 
 
Notice again the regions in the .pir file that are highlighted. First, even though the second 
template does not possess the MEEVD chain, there is still a space for it in the alignment file. 
That is because all templates must be perfectly aligned to the target sequence, so any residues 
that either template does not possess, but exists in either the other templates or the target is 
represented by the gap symbol “-”. 
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Example of modeling script for single chain file using templates 3uq3_TPR2ab.pdb and 
3UPV_mod: multi_chain_and_template_make.py 
 
This script was run from the command line as follows: 
 [user@home]$ python multi_chain_and_template_make.py 
 
# This script requires Modeller version 9.10 to run 
# Homology modeling by the automodel and MyModel class 
 
frommodeller import *    # Load standard Modeller 
classes 
frommodeller.automodel import *   # Load the automodel class 
 
log.verbose()     # request verbose output 
env = environ()     # create a new MODELLER environment 
 
 
# directories for input atom files 
env.io.atom_files_directory = '.' 
 
 
a = automodel(env, 
alnfile = 'PfTPR2ab_multitemp.pir',    # alignment 
filename 
knowns = ('3uq3_TPR2ab', '3UPV_mod'),   # codes of the 
templates 
sequence = 'PfTPR2ab2yeast')     # code of the 
target 
 
#Index Model/s 
a.starting_model= 2 
a.ending_model = 100 
 
# Thorough MD optimization: 
a.md_level = refine.very_slow 
 
a.make() 
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Section 3: Scoring and Analyzing Homology Models in Modeller and 
PyRosetta 
 
The following scripts were used to create simple lists of scores in text files. These text files 
were then opened into an Excel spreadsheet that enabled models to be filtered and sorted by 
scores as desired. The first script is for validating models by N-DOPE Z scores: 
zdope_scores.py.  
This script was run from the command line as follows: 
 [user@home]$ python zdope_scores.py file_list.txt 
 
import sys 
# This script computes a list of N-DOPE Z scores for several protein 
structure files occupying the same folder. 
# This script requires Modeller version 9.10 to run as well as a 
simple text file with a file-list of all .pdb files to be assessed. 
 
# Example for: model.assess_normalized_dope() 
from modeller import * 
frommodeller.scripts import complete_pdb 
 
env = environ() 
env.libs.topology.read(file='$(LIB)/top_heav.lib') 
env.libs.parameters.read(file='$(LIB)/par.lib') 
 
# directories for input atom files 
env.io.atom_files_directory = '.' 
 
# Read a model previously generated by Modeller's automodel class 
files = sys.argv[1] 
 
f1 = open (files) 
filename = "" 
f2 = open ("zdope_scores.txt","a") 
 
for line in f1: 
 if(len(line)>1): 
  filename = str.strip(line) 
  mdl = complete_pdb(env, filename) 
  zscore = mdl.assess_normalized_dope() 
  #print str(zscore)  
  f2.write(str(zscore)+" "+filename+"\n") 
f2.close() 
 
#Script originally written by Matthys Kroon modified by Benjamin 
Kumwenda (22-08-2012). 
#Script revised by Crystal-Leigh Clitheroe (12-09-2012). 
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Validating models by Rosetta Energy scores: Renergy_scores.py.  
 
This script was run from the command line as follows: 
 [user@home]$ python Renergy_scores.py file_list.txt 
 
import sys 
# This script computes a list of Rosetta Energy scores for several 
protein structure files occupying the same folder. 
# This script requires Modeller version 9.10 and a 
PyRosettainstalltion to run as well as a simple text file with a 
file-list of all .pdb files to be assessed. 
 
# Example for: standard score function(pose) 
 
fromrosetta import * 
rosetta.init() 
 
scorefxn = create_score_function("standard") 
 
# directories for input atom files 
#Docenv.io.atom_files_directory = '.' 
 
# Read a model previously generated by Modeller's automodel class 
 
files = sys.argv[1] 
 
f1 = open (files) 
filename = "" 
f2 = open ("Renergy_scores.txt","a") 
 
for line in f1: 
 if(len(line)>1): 
  filename = str.strip(line) 
  pose = pose_from_pdb(filename) 
  Rscore = scorefxn(pose) 
  #print str(Rscore)  
  f2.write(str(Rscore)+" "+filename+"\n") 
f2.close() 
 
#Script modified from zdope_scores.py to run in the PyRosetta 
environment by Crystal-Leigh Clitheroe (12-10-2012). 
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Validating models by Cα-RMSD scores: rmsd_scores.py. 
 
This script was run from the command line as follows: 
 [user@home]$ python rmsd_scores.py file_list.txt 
 
import sys 
# This script computes a list of alpha-Carbon Root Mean Square 
Deviation (Ca-RMSD) scores for several protein structure files 
occupying the same folder. 
# This script requires Modeller version 9.10 and a 
PyRosettainstalltion to run as well as a simple text file with a 
file-list of all .pdb files to be assessed. It also requires the 
original template of the models built to be in the same folder. 
 
# Example for: CA_rmsd(template_pose,model_pose) 
 
fromrosetta import * 
rosetta.init() 
 
scorefxn = create_score_function("standard") 
 
# Read a model previously generated by Modeller's automodel class 
 
files = sys.argv[1] 
 
template_pose = pose_from_pdb("template_file.pdb") 
 
f1 = open (files) 
filename = "" 
f2 = open ("rmsd_scores.txt","a") 
 
for line in f1: 
 if(len(line)>1): 
  filename = str.strip(line) 
  model_pose = pose_from_pdb(filename) 
  RMSDscore = CA_rmsd(template_pose, model_pose) 
  #print str(RMSDscore)  
  f2.write(str(RMSDscore)+" "+filename+"\n") 
f2.close() 
 
#Script modified from zdope_scores.py to run in the PyRosetta 
environment by Crystal-Leigh Clitheroe (12-10-2012). 
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Section 4: Calculating Interaction and Binding Energies for Protein-protein 
Complexes 
 
The following program was written to calculate approximate interaction and binding energies 
for the various protein-protein complexes studied in the project. The rationale and basic 
principles of the script are outlined in Chapter 4, Section 4.2.2. This script produces several 
files. It does this by splitting the complex file into separate chain entries that are written to 
their own .pdb files. Each of these chain files are scored for control and then minimized in 
PyRosetta in one of two ways, using either the classic_relax or repack_rotamers protocols. 
These modified files are then also scored and saved as separate entries. All the saved scores 
are then used to calculate the interaction and binding energies of the original complex. The 
rationale and basic principles of the script’s calculations are outlined in Chapter 4, Section 
4.2.2. The final output file is a text report. An example of the report file produced by this 
script follows the script details below.  The current example of the binding energy calculations 
script is for the model 'HsTPR2ab2yeast_13_PTIEEVDcomplex.pdb: int_bind_calc.py 
 
This script was run from the command line as follows: 
 [user@home]$ python int_bind_calc.py 
 
# To assure the user that program is running: 
print "Binding energy calculator for complexed proteins" 
 
from Bio.PDB import * 
import sys 
 
#Import Rosetta libraries 
fromrosetta import * 
rosetta.init() 
scorefxn = create_score_function("standard")  #set a global 
scorefxn 
relax = FastRelax()   #instantiates the refinement 
protocol 
relax.set_scorefxn(scorefxn) 
 
 
#Import Modeller libraries 
from modeller import * 
frommodeller.scripts import complete_pdb 
env = environ() 
env.libs.topology.read(file='$(LIB)/top_heav.lib') 
env.libs.parameters.read(file='$(LIB)/par.lib') 
# directories for input atom files 
env.io.atom_files_directory = '.' 
 
 
# Load the Complex 
 
 187 
 
start = open('HsTPR2ab2yeast_13_PTIEEVDcomplex.pdb','r') 
oldfile = start.readlines() 
 
linelist = [] 
 
import re   # need to recognise text so import regex 
 
forpatt in oldfile: 
ifre.match('ATOM', patt): 
linelist.append(patt) # search for ATOM entries and split 
#file lines into field entries 
 
 
chA = [] 
chB = [] 
chC = [] 
chD = [] 
 
chain = 0 
 
for chain in linelist: 
 if chain[21:22] == 'A': #Split field entries into chain 
info 
  chA.append(chain) 
 elif chain[21:22] == 'B': 
  chB.append(chain) 
 elif chain[21:22] == 'C': 
  chC.append(chain) 
 elif chain[21:22] == 'D': 
  chD.append(chain) 
   
# Create the new report file 
 
report = 
open("Energy_report_%s"%("HsTPR2ab2yeast_13_PTIEEVDcomplex"),"w")  
report.write("Binding energy report for 
%s.pdb:\n\n"%("HsTPR2ab2yeast_13_PTIEEVDcomplex")) 
 
 
iflen(chA) != 0: 
 newfileA = 
open("%s_A.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex"),"w")  
 
# Create the new .pdb files for chain A 
 
 for j in chA:      #For each line of the 
original file:    
  if j[:4]=="ATOM":   #if an "ATOM" entry 
   newfileA.write(j)  #copy line of old file 
 newfileA.write('END')  
 newfileA.close() 
 
 chainfile_A = ("%s_A.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex")) 
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 unmin_chA = pose_from_pdb(chainfile_A) 
 Rosenergy_unminA = scorefxn(unmin_chA) 
 nomA = complete_pdb(env, chainfile_A) 
 zscore_unminA = nomA.assess_normalized_dope() 
 
 rotam_chA = pose_from_pdb(chainfile_A) 
 taskA = standard_packer_task(rotam_chA) 
 taskA.restrict_to_repacking() 
 mover = PackRotamersMover(scorefxn, taskA) 
 mover.apply(rotam_chA) 
 rotam_chA.dump_pdb("Rotamers_chain_A.pdb") 
  
 Rosenergy_rotamA = scorefxn(rotam_chA) 
 rotA = complete_pdb(env, "Rotamers_chain_A.pdb") 
 zscore_rotamA = rotA.assess_normalized_dope() 
 RMSD_rotA = CA_rmsd(unmin_chA, rotam_chA) 
 
 relax_chA = pose_from_pdb(chainfile_A) 
 relax.apply(relax_chA) 
 relax_chA.dump_pdb("Relaxed_chain_A.pdb") 
 
 Rosenergy_relaxA = scorefxn(relax_chA) 
 relA = complete_pdb(env, "Relaxed_chain_A.pdb") 
 zscore_relaxA = relA.assess_normalized_dope() 
 RMSD_relA = CA_rmsd(unmin_chA, relax_chA) 
 
# Update the report file with Chain A info 
 
 report.write("For Chain A:\n\nState\t\tDope-
Z\t\tRosetta\t\tRMSD\nUnminimised\t%.3f\t\t%.3f\t\tN/A\nRelaxed\t\t%
.3f\t\t%.3f\t\t%.3f\nRotamers\t%.3f\t\t%.3f\t\t%.3f\n\n"%(zscore_unm
inA, Rosenergy_unminA, zscore_relaxA, Rosenergy_relaxA, RMSD_relA, 
zscore_rotamA, Rosenergy_rotamA, RMSD_rotA)) 
 
 
iflen(chB) != 0: 
 newfileB = 
open("%s_B.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex"),"w")  
 
# Create the new .pdb files for chain B 
 
 for k in chB:    #For each line of the original 
file:    
  if k[:4]=="ATOM":   #if an "ATOM" entry 
   newfileB.write(k)  #copy line of old file 
 newfileB.write('END')  
 newfileB.close() 
 
 chainfile_B = ("%s_B.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex")) 
 
 unmin_chB = pose_from_pdb(chainfile_B) 
 Rosenergy_unminB = scorefxn(unmin_chB) 
 nomB = complete_pdb(env, chainfile_B) 
 zscore_unminB = nomB.assess_normalized_dope() 
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 rotam_chB = pose_from_pdb(chainfile_B) 
 taskB = standard_packer_task(rotam_chB) 
 taskB.restrict_to_repacking() 
 mover = PackRotamersMover(scorefxn, taskB) 
 mover.apply(rotam_chB) 
 rotam_chB.dump_pdb("Rotamers_chain_B.pdb") 
  
 Rosenergy_rotamB = scorefxn(rotam_chB) 
 rotB = complete_pdb(env, "Rotamers_chain_B.pdb") 
 zscore_rotamB = rotB.assess_normalized_dope() 
 RMSD_rotB = CA_rmsd(unmin_chB, rotam_chB) 
 
 relax_chB = pose_from_pdb(chainfile_B) 
 relax.apply(relax_chB) 
 relax_chB.dump_pdb("Relaxed_chain_B.pdb") 
 
 Rosenergy_relaxB = scorefxn(relax_chB) 
 relB = complete_pdb(env, "Relaxed_chain_B.pdb") 
 zscore_relaxB = relB.assess_normalized_dope() 
 RMSD_relB = CA_rmsd(unmin_chB, relax_chB) 
 
# Update the report file with Chain B info 
 
 report.write("For Chain B:\n\nState\t\tDope-
Z\t\tRosetta\tRMSD\nUnminimised\t%.3f\t\t%.3f\t\tN/A\nRelaxed\t\t%.3
f\t\t%.3f\t\t%.3f\nRotamers\t%.3f\t\t%.3f\t\t%.3f\n\n"%(zscore_unmin
B, Rosenergy_unminB, zscore_relaxB, Rosenergy_relaxB, RMSD_relB, 
zscore_rotamB, Rosenergy_rotamB, RMSD_rotB)) 
else: 
 Rosenergy_unminB = 0 
 Rosenergy_relaxB = 0 
 Rosenergy_rotamB = 0 
 
iflen(chC) != 0: 
 newfileC = 
open("%s_C.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex"),"w")  
 
# Create the new .pdb files for chain C 
 
 for l in chC:    #For each line of the original 
file:    
  if l[:4]=="ATOM":   #if an "ATOM" entry 
   newfileC.write(l)  #copy line of old file 
 newfileC.write('END')  
 newfileC.close() 
 
 chainfile_C = ("%s_C.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex")) 
 
 unmin_chC = pose_from_pdb(chainfile_C) 
 Rosenergy_unminC = scorefxn(unmin_chC) 
 nomC = complete_pdb(env, chainfile_C) 
 zscore_unminC = nomC.assess_normalized_dope() 
 
 rotam_chC = pose_from_pdb(chainfile_C) 
 taskC = standard_packer_task(rotam_chC) 
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 taskC.restrict_to_repacking() 
 mover = PackRotamersMover(scorefxn, taskC) 
 mover.apply(rotam_chC) 
 rotam_chC.dump_pdb("Rotamers_chain_C.pdb") 
  
 Rosenergy_rotamC = scorefxn(rotam_chC) 
 rotC = complete_pdb(env, "Rotamers_chain_C.pdb") 
 zscore_rotamC = rotC.assess_normalized_dope() 
 RMSD_rotC = CA_rmsd(unmin_chC, rotam_chC) 
 
 relax_chC = pose_from_pdb(chainfile_C) 
 relax.apply(relax_chC) 
 relax_chC.dump_pdb("Relaxed_chain_C.pdb") 
 
 Rosenergy_relaxC = scorefxn(relax_chC) 
 relC = complete_pdb(env, "Relaxed_chain_C.pdb") 
 zscore_relaxC = relC.assess_normalized_dope() 
 RMSD_relC = CA_rmsd(unmin_chC, relax_chC) 
 
# Update the report file with Chain C info 
 
 report.write("For Chain C:\n\nState\t\tDope-
Z\t\tRosetta\t\tRMSD\nUnminimised\t%.3f\t\t%.3f\t\tN/A\nRelaxed\t\t%
.3f\t\t%.3f\t\t%.3f\nRotamers\t%.3f\t\t%.3f\t\t%.3f\n\n"%(zscore_unm
inC, Rosenergy_unminC, zscore_relaxC, Rosenergy_relaxC, RMSD_relC, 
zscore_rotamC, Rosenergy_rotamC, RMSD_rotC)) 
 
else: 
 Rosenergy_unminC = 0 
 Rosenergy_relaxC = 0 
 Rosenergy_rotamC = 0 
  
 
 
iflen(chD) != 0: 
 newfileD = 
open("%s_D.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex"),"w")  
 
# Create the new .pdb files for chain D 
 
 for m in chD:    #For each line of the original 
file:    
  if m[:4]=="ATOM":   #if an "ATOM" entry 
   newfileD.write(m)  #copy line of old file 
 newfileD.write('END')  
 newfileD.close() 
 
 chainfile_D = ("%s_D.pdb"%("HsTPR2ab2yeast_13_PTIEEVDcomplex")) 
 
 unmin_chD = pose_from_pdb(chainfile_D) 
 Rosenergy_unminD = scorefxn(unmin_chD) 
 nomD = complete_pdb(env, chainfile_D) 
 zscore_unminD = nomC.assess_normalized_dope() 
 
 rotam_chD = pose_from_pdb(chainfile_D) 
 
 191 
 taskD = standard_packer_task(rotam_chD) 
 taskD.restrict_to_repacking() 
 mover = PackRotamersMover(scorefxn, taskD) 
 mover.apply(rotam_chD) 
 rotam_chD.dump_pdb("Rotamers_chain_D.pdb") 
  
 Rosenergy_rotamD = scorefxn(rotam_chD) 
 rotD = complete_pdb(env, "Rotamers_chain_D.pdb") 
 zscore_rotamD = rotD.assess_normalized_dope() 
 RMSD_rotD = CA_rmsd(unmin_chD, rotam_chD) 
 
 relax_chD = pose_from_pdb(chainfile_D) 
 relax.apply(relax_chD) 
 relax_chD.dump_pdb("Relaxed_chain_D.pdb") 
 
 Rosenergy_relaxD = scorefxn(relax_chD) 
 relD = complete_pdb(env, "Relaxed_chain_D.pdb") 
 zscore_relaxD = relD.assess_normalized_dope() 
 RMSD_relD = CA_rmsd(unmin_chD, relax_chD) 
 
# Update the report file with Chain D info 
 
 report.write("For Chain D:\n\nState\t\tDope-
Z\tRosetta\tRMSD\nUnminimised\t%.3f\t\t%.3f\t\tN/A\nRelaxed\t\t%.3f\
t\t%.3f\t\t%.3f\nRotamers\t%.3f\t\t%.3f\t\t%.3f\n\n"%(zscore_unminD, 
Rosenergy_unminD, zscore_relaxD, Rosenergy_relaxD, RMSD_relD, 
zscore_rotamD, Rosenergy_rotamD, RMSD_rotD)) 
 
else: 
 Rosenergy_unminD = 0 
 Rosenergy_relaxD = 0 
 Rosenergy_rotamD = 0 
 
# Score the overall complex 
 
ori_complex = pose_from_pdb('HsTPR2ab2yeast_13_PTIEEVDcomplex.pdb') 
Rosenergy_complex = scorefxn(ori_complex) 
 
# Use unminimised versions of each chain to calculate the 
interaction #Energy of the complex: 
 
BE_unmin = Rosenergy_complex - Rosenergy_unminA - Rosenergy_unminB - 
Rosenergy_unminC - Rosenergy_unminD 
 
# Use two different types of minimisation (relaxed = minimised, 
#rotamers = repack the rotamers) to calculate the binding energy of 
#the complex 
 
BE_relax = Rosenergy_complex - Rosenergy_relaxA - Rosenergy_relaxB - 
Rosenergy_relaxC - Rosenergy_relaxD 
BE_rotamers = Rosenergy_complex - Rosenergy_rotamA - 
Rosenergy_rotamB - Rosenergy_rotamC - Rosenergy_rotamD 
 
report.write("Comparative Binding 
Energies:\n\nState\t\tEnergy\nUnminimised\t%.3f\nRelaxed\t\t%.3f\nRo
 
 192 
tamers\t%.3f\n\n"%(BE_unmin, BE_relax, BE_rotamers)) 
 
report.close() 
 
#Script written by Crystal-Leigh Clitheroe (15-10-2012). 
 
An example of the output file for this script: 
Energy_report_HsTPR2ab2yeast_13_PTIEEVDcomplex.txt 
 
Binding energy report for HsTPR2ab2yeast_13_PTIEEVDcomplex.pdb: 
 
For Chain A: 
 
State   Dope-Z  Rosetta  RMSD 
Unminimised -0.859  967.937  N/A 
Relaxed  -1.041  -753.498  10.037 
Rotamers  -0.913  4602.857  0.000 
 
For Chain C: 
 
State   Dope-Z Rosetta  RMSD 
Unminimised 0.218  6.338   N/A 
Relaxed  0.477  -4.743  0.548 
Rotamers  0.051  0.877   0.000 
 
Comparative Binding Energies: 
 
State   Energy 
Unminimised 8.996 
Relaxed  1741.512 
Rotamers  -3620.463 
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Appendix 3: Phylogenetic Analysis 
Section 1: Full-Protein Analysis 
Bayesian Information Criterion (BIC) and Akaike Information Criterion (corrected, 
AICC) Analysis of evolutionary models: 
Parameters: Complete site coverage, all others default. 
Table A3.1: Top ten models selected from the lowest BIC and AICC Amino Acid 
Substitution Table scores in MEGA. The three yellow-highlighted models (best of each 
evolutionary model type) were used for analysis. 
 
Model #Parameters BIC AICc lnL Invariant Gamma 
tREV+G+I+F 138 58912 57754 -28738 0.044538 1.55811 
rtREV+G+F 137 58929 57779 -28752 n/a 1.08544 
WAG+G+I 119 59152 58153 -28957 0.046162 1.79716 
WAG+G 118 59180 58189 -28976 n/a 1.23988 
WAG+G+I+F 138 59282 58124 -28924 0.045915 1.70607 
rtREV+G+I 119 59309 58310 -29035 0.042282 1.56793 
WAG+G+F 137 59313 58163 -28944 n/a 1.16987 
rtREV+G 118 59321 58331 -29047 n/a 1.12958 
JTT+G+I+F 138 59521 58363 -29043 0.045948 1.52534 
JTT+G+F 137 59546 58396 -29060 n/a 1.05874 
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First Phylogenetic ML Tree compared to its Bootstrap consensus Tree: 
Using rtREV +F +G +I Model, Gamma value of 2, 500 Bootstrapped replicates, complete site 
coverage (all other parameters default). 
 
 
Figure A3.1: The Maximum Likelihood (ML) tree using the Reverse Transcriptase 
(rtREV) evolutionary model (left) shows good branching and topological agreement with 
its bootstrap consensus tree (right).There is one area of minor topological 
disagreement,This shows that the rtREV model is a good model to use for the Hop 
protein tree. 
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Second Phylogenetic ML Tree compared to its Bootstrap consensus Tree: 
Using WAG +F +G, Gamma value of 2, 500 Bootstrapped replicates, complete site coverage 
(all other parameters default). 
 
Figure A3.2: A third ML tree was built using the Whelan and Goldman (WAG) model, 
with complete site coverage (left). There are two areas of major topological 
disagreement, in the invertebrates and the Apicomplexa, this indicates a poor 
evolutionary model. 
 
 
Invertebrates: In the ML tree (left), S. kowalevski is the first outgroup to the vertebrates, 
whereas the consensus tree places C. intestinalis as the first outgroup to the vertebrates. In the 
ML tree the next outgroup is an ingroup of the nematodes and the insects (followed by A. 
queenslandica as the next outgroup), whereas in the consensus tree the nematodes are the next 
 
 196 
outgroup to C. intestinalis and vertebrates, with an ingroup consisting of S. kowalevski and A. 
queenslandica being the next outgroup to the nematodes and all others (followed by the 
insects). H. magnipapilata is the final outgroup for all vertebrates and invertebrates in both 
trees. 
Apicomplexa: In the ML tree, T. gondii and N. caninum group are outgrouped to the rest of 
the non-euglenazoanapicomplexans, while in the consensus tree, the Plasmodium genus is the 
outgroup to the rest of the Apicomplexa. Within the plasmodial genus, P. falciparum is 
outgrouped to the rest of the species, while the consensus tree groups P. knowlesi outside of 
the rest of the species. 
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Third Phylogenetic ML Tree compared to its Bootstrap consensus Tree: 
Using JTT +F +G +I, Gamma distributed rates2, 500 Bootstrapped replicates, complete site 
coverage (all other parameters default). 
 
Figure A3.3: A second ML tree was built using the Jones, Taylor and Thornton (JTT) 
model, with complete site coverage (left). There is only minor topological 
disagreement;A. gypseum, T. rubrum and P. brasiliensis are a single out-group to 
innermost fungal group on the bootstrap consensus tree (right), whereas A. gypseum and 
T. rubrum are the outgroup to innermost group plus P. brasiliensis on the ML tree. 
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Comparing the Evolutionary models 
 
Figure A3.4: Comparing the condensed trees (at 70% cutoff) produced from two 
different evolutionary models, JTT (Left) and WAG (right). There is generally greater 
loss of branch resolution (e.g. within the mammals, fungi and invertebrates) in the tree 
produced with the WAG model. 
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Figure A3.5: Comparing the condensed trees (at 70% cutoff) produced from two 
different evolutionary models, JTT (right) and rtREV (left). There is generally some loss 
of branch resolution (e.g. within the mammals, fungi and invertebrates) in the tree 
produced with the JTT model. 
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Figure A3.6: Comparing the condensed trees (at 70% cutoff) produced from two 
different evolutionary models, WAG (right) and rtREV (left). There is generally some 
loss of branch resolution (e.g. within the mammals, fungi and invertebrates) in the tree 
produced with the WAG model. 
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Figure A3.7: Comparing Maximum Likelihood trees produced with the JTT Model (left) 
and with the WAG model (right). There are three areas of topological disagreement, in 
the invertebrates, the fungi and the non-euglenazoanapicomplexans.  
 
Invertebrates: In the WAG tree (right), S. kowalevski is the first outgroup to the vertebrates 
(with C. intestinalisfollowing), whereas in the JTT tree the situation is reversed. In the JTT 
tree, the next outgroup is an ingroup of the nematodes, H. magnipapillata and the insects 
(followed by A. queenslandica as the final outgroup to the vertebrates and invertebrates), 
whereas in the WAG treeH. magnipapillata is the final outgroup for all vertebrates and 
invertebrates. 
Fungi: A. gypseum, T. rubrum and P. brasiliensis are a single out-group to innermost fungal 
group on the WAG tree (right), whereas A. gypseum and T. rubrum are the outgroup to 
innermost group plus P. brasiliensis on the JTT tree. 
Apicomplexa: In the JTT tree, theT. gondii and N. caninumgroup are outgroup to the 
 
 202 
remainingapicomplexans, while in the WAG tree, places the Plasmodium genus as the 
outgroup. Within the WAG plasmodialspecies sub-tree, P. falciparum is outgroup to the rest of 
the species, while in the JTT plasmodialspecies sub-tree,P. knowlesiis the outgroup. It is 
interesting to note that the WAG bootstrap consensus sub-tree (figure B) for this region is 
similar to that of JTT tree (figure C). 
 
Figure A3.8: Comparing Maximum Liklihood trees produced with the JTT Model 
(right) and with the rtREVmodel (left). There are four areas of topological 
disagreement, in the primates, the invertebrates, the fungi and the non-
euglenazoanapicomplexans.  
 
 
Primates: In the JTT tree H. sapiens is an outgroup to P. troglodytes and C. jacchus, whereas 
in the rtREV tree C. jacchus is the outgroup to P. troglodytes and H.sapiens. 
Invertebrates: In the rtREVtree ,S. kowalevski is the first outgroup to the vertebrates (with C. 
intestinalisfollowing), whereas in the JTT tree the situation is reversed. In the JTT tree, the 
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next outgroup is an ingroup of the nematodes, H. magnipapillata and the insects (followed by 
A. queenslandica as the final outgroup to the vertebrates and invertebrates), whereas in the 
rtREV tree H. magnipapillata is the final outgroup for all vertebrates and invertebrates. 
Fungi: A. gypseum, T. rubrum and P. brasiliensis are a single out-group to innermost fungal 
group on the rtREV tree, whereas A. gypseum and T. rubrum are the outgroup to innermost 
group including P. brasiliensis on the JTT tree (right). 
Apicomplexa: In the JTT tree, the T. gondii and N. caninum group are outgroup to the 
remaining apicomplexans, while in the rtREV tree, places the Plasmodium genus as the 
outgroup. Within the rtREVplasmodial species sub-tree, P. falciparum is outgroup to the rest 
of the species, while in the JTT plasmodial species sub-tree, P. knowlesi is the outgroup. 
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Figure A3.9: Comparing Maximum Likelihood trees produced with the rtREV Model 
(left) and with the WAG model (right). There is one area of topological disagreement; In 
the WAG tree H. sapiens is an outgroup to P. troglodytes and C. jacchus, whereas in the 
rtREV tree C. jacchus is the outgroup to P. troglodytes and H. sapiens. However, the 
rtREV tree appears to have greater bootstrap support values (in most but not all 
regions) and shorter branch lengths.  
 
This, in combination with the good agreement with its bootstrapped tree, seems to indicate 
that thertREV model returns the most correct Maximum Likelihood protein tree for Hop. 
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A closer look at the JTT Model tree: 
Ungapped Phylogenetic JTT ML Tree compared to its Bootstrap consensus Tree: 
Using JTT +F +G +I, Gamma value of 2, 500 Bootstrapped replicates, 85% site coverage and 
all other parameters default. 
 
Figure A3.10: Minor topological disagreement In the ML (left) tree H. sapiens is an 
outgroup to C. Jacchusand P. troglodytes, whereas in its bootstrapped tree (right), C. 
jacchusis an outgroup to H. sapiens and P. troglodytes. 
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Comparing the full coverage and 85% coverage ML trees: 
 
Figure A3.11: The same disparity in topological agreement as in figure A is observed: A. 
gypseum, T. rubrum and P. brasiliensis are a single out-group to innermost fungal group 
on the Bootstrap consensus tree, whereas A. gypseum and T. rubrum are the outgroup to 
innermost group plus P. brasiliensis on the ML Tree.  
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Figure A3.12: A look at the condensed versions of the above trees (cut off at confidence 
scores of 70), shows that the 85% coverage tree loses slightly more resolution of the 
branching (e.g. in the mammals and fungi), but overall, the trees are almost identical. 
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First Phylogenetic Neighbor-Joining Tree compared to its Bootstrap consensus Tree: 
Using JTT +F +G +I Model, Gamma value of 2, 500 Bootstrapped replicates, complete site 
coverage (all other parameters default) 
 
Figure A3.13: The Neighbor-Joining (NJ) tree using the JTT evolutionary model (left) 
shows good branching and topological agreement with its bootstrap consensus tree 
(right), with only one region of disagreement. In the NJ tree, X. tropicalis and N. 
carolensis are grouped, whereas in the bootstrap consensus tree, they are separate 
outgroups. This shows that the JTT model is a good model to use for the Hop 
Neighbour-Joining protein tree. 
 
 
 
 
 
 
 209 
Comparing Tree-building Methods 
 
Figure A3.14: Comparison of the condensed (70%) versions of the rtREV ML tree (left) 
against the NJ tree (right); shows that the NJ tree loses more resolution of the branching 
(e.g. in the mammals and fungi), but overall, the trees are similar. 
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• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
sti-l , Caenorhabditis elegans 
Smp_064860, Sch islosoma mansoni 
HOp, Drosophila melanogaster 
AGAP010188, Anopheles gambiae 
GB 19425, Apis mellifera 
STIP1, Homo sapiens 
• 
• STIP1, Pan troglodytes 
STIPI Pongo abelii 
Stipl , Mus musculus 
STIP1, Ornithorhynchus anatinus 
STIP1, Anolis carolinensis 
stipl , Xenopus tropicalis 
Slipl , Danio rerio 
STIP1 , Gasterosteus aculeatus 
ENSCSAVGOOOOOOOI884, Ciona savignyi 
Aqul .218337, Amphimedon queenslandica 
ANIA_09124, Aspergillus nidulans 
NCU00714 , Neurospora crassa 
STll , Saccharomyces cerevisiae 
stil , Schizosaccharomyces pombe 
UM02057, Ustilago maydis 
PGTG_06468, Puccinia graminis 
CMR299C, Cyanidioschyzon merolae 
LmjF.08.1110, Leishmania major 
Eukaryota: 134 homologs 
TIHERM_OOOI3550, Telrahymena thermophila 
PF14_0324, Plasmodium falciparum 
STl l , Dictyostelium discoideum 
• Viridiplantae: 14 homologs 
LEGEND 
x1 branch length 
x 1 a branch length 
x100 branch length 
PITG_17013, Phylophthora infestans 
Gene 10 current gene 
Gene 10 within-sp. paralog 
• speciation node 
• duplication node 
• ambiguous node 
• gene split event 
I I II I •• 111 I ,. ,1 ,111 ,1 I I I 
•• III .,1 ,111 
1IlIII---'---1TTTI I I l-----rr 
.111 I I, I •• III 111111 I 
1.111 .,1 1111 
.1111111 111.111 '.111111 If 
.111111 1 I, II. III .,1 11 I I 
.111111'1'1' 11. 1II-1-----,--.111I11~-1____, 1 
.111111 r I' ll. III .,1 111 I 
.111111 1 I, II. III .,1 11 I I 
11111111 i'I'. III .,1111 I 
•• 11111 I I' II. III .,1 11 I I 
.III1I1T T II. m-I-----, ' .1.1I11-------,--. -----rr 
..11111 1 I' II. III .,1 11 I I 
.1111 III I II. III 1111111 If 
• •• 111. F II. III 111111 I 
- 1111 •• 111111 III. III .,1 1111 I I 
••• 11111111. III 11111111 II 
• •• 11111111.111 .11 111 11 II 
• •• flTllTlT1T __ 1II .11 II I II l-----n 
••• 11111 1 III. III .,1 11 I II 
.1.11111 I". III 111'1IH - IT 
•• III III fll II 
••• 11111 111., 111 .,1 1111 
•• 111 11 I 11 11.1111 .11111 I II 
• •• 1111 i'I'. III .,1 111 I 
I II ,.111,1 r 11 •• 1111 I I .,1111 I I I II 
••• 1111 1 1 •• 1111 .,1 1111 
,---------wl.rllllllfllllll-lil I I 1" nnr'1 I I I III 
I I 1111 ••• 111 I 11 11., 111 11111 I I 
.... collapsed sub-tree 
..... collapsed (current gene) 
.... collapsed (paralog) 
• AA alignment match/mismatch 
• AA consensus> 66% (mis)match 
• AA consensus > 33% (mis)match 
AA alignment gap 
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Appendix 5: Meme Results  
 
Section 1: Single Motif Search 
 
Meme Parameters: Full-length Protein, width 2-150, 1 motif search, multiple occurrences per 
sequence, all other parameters default. 
 
 
 
Figure A5.1: Motif 1 for single motif search 
 
Regex: 
Y[YF][QN]K[SA]L[TV]EH[RN][TN][PR][DE][TV][LR][TKN]KLR[EN][AL]E[KR]AK[KE
][KE][AE]E[RK]EAYI[DN]PE[KLE]AE[EK][AEH][RK]E[KL]GN[EKQ][KYF]F[KQ][EK][
GA][DK][FWY]P[GE]A[VK]K[AHE]Y[TD]E[AM][IT][KR]R[NA]P[DN]D[AP][KR][GL][
YF]SNRAA[AC][LY][TI]KL[ML][AE][FY]P[LSQ]A[LV][KQ]DC[DE][KE][AC]I[EK][LR]
DP[KT]F[IV][KR][AG]YIRK 
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Figure A5.2: MAST results for all sequences, for single motif search 
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Section 2: Five Motif Search 
 
Meme Parameters: Full-length Protein, motif width 2-150, 5 motif search, multiple 
occurrences per sequence, all other parameters default. 
 
 
 
Figure A5.3:  All motifs and scores 
 
 
Figure A5.4: Mast analysis for 5 motif search 
 
Motif Results: 
 
Figure A5.5: Motif 1 for 5 motif search 
 
Regex: 
Y[YF][QN]K[SA]L[TV]EH[RN][TN][PR][DE][TV][LR][TKN]KLR[EN][AL]E[KR]AK[KE
][KE][AE]E[RK]EAYI[DN]PE[KLE]AE[EK][AEH][RK]E[KL]GN[EKQ][KYF]F[KQ][EK][
GA][DK][FWY]P[GE]A[VK]K[AHE]Y[TD]E[AM][IT][KR]R[NA]P[DN]D[AP][KR][GL][
YF]SNRAA[AC][LY][TI]KL[ML][AE][FY]P[LSQ]A[LV][KQ]DC[DE][KE][AC]I[EK][LR]
DP[KT]F[IV][KR][AG]YIRK 
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Figure A5.6: Motif 2 for 5 motif search 
 
Regex: 
[ND]H[VI]LYSNRS[AG]AYA[SAK]L[GK][DK][YF]Q[KE]ALEDA[NE]K[CT][IVT][ES][I
L]KPDW[APG]KG[YW]SRK[GA]AA[LE]HGL[GR][DR][LY][DEL]E 
 
 
 
 
Figure A5.7: Motif 3 for 5 motif search 
 
Regex: 
[ND]H[VI]LYSNRS[AG]AYA[SAK]L[GK][DK][YF]Q[KE]ALEDA[NE]K[CT][IVT][ES][I
L]KPDW[APG]KG[YW]SRK[GA]AA[LE]HGL[GR][DR][LY][DEL]E  
 
 
 
Figure A5.8: Motif 4 for 5 motif search 
 
Regex: 
P[KT][DN]ITYL[NT]N[KI][AG]A[VA][YK]FE[KM][GK][DE]Y[DEQ][KG][CA]I[EA]TC[
EQ]KA[IV][ED][EV]GRENRAD[FY]KLIAK[AS][FY][AT]R[IL][GA][NT][ASC]Y[EQ]K 
 
 
 
Figure A5.9: Motif 5 for 5 motif search 
 
Regex: 
[LQ][VA][NL]E[LE]K[EN]KGN[KE][AC][LF][SQ][KA]G[ND][IY][DP][DQ]A[LM][QK][
CH]Y[ST]EAIK[LR][DN]P[KQ][ND][HA][KV]LYSNR[SA]A[AC]Y[AT]K[KL][GL][DE][
YF]Q[KL]A[YL][EK]D[GC][CE][KE][TC][VI][DQ]L[KE]P[DT][WF][GI]KGY[ST]RKAA
ALE[FA][LM][NK][RD][FY][ET][EK]A[KM][DR][TV]Y[EQ][EK][GA]L[KD][HL][ED][A
S][NS][NC][KP][QE][LA][KA][ED]G[LY]Q 
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Figure A5.10: Mast results for all sequences submitted to Meme for 5 motif search 
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Section 3: Multiple Motif Search 
 
Meme Parameters: Full-length Protein, motif width 2-150, 5, 10 and 20 motif searches, 
multiple occurrences per sequence, all other parameters default. 
 
 
Figure A5.11:  All motifs and scores from a 10 (top left), 15 (top right) and 20 (bottom) 
motif search. 
From Figure A5.11, it is obvious that the maximum amount of motifs that Meme finds is 11, 
so only one motif set (from the 20 motif search) was analysed further. 
 
Figure A5.12: Mast analysis for 20 motif search 
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Motif Logos: 
 
Figure A5.13: Motif 1 for 20 motif search 
 
Regex: 
Y[YF][QN]K[SA]L[TV]EH[RN][TN][PR][DE][TV][LR][TKN]KLR[EN][AL]E[KR]AK[KE
][KE][AE]E[RK]EAYI[DN]PE[KLE]AE[EK][AEH][RK]E[KL]GN[EKQ][KYF]F[KQ][EK][
GA][DK][FWY]P[GE]A[VK]K[AHE]Y[TD]E[AM][IT][KR]R[NA]P[DN]D[AP][KR][GL][
YF]SNRAA[AC][LY][TI]KL[ML][AE][FY]P[LSQ]A[LV][KQ]DC[DE][KE][AC]I[EK][LR]
DP[KT]F[IV][KR][AG]YIRK 
 
 
Figure A5.14: Motif 2 for 20 motif search 
 
Regex: 
[ND]H[VI]LYSNRS[AG]AYA[SAK]L[GK][DK][YF]Q[KE]ALEDA[NE]K[CT][IVT][ES][I
L]KPDW[APG]KG[YW]SRK[GA]AA[LE]HGL[GR][DR][LY][DEL]E 
 
 
 
 
Figure A5.15: Motif 3 for 20 motif search 
 
Regex: 
[AI][MQ]ADPE[IV][QM][QSA]I[LM][QS]DP[VAQ]M[QR]LIL[QE]Q[AM][QK][ES][DN]P
AA[LI][QS][ED][HY][ML]K[ND]PK[IV][AR]x[KG]I[QN]KL[IM]AAG[IVL][IL]R[ILV][G
R] 
 
 
Figure A5.16: Motif 4 for 20 motif search 
 
Regex: 
P[KT][DN]ITYL[NT]N[KI][AG]A[VA][YK]FE[KM][GK][DE]Y[DEQ][KG][CA]I[EA]TC[
EQ]KA[IV][ED][EV]GRENRAD[FY]KLIAK[AS][FY][AT]R[IL][GA][NT][ASC]Y[EQ]K 
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Figure A5.17: Motif 5 for 20 motif search 
 
Regex: 
[LQ][VA][NL]E[LE]K[EN]KGN[KE][AC][LF][SQ][KA]G[ND][IY][DP][DQ]A[LM][QK][
CH]Y[ST]EAIK[LR][DN]P[KQ][ND][HA][KV]LYSNR[SA]A[AC]Y[AT]K[KL][GL][DE][
YF]Q[KL]A[YL][EK]D[GC][CE][KE][TC][VI][DQ]L[KE]P[DT][WF][GI]KGY[ST]RKAA
ALE[FA][LM][NK][RD][FY][ET][EK]A[KM][DR][TV]Y[EQ][EK][GA]L[KD][HL][ED][A
S][NS][NC][KP][QE][LA][KA][ED]G[LY]Q 
 
 
 
 
Figure A5.18: Motif 6 for 20 motif search 
 
Regex: 
KPSDLGTKLQDPR[IV]MTTLSVLLGVDLGSMDEEEE[VAI]ATPPPPPPPKKE[TP]KPEP
MEEDLPENKKQALKEKELGN[DE]AYKKKDFD[TK]ALKHYD[KR]AK[ED]LDPTNMT
Y[IM]TNQAAV[YH]FEKGDY[NG]KCRELCEKAIEVGRENREDYRQIAKAYARIGNSYF 
 
 
Figure A5.19: Motif 7 for 20 motif search 
 
Regex: 
[DP][PE][DNE][LV][FIK][QR][KR][LA][AM][SA][DN]P[KER][TV][SQ]Q[LI][LM][SA]D
P[ADE][FYM][MRV][AL][KI]L[EQ]Q[LIM][QK][KQ][ND]P 
 
Figure A5.20: Motif 8 for 20 motif search 
 
Regex: 
D[AKE][EL]K[EK][LK]GN[AED][AF][YF]K[KA]K[DQ]F[DE][ET]A[IL]EH[YF]TKA[IW
]EL 
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Figure A5.21: Motif 9 for 20 motif search 
 
Regex: 
AHD[AT]YE[EK][GA]LK[LV]DP[NS]N[EA][QE][LCA]K[ED]GLNR[VC]KR[AK]I 
 
 
Figure A5.22: Motif 10 for 20 motif search 
 
Regex: 
[EM]AD[EA]LK[AE][EK]GN[KE][AL][FY][KS][AQ][KG][KD][FY][ED]EA[ILV][KE]K[
YF][TS][EKQ]AI 
 
 
Figure A5.23: Motif 11 for 20 motif search 
 
Regex: 
[EH][LM][KQ][DN]P[RV][FIV][LMA][QT][VTK][LMI][SGQ][VK]L[LM][GD][VI][DG][L
M][SI][FA] 
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Figure A5.24: Mast results for all sequences submitted to Meme for 20 motif search 
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Appendix 6: Pairwise Alignments for HsHop, PfHop and ScHop 
 
Figure A6.1: Pairwise alignment of ScHop with PfHop, produced in Jalview. 
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Figure A6.2: Pairwise alignment of ScHop with HsHop, produced in Jalview. 
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Figure A6.3: Pairwise alignment of HsHop with PfHop, produced in Jalview. 
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